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SUMMARY
This thesis is concerned with various aspects of animal 
trypanosomiasis in Somalia, with the objective of highlighting 
the need for further research and study. Some of the results 
described in this thesis constitute the first preliminary work on 
animal trypanosomiasis in Somalia.
The thesis consists of four chapters. The first is a 
general introduction and review of trypanosomiasis. In the 
review the different species of pathogenic trypanosomes are 
described together with clinical signs they cause in different 
species of domestic livestock. Particular emphasis is given to 
the main species of Trypanosoma found in Somalia, namely 
T. congolense, T. vivax and evansi. In Somalia, as in most 
African countries, there has been heavy reliance on use of 
chemotherapeutic and chemoprophylactic drugs to control 
trypanosomiasis. The various drugs are described and the 
advantages and disadvantages of their use are discussed. One 
important potential problem is the presence of drug-resistant 
strains of trypanosomes and this aspect is considered in greater 
detail later in the thesis.
The second chapter deals with a survey of cattle 
trypanosomiasis along the two main rivers in Somalia, namely the 
Jubba and the Shabelle. The survey encompassed the use of both 
questionnaires and clinical examinations, including blood 
sampling of individual animals. The survey's questionnaire asked
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the animal owners various aspects of herd health with particular 
reference to trypanosomiasis and the availability and utilisation 
of the various available trypanocidal drugs in the field. A 
total of 4,152 cattle in 54 herds were examined. There was an 
overall infection level of 10% and the incidence of T. congolense 
infection showed a significantly increasing trend with the level 
of tsetse challenge, while the incidence of T. vivax did not show 
this trend. However, there was no evidence of mechanically 
transmitted T. vivax infection occurring outside the tsetse belt. 
The results of this survey showed that trypanosomiasis is 
widespread along the tsetse-infested riverine areas of Somalia 
and is regarded as a major animal health and production problem 
by the cattle owners.
The control of cattle trypanosomiasis in Somalia has 
essentially depended upon the two trypanocidal drugs, 
isometamidium chloride and diminazene aceturate. However, there 
have been persistent rumours that drug resistant strains of 
T. congolense exist in Somalia, although this has never been 
clearly demonstrated.
Chapter Three describes how two drug resistant strains of 
T. congolense were isolated from the lower Shabelle region. In 
the study a trypanosome-naive calf was transported into each 
study area and inoculated with blood from local cattle infected 
with T^_ congolense. It was then kept in isolation and when a 
parasitaemia developed it was treated with a standard dose of 
isometamidium chloride (0.5 mg/kg) and continually monitored for
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the development of a relapse infection. The development of such 
an infection was taken to be indicative of the presence of a 
drug-resistant strain of congolense and blood was taken at 
this time and injected into groups of calves, goats and mice for 
subsequent trials to determine the level of drug resistance. 
Using these relatively unsophisticated techniques it was possible 
to demonstrate the existence of drug-resistant strains of 
T. congolense from the two sites in Somalia. Both strains were 
highly resistant.
A possible method of treatment for drug-resistant strains of 
T. congolense was investigated in Section II of Chapter Three, 
using intravenous as opposed to intramuscular administration of 
isometamidium chloride. Following the administration of 
isometamidium by these two routes to goats infected with a 
Samorin-resistant strain of T. congolense it was found that the 
intravenous administration of isometamidium offered no clear 
advantage over intramuscular administration.
Nevertheless, drug levels as measured by a newly developed 
ELISA assay for isometamidium indicated that by four hours post 
injection, intravenous administration did result in higher blood 
concentrations of isometamidium than intramuscular 
administration.
Chapter Four, Section I, presents studies on the 
chemotherapy of T^_ evansi infections in mice.
Sensitivity tests of two stabilates, T. evansi GRVPS 13 and 
T. evansi GRVPS 19, to six trypanocidal drugs (quinapyramine
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sulphate/prosalt, isometamidium, diminazene aceturate, 
melarsoprol, DFMO and suramin) produced varying results. 
T. evansi GRVPS 13 which was known for its high degree of 
suramin-resistance was resistant to the maximum dose of suramin 
(160 mg/kg). But this strain was sensitive to all the other 
drugs. The isolate GRVPS 19 was resistant to diminazene 
aceturate but was sensitive to all the other drugs.
In a similar way, studies of the chemotherapeutic activity 
of a new arsenical drug Mel Cy and Trimelarsan (Mel W) against 
early and late infections of T. evansi GRVPS 13, indicated high 
sensitivity of this suramin-resistant strain to these two drugs. 
However studies of the prophylactic activity of Mel Cy against 
T. evansi GRVPS 13, infections failed to demonstrate any 
protection beyond three days.
In Section II the therapeutic activity of Mel Cy at a dose 
rate of (0.25 mg/kg) was examined in goats infected with 
T. evansi. Following treatment microscopic examination of the 
goats' blood failed to detect parasites, however, blood collected 
from the goats 30 days after treatment and subinoculated into 
irradiated mice revealed the presence of trypanosomes, indicating 
that this dose of drug was not curative.
Finally, when irradiated and normal groups of mice were 
infected with either T  ^evansi GRVPS 13 or T. evansi GRVPS 19 and 
treated with increasing doses of isometamidium it was shown that 
a significant decrease in drug sensitivity could develop.
Furthermore, the results of this experiment showed that under 
laboratory conditions, the development of drug-resistance could 
be promoted more readily in immunosuppressed mice than in normal 
animals.
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CHAPTER ONE
GENERAL INIKXOCTrCN AND REVIEW
1
The Parasite
The disease caused by pathogenic trypanosomes first 
attracted the attention of investigators during the latter part 
of the 17th century and the main landmarks of the early work have 
been compiled by Hoare (1972) in his excellent monograph on the 
mammalian trypanosomes.
Parasitic organisms of the Family Trypanosomatidae are found 
in domestic and wild game throughout the world (Hoare 1972). The 
classification of trypanosomes has been discussed in different 
reviews by Hoare (1957a, 1964, 1966, 1970). Trypanosomes are 
members of the Order Kinetoplastida, Family Trypanosomatidae and 
Genus Trypanosoma (see Table 1). The Genus is subdivided into 
two sections; the Stercoria and Salivaria, on the basis of the 
site of development of the organisms in the insect vector that 
transmit them.
Stercoria trypanosomes develop in the hind gut of biting 
insects, following ingestion of a parasitised blood meal, and 
infection is transmitted to new hosts by faecal contamination of 
any superficial wound. This section comprises a heterogenous 
assemblage of a large number of non-pathogenic micro-organisms 
(e.g. T^_ theileri, T. musculi, T. lewisi, T. cruzi). T. cruzi, 
the only pathogen in this section, is an important parasite of 
man in South and Central America. It is transmitted by reduviid 
triatomine bugs.
The Salivarian trypanosomes, which are more homogenous, 
contains several species of trypanosomes of medical and 
veterinary importance. They are, in general, transmitted by 
different species of Glossina (tsetse) flies. The cyclical
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development of Salivarian trypanosomes is completed in the 
salivary medium of the anterior station of the insect host, hence 
their transmission is inoculative. Conventionally, the 
Salivarian trypanosomes are grouped under four subgenera 
accordingly to their morphological and biological similarities.
(1) Subgenus Duttonella which is represented by 
T. (Duttonella) vivax and (Duttonella) uniforme.
(2) Subgenus Nannomonas containing (Nannomonas) congolense 
and (Nannomonas) simiae.
(3) Pycnomonas is the least represented and has only one 
species, (Pycnomonas) suis.
(4) Subgenus Trypanozoon, contains five species, viz.
T. (Trypanozoon) brucei brucei,
T. (Trypanozoon) brucei rhodesiense,
T. (Trypanozoon) brucei gambiense,
T. (Trypanozoon) evansi, and 
T. (Trypanozoon) equiperdum.
T. rhodesiense and gambiense are human trypanosomes while the 
other three are responsible for animal trypanosomiasis.
The last subgenus has considerable medical and veterinary 
importance and it seems to be in the midst of rapid evolution 
(Baker, 1969) making it difficult for systematists to divide it 
up neatly into distinct species. T. evansi and T. equiperdum are 
not cyclically transmitted while the remaining other three 
species are cyclically transmitted by Glossina species. 
Nevertheless it is now regarded by many that these two latter 
trypanosomes may be regarded as T. (Trypanozoon) brucei evansi and
T. (T. )b.equiperdum which have evolved from T.b.brucei.
The animal trypanosomiases caused by congolense, T. vivax 
and T.b.brucei are generally known by the name, 'Nagana' in 
Africa, south of the Sahara whilst 'Surra' is caused by 
T. evansi in North Africa and Asia, and 'Dourine', due to 
T. equiperdum.
Whilst, in the course of infection there are differences 
among trypanosome species (Losos and Ikede, 1972; Maxie, Losos 
and Tabel, 1979), there is also an underlying similarity in the 
pathogenesis of trypanosomiasis.
The problems imposed by animal and human trypanosomiasis in 
Africa are immense and well documented (Hoare, 1970). It is 
estimated that most of the fertile land in Africa is held captive 
by tsetse flies and the trypanosomes which they transmit (Wilson, 
Morris, Lewis and Krog, 1963). In Somalia, for example, the 
tsetse infested zone is along the two rivers Shabelle and Jubba. 
This area is a fertile and productive zone, but the tsetse fly 
had prohibited development of mixed farming in that area.
The importance of African trypanosomiasis has been 
recognised for many years (Harris, 1921; Bruce, 1895), yet the 
disease remains endemic in the animal and human populations 
across vast expanses of Africa. Evans (1881) described 
trypanosomes (T^  evansi) in the blood of Indian camels and 
equines. In 1895, Bruce reported the pathogenic organism, 
Trypanosoma brucei in livestock and showed that the disease could 
be transmitted by tsetse flies. However, there is still a lack 
of concise data relating to the occurrence of trypanosomiasis in
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both human and animal populations (Henson and Noel, 1979). There 
is often an underestimate of unknown magnitude since many of the 
countries where the disease is endemic do not have available the 
accurate data necessary for determining the concise occurrence 
and distribution of the disease.
The disease is seen in many forms from peracute to 
subclinical, in all hosts. There is an acute phase of the 
disease soon after infection, when a slight pyrexia usually 
occurs before trypanosomes are detectable in the blood. Pyrexia 
is more severe after trypanosomes are established in the blood 
stream or tissues of the host within three to twenty or more days 
after inoculation. In extreme cases, the host animal may die 
within a few days of infection, with no obvious signs of disease 
except those associated with pyrexia.
Host-para site relations
The severity of the disease varies according to the degree 
of susceptibility of the hosts, strain of parasite and local 
epizootiological conditions. Although tsetse transmitted 
trypanosomiasis is regarded as most important in cattle, other 
species of domestic livestock can also be affected. Horses are 
very susceptible while sheep and goats are known to be 
susceptible under laboratory conditions, although the incidence 
of natural infection appears to be less than that of cattle.
T.congolense and T.vivax
Soon after the causation of trypanosomiasis was established, 
it was recognised that these two parasites were chiefly 
responsible for the death of cattle from the disease. For many 
years before the advent of effective trypanocidal drugs, T. vivax
was the most common pathogenic trypanosome in West Africa 
(Unsworth, 1953; Momet, 1954), while T. congolense caused more 
damage to livestock in East Africa (Ford, 1971). However, with 
the widespread use of drugs in the years up to the 1939-1945 war, 
there was some evidence that the relative prevalence of the major 
species of pathogenic organisms changed. After long observation, 
Killick-Kendrick and Godfrey (1963) suggested that homidium, 
widely used in northern Nigeria was more effective against 
T. vivax than T^ congolense and therefore reduced the prevalence 
of the former in the cattle population faster than the latter. 
The use of quinapyramine in East Africa probably favoured the 
survival of T. vivax (Ford, 1964).
Preliminary investigations revealed that there was some 
evidence for the existence of separate morphologically 
identifiable strains of varying pathogenicity within the species 
(Fairbairn, 1953; Lewis, 1954). Godfrey (1961) showed that 
similar variations existed with T^ _ congolense and he 
distinguished longer, more virulent and shorter less virulent 
strains.
The virulence of different strains of the same species may 
vary considerably in similar conditions of infection. Krampitz
(1970) gave an example of the variable response of cattle to the 
same strain of T. congolense, when acute and chronic infections 
were induced by similar infecting doses of trypanosomes. 
T. vivax in West Africa is often very virulent causing acute 
disease in cattle (Unsworth, 1953), while in East Africa this 
species is generally of lower pathogenicity (Hudson, 1944).
7
Trypanosomiasis in sheep and goats has received relatively 
little attention, but results from experimental infections 
indicate that they are susceptible to all the common tsetse 
transmitted pathogenic trypanosomes including T. simiae. Opasina 
and Onyeka (1982) reported studies on the incidence of 
trypanosomiasis in West African dwarf sheep and goats in South 
West Nigeria. Of 44 sheep and 38 goats monitored, 18% and 34% 
respectively were positive forvtrypanosomiasis, due predominantly 
to vivax infection. In Somalia, the species of trypanosomes 
which are naturally pathogenic for ovine and caprine are 
T. vivax, T. congolense and brucei (Di Domizio, 1925; Croveri, 
1936).
In a review of trypanosomiasis in sheep and goats, Griffin 
(1978) indicated that many of the accounts of naturally occurring 
trypanosomiasis in sheep and goats came from East Africa and were 
caused by congolense. Studies on the economic effects of 
natural congolense infection in sheep and goats in Kenya 
indicated significant financial losses in both species over a 35 
week period (Griffin and Allonby, 1979a).
Early reports have mentioned congolense in camels 
(Broden, 1906; Leese, 1933). The fact that camels are highly 
susceptible to simiae, which has some characteristics in 
common with the congolense organism, may indicate that the 
dromedary would also be quite susceptible.
T. brucei
Camels are highly susceptible to infection with Tt_ brucei.
Horses, donkeys and mules are also susceptible to infection 
with T^_ brucei and death occurs within a fortnight to three
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months if the animals are untreated (Stephen, 1970). brucei 
is usually an acute disease for dogs and if untreated almost 
invariably ends fatally. In T^ brucei infections of ruminants 
the parasitaemia is often low. Cattle in all regions of tropical 
Africa exhibit a degree of resistance to brucei and while 
infections can become established in cattle, clinical signs of 
disease are seldom observed, even when there is high 
parasitaemia. Exotic breeds, however, are much more susceptible 
(Stephen, 1970).
According to Bradford and Plimmer (1902) the pig shows 
T. brucei in the blood very rarely and in very small numbers. 
Laveran and Mensil (1912) have described the course of infection 
in a piglet experimentally inoculated with T^_ brucei. The animal 
lived for 94 days and during the first half of the infection no 
signs of illness were seen. Thus it appears that experimental 
infections with T. brucei in pigs run a chronic course. Stewart 
(1935) observed that when pigs were challenged by tsetse flies 
known to be infected with T^ congolense, T. vivax and T^_ brucei 
they only developed an infection with T. brucei.
Van Hoof (1947) reported a natural infection of T. brucei in 
the pig and commented that such occurrences were exceptional. He 
further stated that the blood was positive only at rare 
intervals, and that spontaneous cures occurred between one year 
and 15 months.
T. simiae
Various authors have observed that T. simiae produces a very 
acute disease with high parasitaemia in the pig (Isoun, 1968; Van
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Dijk, Zwart and Leefland, 1973; Janssen and Wijers, 1974), and 
possibly in previously uninfected warthogs (Roberts, 1971).
Of all the pathogenic trypanosomes found in Somalia, 
T. simiae was the only one which could not be experimentally 
transmitted to cattle (Pellegrini, 1948). In addition Roberts
(1971) appears to have demonstrated quite conclusively that 
cattle are not susceptible to infection by simiae. Earlier, 
Di Domizio (1929) reported that the camel in Italian Somaliland 
(Somalia) was highly susceptible to T. simiae and this was later 
confirmed by Pelligrini (1948) who described the disease in the 
dromedary as being hyperacture, and in his opinion the camel was, 
after the pig, the most susceptible animal to T. simiae infection 
whether by fly or syringe transmission.
T, evansi
Surra affects a wide range of diverse mammalian species, 
including equines, bovines, dog, elephant, deer etc., but the 
camel is its principal host. It is interesting to note that two 
other species of the family Camildae (Lama pasos - the alpaca, 
and Lama glama - the llama) are not affected. Cattle are 
slightly affected by Surra and horses appear to be refractory, at 
least in Somalia and Northern Kenya (Hoare and Bennet, 1939). 
However, in North Africa camels and horses are thought to be 
equally susceptible. In the absence of camels, horses are the 
principal hosts of Surra.
However, in India camels were found to be the most 
susceptible to Surra followed by equines and bovines (Srivastava, 
1973).
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Hoare (1956) suggested that there is evidence that the mean 
lengths of equine strains of T^_ evansi increase progressively 
from Western Morocco to the East Philippines. It would seem that 
this graduation is correlated with the pathogenicity of the 
equine strains, which could explain why the disease of horses in 
East Africa is apparently symptomless but extremely acute and 
fatal in Indochina and the Philippines.
Mohan (1968) reviewed the literature related to Surra in 
buffaloes and cattle in the Far East and stated "the infection is 
generally latent or subclinical in buffaloes as more important 
reservoir hosts than cattle". The authors survey indicated that 
Surra is prevalent and widespread throughout India, Indonesia, 
Philippines, Indochina, Thailand and Taiwan.
In U.S.S.R., Petrovski (1974) was unable to observe any 
appreciable difference in Surra infections between camels, 
equines and dogs, but Kunichkin and Eskaliev (1975) reported a 
severe outbreak of T^ evansi in Kalakhstan which killed many 
infected camels and caused abortions to many pregnant and 
infected female camels. It would appear that the effect of the 
parasite varies from region to region and depends also on the 
observer.
In North Vietnam, buffaloes were reported to be highly 
susceptible (Wells, 1982) with a very high mortality.
Transmission of Trypanosomes
Trypanosomes are fascinating parasites which possess a 
considerable capacity for adapting to inhospitable environments 
(Clarkson, 1980).
It is widely accepted that different species of tsetse flies
(Glossina spp) can transmit several species of the Salivarian 
trypanosomes.
After the tsetse fly selects a site on the host, it 
disengages the labium from between the palps. The freed labium 
is directed to the skin of the host and immediately after 
penetration the vector starts to feed. During the process of 
feeding a relatively minute jet of saliva is being intermittently 
discharged from the tip of the hypopharynx and this saliva 
prevents the clotting of the blood. If the fly is infected, 
infective metacyclic trypanosomes injected with the saliva will 
be distributed in the haemorrhagic areas and in the intervening 
tissues. Some may enter directly into the lumen of torn 
capillaries. The metacyclic trypanosomes will undergo a period 
of adaptation from the poikilothermic environment of the fly to 
the relatively homeothermic conditions in the host.
Gray and Roberts (1971b) transmitted T. vivax from sheep to 
sheep using G^ morsitans and G^_ tachinoides which had emerged 
from pupae in the laboratory, and the infection rate in both 
species of flies was 80%. Whitnall (1932) studied trypanosome 
infection rates of wild caught flies of G. pallipides. The ratio 
of T. vivax : T. congolense type infections was 1.8 : 1. This 
account is interesting because in Somalia the ratio of 
T. vivax : T^ _ congolense in infected animals of the survey on 
cattle trypanosomiasis (see later section) was similar. It also 
indicates that G^ pallipides is probably the vector of vivax 
in the surveyed area.
Using data from all sources of information available to him,
including his own studies, Jordan (1961) reported that a large 
number of different species of Glossina, each with its own 
individual characteristics, is capable of permitting the cyclical 
development of both congolense and vivax to some stage of 
maturity.
Harley (1966) reported that the majority of trypanosome 
infections, at all seasons, in G^_ pallidipes were of the 
T. vivax-type, T. congolense-type were much less common, and 
those of brucei-type were very rare. In case of 
G. brevipalpis, Harley (1 966) reported that T. congolense 
infections although low were relatively constant and occasionally 
higher than T. vivax, and T. brucei were very rare. It is known 
that G. brevipalpis takes a large part of its diet from bush pig 
(Weitz, 1970).
In their experimental studies Wilson, Dar and Paris (1972) 
reported that G. fuscipes appeared to be a more common vector of 
T. vivax to cattle than Gu_ pallidipes, and that G^ pallidipes was 
a much better transmitter of T. congolense than G. swynnerton.
Many workers (Desowitz and Watson, 1953; Stephen and Gray, 
1960; 1961; Stephen, 1962) have mentioned that pigs can be 
infected with simiae by the bites of G^_ morsitans sub- 
morsitans. Later Roberts and Gray (1972) also reported that wild 
caught G.m.sub-morsitans produced simiae infections in pigs. 
An absolute proof that G. tachinoides was capable of transmitting 
T. simiae was provided by Roberts (1971), after feeding G.m.sub- 
morsitans and G. tachinoides, which had emerged from puparia, on 
sheep and pigs.
In the pleomorphic trypanosomes the relationship is much
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less clear. The extremely low parasite infection rates found in 
the field allow little opportunity for comparisons to be made. 
However, in his experimental work Duke (1930) failed many times 
to transmit T^_ gambiense by cyclically infected (L_ palpalis, 
likewise Carson (1932) also failed to transmit T. rhodesiense by 
G. palpalis, in East Africa. However, in contrast to the latter 
worker, Van Hoof, Henrard and Peel (1937) successfully 
transmitted gambiense cyclically from man to various pigs and 
back to man by G. palpalis.
A series of experiments carried out by a number of workers 
(Wilson et al, 1972; Moloo, 1973; Lewis and Langridge, 1947) 
suggested that T. rhodesiense readily establishes infections that 
proceed to the stage where metacyclic trypanosomes occur in the 
saliva in G^ morsitans, G. palpalis, and Gu_ pallidipes in East 
Africa. T. gambiense on the other hand is capable of developing 
cyclically in G^ palpalis, but there is little experimental 
evidence that Gu_ tachinoides is a particularly suitable vector 
and G^ morsitans sub-morsitans in West Africa may be refractory. 
In his experimental studies Jordan (1965) postulated that most 
T. brucei infections were the result of heavy fly challenge by 
G.m.sub-morsitans. This experiment supports the idea that 
T. brucei (Stephen, 1966) develops readily in G.m.sub-morsitans.
In contrast to the above mentioned tsetse transmitted 
pleomorphic trypanosomes, there are other groups of trypanosomes 
which have lost their tsetse fly transmissibility. This 
phenomenon is illustrated by Trypanosoma evansi and 
Trypanosoma equiperdum. These two species of trypanosomes are
14
widely distributed throughout the world, beyond the limits of the 
tsetse fly.
In evansi no cyclical transmission occurs and the 
infection is transmitted between hosts by mechanical transmission 
effected by biting flies, particularly horseflies (Tabanus) and 
stable flies (Stomoxys). This method of dissemination depends on 
the movement of a fly with trypanosome-contaminated mouthparts to 
a new host within a short time, so the parasites in the 
mouthparts remain infective. Such transmission depends on an 
interrupted feed as it is necessary for the fly to continue to 
probe and feed when it has moved to another host. Thus the 
shorter the interval between feeds or attempted feeds, the 
greater the chance of transmissions. The abundance of tabanids 
is also important and there is an apparent link between these 
biting flies and the seasonal occurrences of outbreaks of 
T. evansi in camels both in Sudan (particularly Tabanus taeniola) 
and in Somalia.
Although feeding preferences of those species which may 
convey Surra seem to have escaped attention, it appears that some 
of them prefer some host species over others. In the presence of 
camels these flies will not attack sheep or goats and prefer to 
puncture the thick skins of camels, equines and bovines.
During the heat of the day, the animals crowd together under 
the shade of the trees, the tabanids swarm on them and keep up a 
perpetual motion thus creating extremely favourable conditions 
for mechanical transmission (Hornby, 1952).
In Somalia, Pangoma species of fly are the agents of 
transmission (Peck, 1936) and it appears that the prevalence of
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T, evansi infections is highest during the two rainy seasons, 
(April-June) and (October-December) which correspond to the 
highest density of the population of a biting fly known locally 
as "Dhug" which is believed to be the main transmitter of Surra.
Donatien and Lestoguard (1923) observed that dogs in stables 
occupied by infected camels became infected through the bites of 
Stcmoxys.
The possible role of ticks was first investigated by Cross 
(1923) who transmitted T. evansi from camel to rabbits by means 
of Ornithodoros crossi and 0^ labrornsis. Another two authors 
Kirmse and Taylor-Lewis (1978) using the same species of tick 
that Cross used, recorded that ticks are not efficient 
transmitters of evansi. In contrast to the other findings 
Kasim (1984) has isolated T. evansi from Saudi Arabian camels and 
incriminated the transmission of the disease by adult 
Hyaloma anotoliathm.
The vampire bat (Desmodus rotundus) of the American tropics 
is another vector of Surra trypanosomes.
The undoubted efficiency of vampire bats had overshadowed 
the role played by haematophagous arthropods of America. In his 
studies Dunn (1932) showed that vampire bats (Desmodus rotundus) 
could become infected with evansi by feeding on infected 
animals, such as horses, mules and guinea-pigs. Later Clark and 
Dunn (1933) stated that the incubation period in the bat is six 
or eight days. This author also stated that if unmolested the 
bats feed for one to two hours, voiding urine at frequent 
intervals. This system of consuming large quantities of blood
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enables the bat to imbibe trypanosomes from even a lightly 
infected host.
Moreover, Wells (1984) considers that, after feeding on 
infected blood, bats may contract the disease which may last up 
to one month before spontaneous recovery or carrier status 
results. The trypanosomes taken in with the infected meal 
penetrate the oral mucosa and cause a generalised blood infection 
and then return to the buccal cavity where they are subsequently 
transmitted in the saliva.
Direct transmission is also probable through skin abrasions 
or bites in camels (Leese, 1927). This sort of transmission 
could possibly occur between old male camels which usually fight 
for territorial integrity. In addition carnivores can be 
infected by consuming the blood and tissues of diseased animals 
which have died from the disease through lesions of the skin or 
mucous membranes (Hutyara and Marek, 1938; Dejesus, 1951). 
Recently Raina, Rakesh Kumar, Rajora, Sridhar and Singh (1985) 
have conducted an attempt to transmit T. evansi orally in dogs 
and mice by allowing them to feed on infected meat and blood. 
The findings of the authors demonstrated the possibility of oral 
transmission of T. evansi in both these species. These authors 
concluded that beside the hypothesis of regarding the entry of 
organisms through breaks in the buccal mucous membranes there may 
also be the possibility of tissue invasion by T. evansi.
Direct transmission to the foetus in pregnant camels was 
reported by Sergent, Sergent and Lhertier (1919) and Sergent, 
Sergent and Donatien (1920) especially during the acute phase of 
the infection when circulating parasitaemias are maximal.
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Compared to other trypanosome species, T^_ equiperdum is a 
specific and unique trypanosome of equines. The organism shows a 
remarkable tropism for the mucosa of the genital organs, the 
subcutaneous tissues and the central nervous system.
Dourine is transmitted from the stallion to the mare or from 
mare to stallion during the act of copulation, and so far as is 
known no other natural means of transmission exists.
The mode of transmission of Dourine may be more complex than 
is generally thought even amongst equines. Blood obtained from a 
horse infected with Dourine equiperdum) rarely produces 
disease when injected into healthy subjects according to Watson 
(1920) unless it is taken during a very active stage early in the 
infection. In a more recent study Barrowman (1976) attempted to 
transmit trypanosomes from naturally infected horses to rats and 
rabbits, in citrated whole blood, in the eluate from an ion 
exchange column, and in cerebrospinal fluids containing 10 to 40 
trypanosomes per ml without success.
In South America strains of T^ vivax have lost the ability 
to develop in tsetse, and there is evidence that even in Africa 
in areas beyond the tsetse belt, the trypanosome develops poorly 
or not at all in flies that are considered to be good vectors. 
Pathogenesis of trypanosane infections in domestic animals
Generally, the pathological changes subsequent to 
trypanosome infections and the underlying causes have not been 
fully elucidated and many aspects remain controversial (Moulton, 
Coleman and Thompson, 1974). One reason for the controversy is 
possibly the wide variety of diseases caused by different
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trypanosomes. The precise nature of each disease depends not 
only upon the species of host but also upon the particular strain 
of trypanosome involved (Losos and Ikede, 1972) and in each case 
there may be acute, subacute and chronic forms. This is well 
illustrated by the differences in virulence for susceptible hosts 
which are found with the different strains of the same parasite 
(Fiennes, 1950a). Despite this variability many of the fundamental 
pathological processes in the various forms of animal 
trypanosomiasis appear to be similar (Fiennes, 1970; Moulton 
et al, 1974).
Despite considerable study, it is still not clear exactly 
how the trypanosomes injure their hosts and the cause of death in 
many cases remains an enigma. Various theories concerning the 
mechanism by which pathogenic trypanosomes damage their hosts 
have been proposed. These include toxin production, 
hypoglycaemia, vascular spasm, agglutination of parasites in the 
blood vessels and vascular change (Kliger, 1929; Andrew, Johnson 
and Dormal, 1930; Hoppe and Chapman, 1947; Boreham and Goodwin, 
1967; Goodwin, 1974).
However, in his studies, Von Brand (1951) discussed several 
theories as to how the trypanosomes may affect metabolism of the 
host tissues, although he concluded that anaemia due to 
erythrophagocytosis was the most important factor. According to 
several reports, there may be an immunological basis to the 
disease. At each crisis parasites are destroyed in massive 
numbers and the host is permeated with dead trypanosome protein 
which may act as anaphylactogen (Ormerod, 1970).
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On the other hand, brucei also releases intracellular 
proteases which are potent inducers of blood coagulation and 
platelet aggregation (Steiger, Opperdoes and Bontemps, 1980; 
Lonsdale-Eccles and Mpimbaza, 1986). Very recently Nwagwu, 
Okenu, Olusi and Molokwu (1988) observed in infected mice an 
extracellular protease released by T. brucei.
It has also been hypothesised that antigen-antibody (Ag-Ab) 
complexes formed between successive variants and their specific 
antibodies could produce pathological manifestations similar to 
those seen in immune-complex diseases such as systemic lupus 
erythema and chronic serum sickness (WHO, 1977). Moreover 
Tizard, Hay and Wilkie (1978) explained that it is only 
relatively recently that the disease caused by the parasite has 
been extensively studied with relatively sophisticated 
techniques. It is now realised that the diseases caused by 
different trypanosomes, although they have certain features in 
common tend to be highly variable and possibly differ widely in 
their pathogenesis. In his studies Urquhart (1980) based the 
pathogenesis of trypanosomiasis on three main factors, (a) 
anaemia, (b) tissue lesions such as myocarditis and myositis and 
(c) immunosuppression. There is increasing evidence to support 
the view that anaemia, a common feature of all trypanosome 
infections, may be immunologically mediated (Assouku, 1975; 
Jennings, 1976; Holmes, 1983).
Anaemia
Anaemia is recognised as the most significant factor in the 
disease process in naturally occurring and experimentally induced 
animal trypanosomiasis (Murray, 1974). The anaemia can be
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divided into three types depending on (1) the species and numbers 
of parasites, (2) response to trypanocidal therapy (3) the 
clinical and pathological findings (Fiennes, 1954; Naylor, 1971; 
Losos, Paris, Wilson and Dar, 1973; Wellede, Duxbury, Sadun, 
Lanbehn, Lotzsch, Deindl and Warui, 1973).
The anaemia in hyperacute cases generally associated with 
T. vivax infection has an extremely rapid onset and is very 
severe. The anaemia in these cases results from widespread 
haemorrhages and haemolysis. Death usually occurs within a few 
days.
The onset and severity of anaemia associated with the 
acute/subacute forms of trypanosomiasis is directly related to 
the development and the level of parasitaemia. During this stage 
of the infection the anaemia is haemolytic and is usually 
normochromic and normocytic (occasionally macrocytic) in type 
(Murray, 1979; Valli, Forsberg and McSherry, 1978). The anaemia 
in this form of trypanosomiasis usually responds rapidly to 
treatment with trypanocidal drugs (Holmes and Jennings, 1 976). 
In cattle which remain infected for several months, it may pass 
into a chronic form of anaemia. This form has not been 
adequately investigated under experimental conditions but is 
reported to be associated with low or absent parasitaemia. An 
important characteristic of this form of trypanosomal anaemia is 
that it persists despite the apparent absence of parasites and 
affected animals usually respond very poorly to trypanocidal 
therapy (Morrison, Murray, Sayer and Preston, 1981).
Assouku (1 975) suggested that anaemia due to evansi has
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an immunological basis. Other reports of trypanosome infections, 
such as T. brucei in mice and rabbits (Herbert and Inglis, 1973; 
MacKenzie and Boreham, 1971; Jenkins et al, 1980), T. congolense 
in sheep (MacKenzie and Cruikshank, 1973) and rhodesiense in 
rats (Rickman and Cox, 1979; 1980) have provided some evidence of 
immunological mechanisms as the probable cause of the 
accompanying anaemias of the respective trypanosome infection.
On the other hand, Fiennes (1954; 1970) attributed the 
development of anaemia to reduced red cell synthesis in cattle 
trypanosomiasis, Dargie, Murray, Murray, Grimshaw and McIntyre
(1979) suggested that dyshaemopoiesis may be a complicating 
factor in the long-standing infections.
Initial investigations of the pathogenesis of the 
trypanosomal anaemia employing radioisotopic techniques were 
conducted by Jennings, Urquhart and Murray (1972) in rodents 
infected with T. brucei. A similar study was later carried out 
by Mamo and Holmes (1975) in Zebu cattle experimentally infected 
with congolense. The results from these studies strongly 
indicated that the anaemia in trypanosomiasis is due to 
accelerated cell loss. Despite the use of radiolabels in 
trypanosomal anaemia, the cause of this red cell loss is still a 
subject of considerable debate (Holmes, 1983). Several authors 
have claimed that haemodilution is important in the aetiology of 
the anaemia seen in trypanosomiasis. Fiennes (1954) was one of 
the first to suspect this condition in animal trypanosomiasis. 
He reported the development of hydraemia, or haemodilution by a 
vital-red dilution technique. It was stated that in vivax 
infections the plasma volume was expanded, but total blood
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volumes were unaltered because of decreases in the number of 
circulating red cells (Rees and Clarkson, 1967; Clarkson, 1968). 
Later, markedly expanded plasma and normal total red cell volumes 
were reported (Naylor, 1971; Holmes and Jennings, 1976) after 
studying calves infected with T. congolense.
Destruction of red blood cells
The exact mechanism in which aged red cells are removed from 
the circulation is not exactly known. It appears however that 
the main modes of red cell destruction in health probably results 
from changes in the physiological properties of the surface 
membrane (Schalm, Jain and Carroll, 1975). Normal membrane 
function is therefore essential to the survival of the red cell 
(Brain, 1982). The latter author proposed that disorders of 
membrane functions, by virtue of the role the membrane plays in 
determining cell size, shape and deformability, are the 
underlying cause of all disorders which lead to a diminished red 
cell survival. Fiennes (1954) who had a vast experience of 
ruminant trypanosomiasis particularly congolense infections, 
in East Africa observed erythrophagocytosis and stated, "it is 
evident that the lymphatic glands were concerned in removal and 
destruction of red blood cells in company with the spleen and 
haemolymph glands".
There was considerable renewed interest in this subject in 
the 1970's. MacKenzie and Cruickshank (1973) demonstrated the 
occurrence of erythrophagocytosis in sheep infected with 
T. congolense, and to a lesser extent leucophagocytosis was also 
seen. MacKenzie, Boyt, Emslie, Lander and Swanepoel (1975), in
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an endeavour to determine the cause of the phenomenon of 
erythrophagocytosis, took washed and unwashed red blood cells 
from sheep infected with congolense and tested them for the 
presence of trypanosomal antigen attached to the surface. They 
employed a direct immunoflourescent antibody technique (IFAT) to 
detect the antigen. No antigen was detected on the surface of 
red cells in any of the infected sheep until after the initial 
peak of parasitaemia, probably as a result of trypanolysis and 
release of antigens which, in effect, converted the red cells 
into a foreign protein, in the immunological sense and therefore 
primed them for phagocytosis. Other workers had also reported 
phagocytosis of erythrocytes in TL_ vivax infections in cattle and 
goats (Isoun and Esuruoso, 1972; Van den Ingh, Zwart, Van Miert 
and Schotman, 1976). Later, erythrophagocytosis in the bone 
marrow in goats infected with vivax was reported by Saror
(1980), and Mwongela, Kovatch and Fazil (1981) observed 
erythrophagocytosis in the spleen of cattle infected with an 
acute form of T^_ vivax. In contrast to the latter workers, 
Masake (1980) did not mention any erythrophagocytosis in her 
study of the pathological changes occurring in the mononuclear 
phagocytic system.
Huan, Webb, Lambert amd Meischer (1975) have reported that 
T. congolense, T. vivax and brucei spp yield a haemolytic 
factor or factors.
Tissue Lesions
The lesions provoked by the various animal trypanosomiases 
are very similar. Most tissues and organs are damaged during the 
course of infection, although some are more consistently and
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severely affected than others. In addition to the effects of 
emaciation, anaemia and cachexia there may be yellow gelatinous 
infiltration of the subcutis, small haemorrhages in the serous 
and mucous membranes, serous exudation in the pericardium and 
abdominal cavity, a variable degree of enlargement of the spleen 
and swelling of lymph glands. The underlying factors causing 
cellular infiltrates and possibly the mechanisms involved in cell 
injury would appear to depend on the difference in tissue 
invasiveness between species of trypanosomes (Morrison et al, 
1981).
The heart is one of the organs which all the animal 
trypanosomes consistently damage. However, the histopathological 
changes observed in the heart could be an example of what occurs 
in other tissues and organs but to a greater degree. In tsetse 
transmitted trypanosomiasis, obvious and more severe heart 
lesions are observed in cattle with chronic disease while obvious 
lesions may be absent in the hearts of small ruminants dying of 
acute T. vivax infections. There is often a marked degeneration 
of myocardial fibres in cattle which are separated by 
interstitial and perivascular oedema.
In their study on T. congolense infected animals, Valli and 
Forsberg (1979) found an increase in the number and size of 
splenic follicles, but the parafollicular area around the splenic 
arterioles was reduced. The later authors also found a definite 
interstitial thickening in the lungs, alveolar size was 
unchanged, but there was more free cells in the alveoli and a 
thickening of lobular septa and alveolar wells.
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. Anosa and Isoun (1983) stated that haemolymph nodes were two 
to three times normal size in sheep and goats infected with 
T. vivax. The authors also noted congestion of the subcapsular, 
cortical and medullary sinuses, with proliferation of macrophages 
in the sinuses and cords. Anosa (1983) describes the testicular 
pathology of ruminants as including "degeneration of the 
seminiferous tubules, with disappearance of spermatozoa and 
spermatids and less commonly spermatocytes, resulting in a 
reduction in the mean seminiferous tubular diameter and 
epithelial thickness, there was also spermatid giant cell 
formation and calcification". There is a striking absence of 
severe pathognomic lesions in acute T^ vivax infections despite 
the poor state of the animals prior to death (Anosa and Isoun, 
1983).
The pathology of T. brucei infections in domestic animals, 
was documented by Ikede and his colleagues (Ikede, 1974; Ikede 
and Losos, 1972a, b, c, d; Ikede and Losos 1975a, b). The gross 
pathological lesions seen at post-mortem in T. brucei infections 
of domestic animals differ only marginally from those seen in 
T. vivax and T^ _ congolense infections that have run a chronic 
course. Oedema, serous effusions, fatty degeneration and ocular 
lesions are however more noticeable and the heart shows greater 
evidence of damage. The lesions in the liver and kidney are 
similar to those caused by T. congolense and T. vivax, but 
possibly are more severe.
Ikede, Lule and Terry (1977) studied the effects of chronic 
T. brucei infections on the testicles of rams and described the 
inflammatory and degenerative changes that lead to total
26
aspermatogenosis. Morrison et al (1981) have provided a careful 
and well illustrated study on the pathogenesis of T^_ brucei in 
the dog induced with blood forms of the organism by intravenous 
inoculation. They concluded that infection of dogs with 
T. brucei resulted in high levels of parasitaemia and the 
presence of numerous trypanosomes in the tissues and in the 
afferent lymph.
Raisinghani, Yadov, and Lodha (1981) studied the 
pathological changes in experimentally evansi infected camels. 
Amongst other things, they reported a pronounced myocarditis. 
Verma and Guatama (1978) investigated the histopathological 
lesions subsequent to Surra infection in bovines. Later Seiler, 
Omar and Jackson (1981) studied the histopathology lesions in 
horses that died of T. evansi infections in Malaysia. The author 
found lymphoid hyperlasia in the spleen and lymphohistiocytic 
cells were found in most livers. Slight scattered, non­
suppurative myocarditis was observed in two horses.
Lesions of the Central Nervous System
The pathological importance of trypanosomes in the 
cerebrospinal fluid (CSF) is not clear. The mere presence of the 
parasites in the CSF without an accompanying increase in total 
protein or leucocytes indicates that the trypanosomes are present 
without any demonstrable pathological change in the cerebrospinal 
fluid (Waitumbi, Brown, Jennings and Holmes, 1988).
In view of the current concepts of the pathogenesis, it does 
not seem to be of essential importance whether the parasites 
enter the brain or not (de Raadt and Seed, 1977). It may
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however, have serious implications for the treatment of animal 
trypanosomiasis since no trypanocides exist which are 
specifically marketed for use in animals with cerebrospinal fluid 
trypanosomiasis (Murray and Jennings, 1983), although the 
arsenical, melarsoprol is used in late-stage human 
trypanosomiasis.
Brain lesions in ruminant animals dying of vivax and 
T. congolense infections are probably of little consequence in 
the pathogenesis of trypanosomiasis in these animals. The 
lesions observed in horses and dogs infected with T. brucei are 
of considerable interest to the comparative pathologist, but any 
attempt to attach great significance to such changes in ruminants 
would be a distraction from the lesions of the other tissues 
(Stephen, 1986).
Clinical observations of infected animals have provided some 
evidence of invasion of the central nervous system by T. evansi. 
Ataxia commonly occurs in T. evansi infections, particularly in 
horses. In the first description of the disease in India, Evans 
(1881) mentioned locomotory disturbances in fore and hind limbs. 
Later Steel (1886) reported oedema in the brain and spinal cord 
of evansi-infected mules.
Greenfield (1958) described lesions in sections of the 
forebrain, midbrain and cerebellum caused by gambiense in man, 
and, at post-mortem examination of dogs infected with T. evansi. 
Maychew (1968) reported that the animals showed similar lesions. 
Recently Seiler et al (1981) observed a few scattered petechiae 
in the meninges of the cerebellum and brain stem of horses 
infected with T. evansi. Histologically the meningoencephalitis
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affecting the grey and white matter of some of these horses was 
more serious in some than others.
Masake, Nantulya, Akol and Musoke (1984) isolated 
T. congolense from the brain of a calf inoculated with T^_ brucei 
one year after infection with what was presumed to be a pure 
T. congolense infection. The calf developed both clinical and 
histological evidence of cerebral trypanosomiasis. Recently 
Zweygarth and Rottcher (1987) detected T. simiae in the 
cerebrospinal fluid of experimentally infected pigs in Kenya. 
Immunosuppression
Animals and humans infected by trypanosomiasis frequently 
suffer from immunosuppression. The earliest experimental 
evidence was provided by Goodwin, Green, Gray and Voller (1972). 
Sheep erythrocytes were used as an antigen in the studies on 
Trypanosoma brucei-infected rabbits and mice and it was 
demonstrated that after infection the haemagglutin responses were 
significantly reduced.
Immunosuppression in experimentally infected mice was 
further investigated by Murray (1974a) and Murray, Jennings, 
Murray and Urquhart (1974b).
MacKenzie et al (1975) infected sheep in Zimbabwe by blood 
inoculation and then challenged them with the bacterium 
Vibrio foetus. Their results suggested immunosuppression by 
T. congolense occurred in the sheep, and that an organism which 
would normally be controlled by the host's immune defence system 
could show greater pathogenicity. However, efforts to 
demonstrate immunosuppression in large domestic animals have not
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been unequivocal and most attempts to do so have involved 
ruminants infected in the first place by syringe inoculation of 
trypanosomes, and then inoculated with' a known viral or bacterial 
antigen. A practical aspect of this subject concerns the 
possibility that vaccination programmes could be seriously over 
valued if a vaccine such as rinderpest attenuated virus failed to 
protect cattle in immunologically-deficient trypanosome-infected 
herds. Holmes, Mamo and Thomson (1974) mentioned this 
possibility when they noted that the secondary immune response to 
a polyvalent clostridial vaccine was lower in cattle infected 
with T^_ congolense, than in clean control animals. Scott, 
Pegram, Holmes, Ray, Knight, Jennings and Urquhart (1977) in 
Ethiopia, studied the immune response to a commercial trivalent 
foot and mouth disease (FMD) vaccine in cattle naturally infected 
with congolense. Some of the cattle in the study also 
received a polyvalent clostridial vaccine to confirm the results 
obtained by Holmes et al (1974). Their results showed distinct 
evidence of trypanosome-induced suppression of the immune system 
to foot and mouth disease vaccine, as well to the clostridial 
agent.
Whitelaw, Scott, Reid, Holmes, Jennings and Urquhart (1979) 
tested the antibody response of trypanosome infected cattle to 
Louping 111 virus vaccine. Three groups of cattle were employed 
and they were infected by blood inoculations with vivax, 
T. congolense and brucei before being vaccinated. In cattle 
infected with vivax and congolense the antibody response to 
the vaccine was only 10% of that in clean control animals which 
received the vaccine only. Contrasting with this, the response
of the cattle infected with brucei was not significantly 
reduced. They also showed that the immunosuppressive effects of 
trypanosomiasis could be greatly diminished by giving 
trypanocidal therapy at the time of vaccination.
Although there is clear evidence of suppressed antibody 
responses to foreign antigens in both animals and humans infected 
with trypanosomes, the underlying mechanisms remain obscure and 
much of the evidence is conflicting. Nevertheless it would seem 
that the investigations collectively suggested that the aetiology 
of the immunological hyporesponsiveness induced by trypanosome 
infections is multifactorial.
Many of the observations can be used in support of the 
hypothesis that the B cell system of the host with African 
trypanosomiasis undergoes generalised activation and thus 
proceeds to a stage of differentiation which limits the extent of 
additional responses to antigenic stimulation. Consistent with 
this idea are the observations of a B cell mitogen (Assouku and 
Tizard, 1978; Esuruoso, 1976; Greenwood and Whittle, 1976 and 
Mansfield, Craig and Stelzer, 1976), the occurrence of a 
polyclonal antibody response (Henderson-Begg, 1946) and the 
macroglobulinaemia (Terry, 1976) which are so typical of the 
disease. Other authors (Mansfield, 1978) have suggested that the 
major defect is within the T lymphocyte sub-population. The loss 
of T-dependent areas, histologically favour this idea. 
Furthermore, a deficiency in suppressor T-cells would favour an 
abnormally high proliferation of B-cells, which is also observed 
histologically and could result in elevated immunoglobulin
production. This combined with a deficiency in T-helper cells, 
which would be expected to retard the switching from Igm to IgG 
synthesis, would provide sufficient explanations for the observed 
macroglobulinaemia.
Other workers (Askonas, Corsini and Clayton, 1979) emphasise 
the generalised dysfunction of lymphoid tissue, involving cell 
sub-populations of a variety of functional types, including T- 
and B-memory cells, and T-cells, responsible for mixed lymphocyte 
reactivity.
More recently, Sileghem et al (1986) showed that lymph node 
cells from T^ brucei infected mice suppressed the secondary 
proliferation of reactive antigen primed T cells as well as the 
IL-2 production by mitogen stimulated T lymphocytes. Their 
results suggest that trypanosome-induced immunosuppression is 
mediated by a suppressive cell which interferes at the level of 
IL-2 secretion.
According to Holmes (1980), the veterinary impact of 
immunosuppression may fall into three categories:
(1) the animals may be rendered more susceptible to secondary 
infections, e.g. secondary complications affecting the 
respiratory, gastrointestinal and nervous systems may occur 
(Cross, 1921b; Rutter, 1967).
(2) infected animals may give diminished responses to bacterial 
and viral vaccines e.g. Holmes et al (1974) showed T. congolense 
can actively suppress the responses of Zebu cattle to 
immunisation with a polyvalent clostridial vaccine.
(3) the parasitised host may have a reduced capacity to mount an 
effective response against the trypanosome infection.
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Chemotherapy (General)
Escalating costs of initiating and maintaining tsetse 
control campaigns, together with the non-availability of a 
vaccine, have led to the livestock industries in the vast tsetse- 
infested areas of Africa being almost completely reliant on the 
use of trypanocidal drugs to both treat and prevent 
trypanosomiasis.
It is acknowledged that the early evolution of drugs owes 
much to the preoccupation, about the turn of the century, with 
the control of trypanosomiasis (Davey, 1957 and Williamson, 
1970). Leach and Roberts (1981) have described briefly, the 
history of the chemotherapy of animal trypanosomiasis. In their 
review they mentioned that although the initial chemotherapeutic 
endeavours were at first directed towards the human species, this 
overlapped with the developments in drug treatment of animal 
trypanosomiasis and inevitably occurred simultaneously at a 
number of points. A good example where the chemotherapeutic 
susceptibility of both human and animal parasites converged is 
the production of the drug, suramin.
Trypanocidal drugs can be divided into two groups: those
used to prevent infections (prophylactics) and those used to cure 
infected animals (therapeutics). The ideal compound should have 
broad-spectrum trypanocidal activity, no toxic side effects and 
should not induce drug resistance. Unfortunately, no such ideal 
drug exists. Despite the need and demand for effective 
trypanocides, no new drug has been produced for commercial use in 
the last 25 years. The few available drugs are widely used by
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livestock owners and veterinarians throughout Africa and the risk 
of development of parasite resistance is increasing. To prevent 
the situation deteriorating further, greater economic support is 
needed on testing (Leach and Roberts, 1981). Lack of funds to 
implement control programmes, well trained veterinary graduates 
and other trained staff, the lack of an infrastructure required 
for drug administration are other obstacles encountered in the 
applications of trypanocides (Holmes and Scott, 1982). Because 
of these problems there is an increasing gap between treatment 
demand and the treatment actually administered (MacLennan, 1980).
Chemotherapy and chemoprophylaxis can be effective if 
managed in an efficient way (Blaser, Jibbo and McIntyre, 1979; 
Leach and Roberts, 1981). Unless the incidence of 
trypanosomiasis and the stock carrying capacity are both high, 
the protection of cattle with trypanocides is preferable to 
tsetse control programmes which usually are relatively costly 
(Finelle, 1976).
In places where the tsetse flies have been eradicated, wide 
use of therapeutic drugs will play a role in clearing the disease 
from any infected animals and future mechanical transmission will 
be reduced (Gray, 1983).
Chanotherapy
Those trypanocidal drugs, which are currently in use are 
either prophylactics or therapeutics. The chemical and 
proprietary names, dosage and efficacy of drugs currently used in 
the field are described in Table 2.
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Suramin
Of the drugs currently in use suramin was the first to be 
introduced. (Bayer 2 0 5 , Germanin Antrypol
Belganyl^, Fourneau 309^, Moranyl^, Naphuride^, 
Naganol^). This sulphonated naphthylamine derivative is a 
white, cream-coloured or faintly pink hydroscopic powder, readily 
soluble in water to yield a neutral solution.
Suramin is employed for both human and animal 
trypanosomiasis. It has been recorded to be ineffective against 
T. congolense and vivax infections in cattle (Ruchel, 1 975) 
but Stephen (1966b) observed some therapeutic activity towards 
T. simiae infections of pigs. It is strongly ionic and firmly 
binds with plasma proteins (Boumsnell, Dangerfield and Wormall, 
1939; Bournsnell and Wormall, 1939; Dewey and Wormall, 1946). 
The drug may provoke delayed toxicity, including pronounced 
nephritis (Morcos, 1931). This author advised against treatment 
with suramin in cases where albuminuria is prominent. Suramin is 
efficaceous against infections with trypanosomes of the subgenus 
Trypanozoon, in horses, donkeys and camels (Leach, 1961).
In this respect it compliments the more recently introduced 
drugs. Since it is less toxic than quinapyramine, it is 
particularly useful in the treatment of equine Surra. Suramin 
has been in constant use in the field for more than 60 years and 
it remains the drug of choice for the treatment of early 
infections. Suramin is administered intravenously as it can 
generate local reactions when given intramuscularly or 
subcutaneously. Several attempts to improve suramin's 
trypanocidal activity and to lessen its toxicity to the host
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animals were made without success (Spinks, 1947; Adams, Ashley 
and Bader, 1956).
A single dose of 5g effected a 100% cure in camels (Mahamoud 
and Abdel-Latif, 1958). In ponies affected by Surra a dosage of 
10mg/kg bodyweight is not only curative, but also protects these 
animals for a period of 30 days (Ruchel, 1975). In the case of 
bovine Surra, a dosage of 1g/animal produced good results 
(Fernandez, Rico and Dumag, 1965).
Surami n complexes
Williamson (1957) has described in detail the ability of 
suramin to be combined with basic substances to form relatively 
insoluble complexes, known as suraminates. It has been recorded 
that the complexes considerably reduce the toxicity of cationic 
drug constituents and produce an increase in their prophylactic 
activity (Williamson, 1957).
Suramin produces complexes with quinapyramine 
(Antrycide^), homidium (Ethidium® Novidiun/R)) / pyrithidium 
(Prothidium^), isometamidium (Samorin^) and diminazene 
aceturate (Berenil^). Williamson (1956) reported that the 
highest precipitation of these salt complexes has a 
stoichiometric basis dependent on the number of available ionised 
groups in the combining molecules. Williamson and Desowitz 
(1956) found a maximum decrease of five to three fold in the 
toxicity of suramin complexes of Antrycide and Berenil 
respectively.
Suramin complexes conferred protection in cattle, against 
T. vivax and congolense, when administered subcutaneously to
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cattle. The prophylactic action could be dependant upon the 
accumulation of these relatively insoluble complexes at the 
injection site and the formation of a depot from which small 
amounts of the drug are released into the blood circulation over 
a long period of time. The quinapyramine dimethylsulphate- 
suraminate (Williamson, 1957) was very effective as a 
prophylactic against tsetse transmitted T^_ simiae infections in 
pigs in West Africa (Stephen and Gray, 1960).
Mode of action of Suramin
Suramin is a polybasic anion and binds strongly to 
proteins. This bonding with proteins could account for its long 
retentions and prophylactic activity and may also facilitate its 
entry into the cell (Questel, 1931). The probability that this 
drug enters trypanosome lysomes is strengthened by the 
demonstrations of its lysosomotropic properties in other cells 
(Davies, Lloyd and Beck, 1971; Buys, Elferirik, Bouma, Gruber and 
Niewenhuis, 1973; Jacques, Huybrechts-Godbin and Smeesters, 1975; 
Hart and Young, 1975). Suramin may also interfere with ribosomal 
and lysosomal functions of trypanosomes (Williamson and MacAdam,
1965). Previously MacAdam and Williamson (1964) proposed that 
the drug induced release of lysosomal acid ribonuclease might be 
responsible for the disappearance of the ribosomes.
There is no experimental evidence that lysosomal enzymes 
damage trypanosomes (Leach and Roberts, 1981) and anyway it is 
not clear whether the lysosomal enzymes actually kill or merely 
digest organisms inactivated by other processes. One point 
worthy of note is that exploitation of drug lysosomotropism has a 
potential for the selective delivery, toxicity reductions and the
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controlled release for prophylaxis (Williamson, 1976b). The 
correlations of the properties of suramin with its trypanocidal 
actions are not clear. Nonetheless, lysosome phagosome 
interference is unlikely to be of any relevance in this respect 
since demethylated suramin is as active in the macrophage system 
as suramin, but totally inactive as a trypanocide (Williamson, 
1976a).
Quinapyramine dimethylsulphate/chloride (Prosalt)
Quinapyramine is available in two forms: on the one hand as
quinapyramine dimethylsulphate, a water soluble, yellowish-white, 
crystalline powder with a curative effect and on the other hand 
as quinapyramine chloride, a light yellow compound which is very 
sparingly soluble and this accounts for its prophylactic 
activity. The mixture (three parts dimethylsulphate plus two 
parts chloride) i.e. Prosalt was introduced in the early fifties 
after a series of field trials in Africa (Davey, 1950). The drug 
has a broad spectrum of activity, being active against both 
mechanically and cyclically transmitted trypanosomiasis (Curd and 
Davey, 1950; Leach, 1961; Davey, 1950; 1957).
The drug is absorbed slowly as it forms a deposit after 
subcutaneous injection (Davey, 1950). After treatment with 
quinapryamine prosalt, the depot of unabsorbed drug may be 
surrounded by a fibrous capsule which may calcify. This prevents 
the slow absorption of the active agent, thus reducing the period 
of protection although an appreciable amount of the drug may 
still be present in the depot (Whiteside, 1961). Because it is 
absorbed so much more quickly and completely, the methylsulphate
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is more toxic than the chloride (Davey, 1950).
In the initial experimentation in Africa, Davey (1950) 
showed that the methylsulphate at 5mg/kg could effect a cure in 
animals whereas the chloride at a similar dose exerted a 
prophylactic effect for at least two months. With 1 Omg/kg the 
sparingly soluble chloride gave four months protection. Rottcher 
(1982) published the findings of an experiment involving five 
groups of camels in different locations of Kenya which were used 
in chemotherapy field trials using quinapyramine, (Antrycide^), 
suramin, (Naganol^R^ and isometamidium, (Samorin^) for a 
period of 3 - 1 8  months. The overall results showed that 
Antrycide was the most successful drug for both treatment and 
chemoprophylaxis.
Toxicity in equidae may be prevented by dividing the dose in 
two and injecting the second half 5 - 6  hours after the first 
(Leach and Roberts, 1981).
Mode of Action
The drugs which affect the kinetoplast are cations known to 
bind with DNA. Ormerod and Shaw (1963) observed that cationic 
drugs enter the kinetoplast within minutes of treatment. 
However, MacAdam and Williamson (1972; 1974a) and Williamson, 
MacAdam and Dixon (1975) showed that quinapyramine attacked the 
kinetoplast DNA core specifically. This selective binding may be 
attributed to the circularity of the kinetoplast DNA combined 
with a lack of histones and the preponderance of the adenine- 
thymine content in kinetoplast DNA, in contrast to nuclear DNA 
(MacAdam and Williamson, 1974a). When administered to cultures 
of Crithidia oncopelti, quinapyramine inhibited RNA synthesis at
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concentrations that did not affect DNA synthesis (Newton, 1964). 
The drug also caused aggregation of isolated ribosomes.
Diminazene Aceturate
Diminazene aceturate, (Berenil (R)), is a diamidine and is a 
stable, yellow, odourless powder. Since its introduction 
diminazine aceturate has been extensively used against African 
trypanosomes, for example T. vivax, T. congolense, T. brucei but 
there are few reports of its success in the treatment of 
T. evansi infections (Razzaque and Mishra, 1977). The drug also 
appeared ineffective against T. simiae. Diminazene aceturate is 
highly active against Babesia spp in cattle which is an important 
additional advantage in African conditions.
Diminazene aceturate is noteworthy among trypanocidal drugs 
in being rapidly excreted, almost all of a parenterally 
administered dose being cleared through the kidneys within 
24 hrs. Although there is evidence that some of the drug must be 
retained in the tissues (Lumsden, Herbert and Hardy, 1965), this 
characteristic of quick clearance is thought to lessen the risk 
of resistance developing through prolonged exposure of parasites 
to a waning concentration of the drug and also reduces 
opportunities for the occurrence of chronic toxicity. Recently, 
Kellner, Eckert and Volz (1985) have studied experimentally the 
blood concentrations of diminazene aceturate, its routes and 
rates of excretion and total tissue residues of healthy calves, 
injected intramuscularly. These workers found lower 
concentrations of diminazene in skeletal muscle and fat and 
higher concentration of diminazene in organs with excreting
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functions such as the liver and kidneys. This finding is in 
accordance with Fairclough (1963), who reported that the compound 
is not rapidly and completely metabolised as assumed. Because of 
the lack of widespread resistance occurring, diminazene aceturate 
has replaced homidium and quinapyramine as the curative 
trypanocide of choice.
Early reports described an experiment in which three groups 
of cattle, six animals in each group, all infected with vivax, 
were treated respectively with 1, 2, or 3mg/kg intramuscularly 
(Bauer, 1955a). As a result of this experiment the standard dose 
of 3mg/kg intramuscularly was decided upon. Later the standard 
dose was increased up to 3.5mg/kg. However, the recommended dose 
of T^ brucei is 7.0mg/kg.
In a toxicity study Homeida, Amin, El Adam and Mohamoud 
(1981) found that 10mg/kg of Berenil was highly toxic to camels. 
The main signs of Berenil poisoning were hyperaesthesis, 
salivation, intermittent convulsions, frequent urinations and 
defaecation, itching and sweating. In other studies, camels 
showed severe toxic reaction to 7.0mg/kg (Leach, 1961).
Mode of action
Diminazene aceturate appears to be actively transported into 
trypanosomes against a concentration gradient (Damper and Patton, 
1976a, b). As in many trypanocidal drugs, Berenil interacts 
specifically with kinetoplast DNA. It inhibits the replication 
of the kinetoplast and induces dyskinetoplasty in T^ brucei 
(Killick-Kendrick, 1964; Newton and LePage, 1967; Newton, 1975). 
In marked contrast to homidium, Berenil does not intercalate into 
the DNA helix (Waring, 1970; Festy and Daune, 1973) but binds by
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external attachment across the small groove astride the two 
complementary strands and slightly distorts the helical structure 
(Festy, Sturm and Daune, 1975).
In addition, this drug appears to bind kinetoplast DNA at 
four equidistant sites which also bind RNA polymerase (Brack and 
Delain, 1975). It also affects cytoplasmic membranes and 
lysosomes (MacAdam and Williamson, 1972). Inhibition of 
phospholipid synthesis (Gutteridge, 1969), basic amino acid 
transport (Gutteridge, 1966) and oxygen uptake (Hill and Hunter, 
1968) have also been reported.
Phenanthridium Drugs
The effectiveness of this class of drugs against tsetse- 
borne trypanosomes has been established (Mahamoud and Gray, 
1980). The earliest compound of the phenanthridine series to be 
described was phenidium chloride (Browning, Morgan, Robb and 
Walls, 1938). Local reactions at the injection sites and its 
poor therapeutic activity were obvious drawbacks to its usage 
(Hornby, Evans and Wilde, 1943).
Dimidium bromide was immediately synthesised and was first 
tried in Uganda against T. congolense (Bell, 1945), and the 
results were most promising. They indicated that the drug had a
f
relatively wide margin of safety, and that a dose of 1 mg/kg, 
subcutaneously was sufficient to cure T^ congolense. However, 
Randall and Beveridge (1946) reported that in the first 187 
cattle treated with 2mg/kg subcutaneous ly "nearly all developed 
symptoms of photosensitisation some six weeks after 
administration of the drug, and 41 subsequently died". In
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addition, severe local reactions at the site of injection were of 
frequent occurrence, resulting in sloughing of areas of skin up 
to several inches in diameter. Because of these adverse 
reactions the dose was reduced to 1 mg/kg and the injections made 
intramuscularly (Davey, 1957). Further experimental work 
confirmed in general that photosensitisation was a serious hazard 
in the use of dimidium bromide (Randall and Beveridge, 1946). 
Homidium
Homidium was produced by substituting an ethyl for a methyl 
group on the quaternary nitrogen heteroatom of dimidium (Watkins 
and Woolfe, 1952). The compound was first produced as 
Ethidium^ (bromide salt) and later as Novidium^ (homidium 
chloride).
Novidium which is equally active therapeutically, is soluble 
in cold water (Wragg, 1955). The drug is injected 
intramuscularly, as it can cause severe reactions if given 
subcutaneous ly. Homidium has been shown to have a selective 
effect on vivax infections in cattle (Mwambu, 1971) and has 
been used successfully for treating this parasite in horses. The 
compound was also found active against T^ congolense (Mwambu,
1966). However, a study conducted by Srivastava and Ahluwalia 
(1973) demonstrated that homidium bromide was ineffective against 
T. evansi infections in Asian dogs.
Isometamidium
Isometamidium (Samorin^)) was first introduced in 1958. 
Wragg, Washbournik, Brown and Hill (1958) had combined the 
diazotized p-aminobenzamide moiety of the diminazene molecule 
with homidium chloride in the presence of sodium acetate. This
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yielded two isomeric derivatives that were both trypanocidal. 
The two isomers are one red and one purple. The red isomer was 
named isometamidium chloride and was marketed under the name of 
Samorin^.
The manufacturers recommended that for cattle 
trypanosomiasis (T. congolense and T. vivax) a therapeutic dosage 
of 0.25 to 0.5mg/kg be used for sensitive strains, 0.5mg - 
1.0mg/kg for less sensitive strains and for prophylaxis. 
Intramuscular injection of isometamidium can cause severe local 
reactions and extensive fibrosis (Boyt, 1971). These lesions are 
usually very obvious in cattle where tsetse challenge is high and 
drug treatments are very frequent. It is advisable to divide the 
dose so that not more than 15ml is given at one injection site 
(Finelle, 1973a). To circumvent this difficulty, Toure (1973) 
studied the effect of intravenous administration, three calves 
treated with 0.5mg/kg were inoculated with T. brucei thirty-four 
days later and their blood films remained negative during the 
subsequent two months. Isometamidium is also the drug of choice 
for T. congolense infections of dogs (Aliu, 1981). Isometamidium 
has successfully treated T^ evansi infections of camels and 
donkeys at 1.0mg/kg and 2.0mg/kg respectively (Petrovski, 1974; 
Chand and Singh, 1970).
Some workers have made attempts to decrease the extensive 
ulceration and necrosis of isometamidium administration by 
complexing isometamidium with dextran sulphate (Aliu and Chineme,
r
1980; Fluck, 1987), and the complex provoked no gross changes.
Balis and Richard (1977) carried out trials in guinea pigs
45
and dromedaries infected with evansi in Ethiopia with 
isometamidium chloride. They found that it was curative in 
guinea pigs at dose rates ranging from 0.25 to 2.0mg/kg body 
weight. A dose of 2.0mg/kg caused in camels a pronounced shock 
with collapse, salivation, diarrhoea and increased pulse rate. 
In addition, intramuscular injections of 2.0mg/kg were only 
partially effective with trypanosomes reappearing in the blood 
after one to two months, and at the time of injection extensive 
pain was noted with consequent development of lesions. The 
authors concluded that isometamidium chloride is only moderately 
active against evansi.
Chemoprophylaxis
There are only two situations where treatment with 
prophylactic drugs should be encouraged, firstly when animals are 
to be exposed to tsetse challenge for a specific and limited 
period of time, which is shorter than the protective period of 
the drug concerned; and secondly when the animals are sedentary 
and are available throughout the year for regular inspection and 
treatment. MacLennan (1970) summarised the problems attending 
control by chemoprophylaxis.
Quinapyramine prosalt which was the first prophylactic drug 
used in the field conferred protection for two months to cattle 
in close contact with tsetse fly (Fiennes, 1953). Earlier 
workers have recorded that pyrithidium bromide (Prothidium^) 
would protect cattle for 4 - 8  months (Marshall, 1958; Lyttle, 
1960; Finelle and Lacotte, 1965). Watkins and Woolfe (1956) 
introduced the later drug as a prophylactic against cattle 
trypanosomiasis. The drug has been shown to be superior to
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quinapyramine as a prophylactic (Smith and Brown, 1960). The 
usage of pyrithidium declined later because of its toxicity 
problems and the development of resistance and it was withdrawn 
from the market in late 1970s.
Suramin injected intravenously into camels in doses of about 
3.0mg/kg body weight affords protection of 2 - 4 months, while 
quinapyramine (Antrycide Prosalt<R)) (4.0mg/kg) administered 
subcutaneously protects animals such as ponies, camels and 
bovines for 2 - 3  months (Woo, 1977).
In evansi infections of domestic animals the period of 
protection conferred by the two drugs used for treatment (suramin 
and quinapyramine prosalt) is of short duration rarely exceeding 
three months or at the most four months (Wilson, 1984). The 
susceptibility of animals to trypanosomes and the duration of 
protection can be affected by seasonal variations in relation to 
fly density, food availability etc. The effect of intercurrent 
diseases on chemotherapy and chemoprophylaxis is well recognised 
(Leach and Roberts, 1981; Holmes and Scott, . 1982). In addition, 
experience has shown that stock owners accept the treatment of 
their animals only when clinical symptoms or parasitaemia become 
evident. Therefore good collaboration between animal owners and 
veterinarians is vital (Holmes and Scott, 1982).
During the last two decades isometamidium has been the only 
prophylactic drug used in the tsetse-infested areas of Africa 
(Williamson, 1976a; Connor, 1984). The other commonly used 
trypanocides, homidium chloride and diminazene aceturate have 
little if any prophylactic properties. However, diminazene
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aceturate is commonly used as a sanative treatment for animals in 
which trypanosomes have been observed before the next 
prophylactic treatment of isometamidium (Finelle, 1973b).
Many workers from different parts of Africa have reported 
the economic return associated with using isometamidium 
prophylaxis in trek cattle, ranch cattle, and work oxen (Na'Isa, 
1969; Wilson, Le Roux, Paris, Davidson and Gray, 1975a; Wilson, 
Njogu, Gatuta, Mgutu, Alushula and Dolan, 1981; Bourn and Scott, 
1978; Logan, Goodwin, Tembely and Craig, 1984; Trail, Sones, 
Jibbo, Durkin, Light and Murray, 1985).
There are fewer reports to the use of Samorin in dairy 
cattle. However Samorin was systematically used for several 
years in 200 breeding females of grade cattle (mainly Friesian 
type). The cattle were maintained in an area in Kenya where the 
challenge of G^ pallidipes, G. austini and G^ brevipalpis was 
moderate to heavy. The increased productivity, associated with 
the therapeutic and prophylactic use of isometamidium chloride in 
dairy cattle, resulted in an improved economic return (Fazil, 
1987; cited by Murray and Mo loo, personal communication).
Isometamidium chloride is normally recommended for 
prophylaxis at a dose of 0.5 to 1.0mg/kg body weight, 
(Fairclough, 1963a; Pinder and Authie, 1984), and at these levels 
livestock owners have recorded protection against trypanosomiasis 
lasting from two weeks to 14 weeks. The period of prophylaxis 
conferred by isometamidium to cattle after deep intramuscular 
injection varies widely.
In their extensive review of chemotherapy and 
chemoprophylaxis of animal trypanosomiasis, Leach and Roberts
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(1981) have suggested that in circumstances where reliance is 
placed on drug treatment for control of trypanosomiasis, a choice 
must be made between chemotherapy and chemoprophylaxis. The slow 
elimination of prophylactic drugs which is required if they are 
to afford protection over an extended period implies that 
eventually a concentration insufficient to prevent infection is 
reached. When this happens, trypanosomes may have an opportunity 
to multiply in the presence of the drug and are likely to develop 
some degree of resistance to it. Hence, regular repetition of 
treatments within the protection period of the drugs concerned is 
the cornerstone of successful chemoprophylaxis. In evaluating 
the prospects of success for such an approach, it is therefore 
necessary to consider such logistical restraints as the 
continuing availability of trained staff and of reliable 
transport, as well as certainty of access to the animals 
involved. It follows that nomadic and semi-nomadic livestock are 
seldom suitable targets in attempts to control trypanosomiasis by 
chemoprophylaxis.
Conversely, it may provide an economic solution for stock 
under ranch management, as the previous authors (Leach and 
Roberts, 1981) indicated. One important economic factor in 
consideration of chemoprophylactic programmes is that the period 
between treatments should be as long as possible yet it must also 
be adjusted to correspond to the severity of risk and the 
sensitivity of the infecting strains to the drug in use 
(MacLennan, 1970).
Lyttle (1960) stated that the prophylactic period conferred
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by a drug depends on the number of tsetse bites received per unit 
and the virulence of the trypanosomes. Other workers have 
discovered that Trypanosoma brucei can re-emerge from tissues or 
organ especially the central nervous system (CNS), which are 
inaccessible to most trypanocides, after the animals have shown a 
period of apparent cure (Jennings, Whitelaw, Holmes, Chizyuka and 
Urquhart, 1979). Immunity acquired by animals treated with 
trypanocidal drugs may increase the prophylactic period (Wilson, 
Paris, Luckins, Dar and Gray, 1976; Bourn and Scott, 1978).
An experiment was conducted by Whitelaw, Bell, Holmes, 
Moloo, Hirumi, Urquhart and Murray (1986) to study isometamidium 
chloride prophylaxis against Trypanosoma congolense challenge and 
the development of immune responses in Boran cattle. Twenty-four 
Boran cattle were injected with isometamidium chloride (1 mg/kg 
bodyweight) to investigate the duration of drug-induced 
prophylaxis against infection by metacyclic forms of 
Trypanosoma congolense and to determine if specific antibody 
responses to the organism were mounted by animals under 
chemoprophylactic cover. Complete protection against either 
single challenge by five tsetse flies infected with 
T. congolense, or repeated challenge at monthly intervals by five 
tsetse flies, lasted for five months. Six months after 
treatment, two-thirds of the cattle were still resistant to 
challenge, irrespective of whether subjected to single or 
multiple challenge with trypanosome-infected tsetse flies, or 
titrated doses of jln vitro-cultured metacyclic forms of 
T. congolense (from 500 to 500,000 organisms), inoculated 
intradermally. No animal which resisted infection developed
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detectable skin reactions at the site of deposition of metacyclic 
trypanosomes or produced trypanosome-specific antibodies. The 
authors concluded that drug residues effectively limited 
trypanosome multiplication at the site of deposition in the skin, 
thus preventing subsequent parasitaemia or priming of the host's 
immune response.
Ercoli (1978) stated that the prophylactic period conferred 
by chemoprophylaxis consists of true prophylactic period and 
false prophylactic period; the treated animals are initially able 
to resist the challenge but during the false prophylactic period 
the animals are not completely resistant and infections develop, 
although the onset of parasitaemia is extended, giving false 
indication of the prophylactic period.
Drug resistance
There is no compound currently in use for the treatment of 
animal trypanosomiasis against which drug resistance has not 
arisen.
Zakrezewskie (1973) has described some of the fundamental 
mechanisms which may be responsible for the emergence of drug 
resistance (a) altered drug uptake (b) altered metabolism or, (c) 
inactivation of the drug. Most of the investigators are inclined 
to support the first mechanism (Hawking, 1934; 1937; von Brand, 
1951; Williamson and Rollo, 1959).
Whiteside (1961) discussed several ways in which drug 
resistance may emerge, especially in the tsetse-borne species, 
and experience has shown that they are equally applicable to 
mechanically transmitted trypanosomes e.g. evansi. First,
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underdosing due to incorrect estimation of body weight. Secondly 
the combined effect of a high incidence of trypanosomiasis and 
the use of therapeutic and prophylactic drugs may result in the 
emergence of the drug resistant strains. Thirdly, irregular 
treatment with prophylactic drugs or stopping their use 
altogether while animals are still at risk can produce resistant 
strains of trypanosomes. The belief in the field, that drug 
resistant trypanosomes may often be of comparatively low 
pathogenicity (Gobel, Ferrell and Steiglitz, 1959; Stephen, 1962) 
is encouraging, even though this needs further confirmation.
Since trypanosomiasis occurs in developing countries mostly 
with inadequate veterinary services, the misuse of the drugs by 
the animal owners almost certainly contributes to the emergence 
of resistance strains.
Sergent and Donatien (1922) observed long periods during 
infection of T. evansi in the camel, when the parasites could not 
be detected in the circulation. Similarly after drug treatment, 
it is common for trypanosomes to be absent from the peripheral 
circulation for a time only to be followed by their reappearance. 
Although this behaviour may be due to drug resistance, sometimes 
the relapsed population retains the same sensitivity as the 
earlier infection. Jennings, Whitelaw and Urquhart (1977b) 
showed, at least in brucei infections, that these relapses 
were not due to drug-resistance, as the relapsed trypanosomes 
remained as sensitive to the treatment as the parent inoculum. 
Instead such relapses were due to trypanosomes occurring in sites 
which were inaccessible to drug penetration. Later Jennings 
et al (1979) and other workers demonstrated that the brain was
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the main cryptic focus of infection.
In the literature the development of drug-resistance is 
usually attributed to the use of chemoprophylactic drugs. Of the 
chemoprophylactics, widespread resistance to quinapyramine led to 
the withdrawal of its usage for bovine trypanosomiasis, such as 
T. congolense and T. vivax (Whiteside, 1960a; Cockbill, 1967). 
Wilson (1949), mentioned how readily a single treatment with 
quinapyramine produced resistance in bovine trypanosomiasis. In 
contrast, many workers have recorded that resistance to 
isometamidium does not appear to develop readily when repeated 
treatments are administered (Folkers, 1966; Lewis and Thomson, 
1974). Later, other workers found putative resistance in the 
field as shown by early breakthroughs, using isometamidium as a 
prophylactic drug (Kupper and Wolfers, 1983; Pinder and Authie, 
1984).
There are limitations to the detection of resistance strains 
in small laboratory animals since it has been suggested that 
these animals are often not susceptible to infections with 
resistant strains (Williamson and Stephen, 1960).
The literature concerning drug-resistance by evansi in 
the field is not adequately available (Leach and Roberts, 1981). 
However, the disparity in the response to drug treatment reported 
from various countries may be largely attributed to resistance 
developed by the parasite as a result of prolonged exposure to 
the drug, especially where chemotherapy is extensively applied in 
the control of this disease in domesticated animals (Yutuc, 1940; 
Abebe, Jones and Boid, 1983).
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Granouillet and Do-van-Vien (1938) have registered the 
failure of suramin (Naganol) treatments, in a spontaneous 
outbreak of evansi in horses and dogs. The authors proposed 
that the passage of trypanosomes through horses, may enhance 
their virulence for dogs, cattle, buffaloes and also reduce their 
drug sensitivity. Mice infected with three stocks of T. evansi 
isolated from camels required 60mg/kg suramin compared with only 
10mg/kg needed to cure infection with normally susceptible stock.
Several years ago Gitaha (1981) described an experiment in 
which four isolates of T. evansi, isolated from camels in Kenya 
were tested for drug resistance in mice. All four isolates were 
resistant to diminazene aceturate at 3.5, 7.0 and 10.5mg/kg; they 
were also resistant to different concentrations of isometamidium 
chloride, homidium bromide and homidium chloride.
Strains resistant to suramin and quinapyramine have been 
shown to be fully susceptible to Berenil (Gill, 1971a, b). It is 
therefore likely that those isolates which did not respond to 
three times the standard dose of Berenil are naturally resistant 
to this drug. The risk of developing drug-resistant parasites is 
less with Berenil than with other trypanocidal drugs which 
persist in the body for a relatively long period of time. Indeed 
some workers were unable to experimentally induce Berenil 
resistance (Fussganger and Bauer, 1960; Bauer, 1962). Although 
others were successful (Whiteside, 1963; de Raadt, van Hoeve, 
Hart and Grainger, 1965).
It is important, however to note that although Berenil is 
rapidly removed from the circulation, there is some evidence for 
the existence of deep tissue depots, most notably expounded by
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Klatt and Hadju (1976). This may account for the prophylactic 
activity reported to have been afforded by Berenil against 
T. brucei (Van Hoeve and Cunningham, 1964). Perhaps the slow 
development of Berenil resistance observed in the field is 
accounted for by the drug's tissue depot.
Homidium - resistant congolense have been described in 
many parts of Africa, such as Sudan, Nigeria, Ethiopia and Kenya 
(Jones-Davies and Folkers, 1966c; Na'Isa, 1967; Folkers, van 
Hoeve and Buys, 1968; Williamson, 1970; Gadir, Tahir, Razig and 
Osman, 1972; Scott and Pegram, 1974; Gitaha, 1981). But in 
contrast, Ilemobade and Buys (1970) did not mention any homidium- 
resistance in their work. However, Williamson and Stephen (1960) 
suggested that T^ congolense has a higher level of innate 
resistance to homidium than T^ vivax, and T^ vivax has a higher 
level of innate resistance to diminazene aceturate than 
T. congolense (Williamson, 1960).
Relapse of Infection
When an infected animal is injected with a trypanocidal 
drug, the treatment initially appears successful in eliminating 
trypanosome from the peripheral blood, but relapse infections in 
the blood occur later. According to Jennings and Gray (1983), if 
an animal with a T brucei infection is treated with a 
trypanocidal drug in the field and is subsequently shown to be 
still infected, one or more of three causes are normally 
incriminated; reinfection, underdosage of the drug, or drug 
resistance. The first cause is said to be determined by the time 
between treatment and re-examination and the intensity of fly
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challenge. If, however, the drug fails to clear the parasites 
from the bloodstream, underdosage or resistance is implicated.
Relapses following treatment usually results from inadequate 
dosage or waning concentrations of prophylactic drug and may 
eventually give rise to resistant stocks. Gill and Malhotra 
(1971) have observed relapse infections of T^_ evansi following 
prophylaxis in horses. These infections were characterised by 
low grade sub-microscopic parasitaemia. However, as the relapse 
strains showed loss of virulence to laboratory animals, the 
atypical character of the infections was attributed to the 
residual effects of the drugs and development of some degree of 
immunity.
Very recently, a series of experiments were conducted in 
Kenya by Sones, Njogu and Holmes (1988). The sensitivities of 
three strains of Trypanosoma congolense to isometamidium chloride 
(Samorin) were determined in mice and cattle, with the objective 
of evaluating sensitivity testing in mice as a means of 
predicting curative doses in cattle. A comparison of effective 
dose and curative dose for mice with minimum curative dose values 
for cattle demonstrated a wide variation between strains, with 
mice requiring from one to more than 100 times the cattle dose. 
It was concluded that although a mouse test may give a broad 
indication of whether a strain is sensitive or resistant, it 
cannot be used accurately to predict curative doses for cattle.
In his work Abebe et al (1983) illustrated that the use of 
sub-curative doses of suramin to treat T^_ evansi generates 
relapse infections. Moreover, Jennings and his colleagues 
(1977a, b) suggested that the timing of the treatment relative to
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the primary infection may be crucial in the development of the 
relapse infections. However, there are records of both 
experimental and natural infections of T. brucei which indicate 
that whenever strong nervous symptoms are evident, the effect of 
chemotherapy is bound to fail (May Chew, 1968; Ng and Vanslow, 
1978).
Care must be taken in all therapeutic drug sensitivity 
studies to ensure that treatment occurs sufficiently soon after 
infection to rule out the possibility of relapses occurring from 
sites inaccessible to drugs (Jennings et al, 1977a, b; 1979). 
However, the occurrence of the relapse phenomenon in the field is 
difficult to evaluate since conditions precluding reinfection are 
difficult, if not possible to achieve.
Stability of Drug Resistance
Trypanosomes become resistant against many drugs but the 
speed with which the resistance develops and the tenacity with 
which it is retained varies with different compounds (Von Brand, 
1951). In tsetse-borne species, it was shown that drug 
resistance can be stable and transmissible (Gray and Roberts, 
1971a, b). A series of experiments conducted by the latter 
authors demonstrated that it can persist up to 29 months, in the 
absence of drug treatment, while being transmitted through tsetse 
and cattle. The persistence of drug-resistant stocks, even after 
passage through tsetse fly, has also been shown by Finelle 
(1973a). On the other hand, Whiteside (1963) has shown that 
T. congolense resistant to diminazene aceturate appeared to be 
unstable during repeated bovine passages. In fact Gray and
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Roberts (1971b) pointed out that the disappearance of drug- 
resistant trypanosomes in the field does not result from reduced 
infectivity for animals or tsetse or from loss of drug- 
resistance. They suggested that the apparent disappearance may 
be caused by a reduction in the proportion of drug-resistant 
trypanosomes in the total trypanosome population in the reservoir 
hosts to a level where they are not easy to detect. Moreover, 
Gray and Roberts (1971a) demonstrated the stability of a 
T. congolense strain resistant to various trypanocidal drugs 
(diminazene aceturate at 7mg/kg, homidium chloride at 2mg/kg and 
isometamidium chloride at 0.5mg/kg) and a T. vivax strain 
resistant to diminazene aceturate at 7mg/kg and quinapyramine at 
5mg/kg, after repeated cyclical transmission.
One important factor which may operate against propagation 
of resistant trypanosomes was their apparent inability to 
transfer resistance to either parasites of the same or different 
strain (Amrein, 1957; Amrein and Fulton, 1959; Amrein, 1965). 
However, the transfer of genetic information between trypanosomes 
has recently been demonstrated during cyclical passage through 
tsetse flies and this may permit transfer of resistance (Hawking, 
1963).
Whiteside (1960) suggested that, if cattle infected with 
drug-resistant congolense or vivax are moved from the 
original area into another area and the use of the trypanocidal 
drug in question is stopped, drug-resistant strains will tend to 
disappear from tsetse in approximately nine months. In his 
observations, Hawking (1963) suggested that loss of resistance 
was presumably due to overgrowth by sensitive individuals which
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have muliplied more rapidly than the resistant ones.
(heliotherapy and Immunity
A number of field studies have suggested that there may be a 
relationship between drugs and immunity in cattle exposed to 
trypanosome challenge. It was Bevan (1928) who apparently first 
suggested that "tolerance" might be produced in cattle by giving 
a trypanocidal drug after infection.
He frequently observed that, though trypanosomes were often 
present, treated animals improved markedly in condition. 
However, when infected blood was injected into susceptible 
untreated animals, the parasites were highly pathogenic. This 
indicated to the author that the host had acquired a degree of 
tolerance or non-sterile immunity to trypanosomes as a result of 
drug therapy.
Following these valuable observations a series of
out
experiments were carriediin East Africa in the 1970s. Initially 
in Uganda, Wilson et al (1975a) studied the performance of a 
breeding herd introduced and maintained for two years in an area 
of heavy trypanosome challenge. Chemotherapy using a short- 
acting curative drug, diminazene aceturate was only given to 
animals on an individual basis whenever their haematocrit fell 
below 20% or if they were clinically ill. During the two years 
of observation period each animal required an average of eight 
treatments, and became parasitaemic again generally about 35 days 
after each treatment. Under this regimen the number of live 
calves bom increased and subsequent calf mortality decreased, 
the incidence of abortion was also reduced.
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In an area of medium trypanosome challenge in Kenya, Wilson 
et al (1975b; 1976), obtained better results using a similar 
system of chemotherapy and the same drug.
Non-sterile immunity to trypanosomiasis has been 
successfully exploited in many commercial situations in Africa 
but it has been rarely monitored and reported. However the 
remaining parasitaemias may act as a constant source of infection 
for the vector (Ruchel, 1975).
The mechanisms of non-sterile immunity still requires 
elucidation; there are several possibilities. It may be that 
there is a limited number of serodemes in a particular area and 
extended maintenance of cattle in such areas under a drug 
umbrella will allow them to develop a degree of immunity to the 
limited range of variant antigenic types (VATs). Alternatively, 
repeated use of drugs may permit the build-up of drug residues in 
cattle which confer protection by restricting parasite 
replication. The development of immunity in cattle in the field 
has been assessed indirectly, by observing the changing needs for 
trypanocidal drug treatment, the ability to maintain normal blood 
values and the ability to gain weight in face of virulent 
trypanosome challenge when drug treatment is discontinued. It 
has also been assessed by the changes in serum immunoglobulin 
levels and the immunofluorescent antibody test as indices of the 
immune status on a herd basis (Wilson et al, 1975a; Wilson, 
1976).
Experimentally, sterile immunity to homologous congolense 
and T. brucei challenge has been readily conferred by a strategy 
of infection and cure (Wilson, Cunningham and Harley, 1969; Akol
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and Murray, 1983). The resultant and protective antibody 
response has been shown to last up to seven months following 
treatment (Wilson and Cunningham, 1972).
Tsetse control
Successful control of tsetse flies only became possible when 
their unique life history and habitat requirements were properly 
understood (Allsop, 1984). Tsetse control can be either non­
chemical control which consists of game destruction, bush 
clearing or chemical control which consists of using insecticides 
by means of either ground spraying or aerial spraying or modem 
targets impregnated with insecticide and chemical attractants. 
Nan-chemical control
(a) Game destruction. The destruction of game is one of the 
processes of eliminating both the tsetse flies and the reservoir 
of infection. This view gained wide acceptance in the wake of the 
great Rinderpest epidemic of 1889-90 and 1896. Many game species 
disappeared at that period in north eastern Africa. Echoing 
Livingstone's words, Bruce, Harvey, Hamerton, Davey and Lady 
(1913) stated "it is self evident that wild animals should not be 
allowed to live in tsetse fly country, where they constitute a 
standing danger to the inhabitants and domestic animals".
This view proved very influential and the first experiment 
to rely largely on elimination of game animals was started in 
Zimbabwe, a similar scenario was enacted in Uganda, South Africa, 
Botswana, Mozambique, Tanzania, Zambia, as well as in small 
campaigns in other countries (Chorley, 1958; Jahnke, 1976; 
Dutoit, 1954; Davies, 1980b; Andrade Silva and Marques da Silva,
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1960; Banage, 1979). The destruction of these animals 
fortunately did not encourage further slaughter of wild animals 
as it soon became evident that these measures were not effective. 
Many setbacks occurred, mainly because of game migration from 
outside the control areas and failure to eradicate the smaller 
animals which live in dense vegetation (Lovemore, 1961).
In Somalia after 1975 many species of wild animals such as 
elephant, giraffe, leopard and black rhinos were extensively 
hunted by the poachers, yet their destruction did not produce any 
significant effects on tsetse infestation of the riverine areas,
(b) Bush clearing. The clearance of vegetation and the use of 
the cleared land for pastoral or agricultural development, thus 
creating an adverse environment for tsetse, are long practised 
successful techniques. In theory the occupation of virgin 
territory then takes place in a controlled and optimum fashion 
(Jahnke, 1976; Jordan, 1979).
In Africa, the countries which carried out major clearing 
programmes included Uganda, Tanzania, Nigeria, Botswana and 
Ghana, and most African countries have attempted the technique on 
a more limited scale. The advantages obtained from bush clearing 
are difficult to quantify because the proportions of total 
clearing was not recorded in many cases. Bush clearing systems 
are not as popular as other tsetse control systems, and 
environmentalists have discouraged the destruction of the 
vegetation in zones which cannot be immediately occupied after 
the clearance.
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Chemical control using insecticides
Game destruction and bush clearing have now been largely 
superseded by the use of insecticides for tsetse control (Jordan, 
1974; Mulligan, 1970; Allsopp, 1984), primarily for reasons of 
cost effectiveness. Only three compounds have been used in large 
scale field programmes dichlorodiphenyl-trichloroethane (DDT), 
dieldrin, and endosulfan.
The persistant organochlorines, DDT became available during 
World War II. The first large scale use of the compounds was in 
Zululand by Dutoit (1954) and the use of DDT spread rapidly to 
all African countries. A single administration of DDT is used 
since the deposits can remain lethal for tsetse up to one year 
after application (Baldry, 1963). However, Dutoit (1954) 
recorded major kills of several non-target insect groups 
following the DDT spraying in Zululand.
Dieldrin is also a residual insecticide. Trials have shown 
dieldrin is better than DDT in tsetse eradication, but has many 
environmental side effects (Burnette, Robinson and Le Roux, 
1957), particularly in places with heavy rainfall.
Endosulfan, at this moment, appears to have operational and 
environmental advantages over DDT and dieldrin because of its 
short term persistence and its good solubility in the spray 
solvents which are suited for aerial spraying (Hocking, Lee, 
Beesley and Matechi, 1966).
Detailed studies conducted by many workers (Douthwaite, Fox, 
Mathiessen and Russell-Smith, 1981 ? Muller, Nagel and Flack, 
1981; Koeman, Rijksen, Smies, Na'Isa and MacLennan, 1971; Koeman, 
Den Boer, Feith, de Longh, Spliethoff, Na'Isa and Spielberger,
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1978) have recorded the severe side effects and environmental 
pollution which the use of insecticides can bring. Of the above 
mention three insecticides endosulfan is recorded to have fewer 
general adverse ecological impacts (Gray, 1983). In Somalia it 
has been found that honey bees and little bee-eaters were at risk 
when dose rates exceed 18g/ha (Douthwaite, 1985).
However, the development of safer and environmentally 
acceptable techniques are urgently required to solve the problem.
Generally tsetse control departments do not consider the 
land use implications of their work, but the National Tsetse and 
Trypanosomiasis Control Project of Somalia is an exception, 
considering some of the wider issues of tsetse eradication 
through an Environment Section. It remains to be seen whether 
the timing of eradication in Somalia will be influenced by this 
section's findings.
Traps and Targets
Different types of traps have been designed to attract and 
catch tsetse flies. Currently, new traps and targets are being 
tested in order to improve their power of attracting and catching 
tsetse flies.
Many workers have recorded that the efficiency of traps 
could be greatly improved if a source of natural host odour 
(Vale, 1974; Hargrove and Vale, 1979) or a mixture of carbon 
dioxide and acetone (simulated host odour) (Vale, 1980) was 
associated with trap. Perhaps, these investigations may bring an 
easy way of controlling tsetse in the future.
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The results obtained from the host odour attractants and 
target development studies carried out in Zimbabwe (Lovemore, 
1986) had led to the creation of the odour-baited, insecticide 
treated target, in the context of tsetse eradication. It was 
observed that this system of odour baited, insecticide treated, 
target would provide a means of dealing with those seemingly 
intractable tsetse 'pockets' which remain from time to time after 
progressive operations through broken terrain. The odour-baited, 
insecticide-treated, targets have also been used as a means of 
setting up invasion barriers, using a single line of baits, 
spaced 100 m apart from each other and in an attempt to eliminate 
or at least reduce re-invasion of land recently cleared of 
tsetse.
Very recently this technique of using odour-attractants and 
targets has been used in a pilot project by Overseas Development 
Administration in the pockets outside the original tsetse 
habitat, of Middle Shabelle Region of Somalia. It was also 
visualised that the system may be able to identify new infested 
areas where the ordinary conical challier traps do not attract 
the tsetse.
Diagnosis of Trypanoscme infection
The diagnosis of the animal trypanosomiasis is not easy. 
Because the signs of trypanosomiasis cover a very wide spectrum, 
and are often difficult to differentiate from other diseases 
(e.g. tick borne diseases), which have the same clinical signs 
such as anaemia and swelling of lymph nodes. In susceptible 
livestock, infection with a virulent strain of trypanosome may 
lead to acute disease with such signs as abortion or a
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haemorrhagic syndrome.
In contrast, in animals relatively tolerant to trypanosome 
infections, there may be no overt signs of ill health. 
Furthermore, the ability of trypanosomes to vary their antigenic 
surface coat (VATs) is associated with intermittent presence of 
parasites in the blood stream. In addition, low parasitaemias 
are characteristic of chronic infections, and since positive 
diagnosis relies upon detection and identification of the 
parasites in the peripheral blood or lymph, many techniques such 
as direct microscopy, using fresh blood and thin or thick films 
give usually a proportion of false negative results.
Some species of the mammalian trypanosomiasis, e.g. 
Trypanosoma (Trypanozoon) brucei brucei can invade the 
cerebrospinal fluid of domestic and wild animals (McCulloch, 
1967; Hornby, 1952) although examination of this fluid is seldom, 
if ever, used as a diagnostic aid in animals, partly no doubt due 
to the technical difficulties involved.
The urine of camels affected by Trypanosoma evansi, has a 
characteristic pungent odour, the cause of which is unknown 
(Hunter, 1986) and this odour is one of the methods by which 
camel herders of Somalia and Sudan are able to separate affected 
animals from the healthy ones. Furthermore, the cattle owners 
along the two rivers (Jubba and Shabelle) of Somalia are able to 
distinguish healthy cattle from the infected animals by the smell 
of the skin of the infected animals which has a characteristic 
strong putrid odour. They also claim to be able to recognise 
chronic infections, in spite of the emaciated clinical condition,
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by the cliphair at the tip of the tail of the infected animal.
However, standard techniques for field use in the diagnosis 
of animal trypanosomiasis include, microscopic examination of 
fresh, wet blood films, dry thick and thin blood films and a wet 
preparation of the buffy coat of centrifuged blood 
microhaematocrit technique (MHCT). Less frequently, the 
inoculation of blood from a suspected case of trypanosomiasis, 
into laboratory rodents (biological test) is practiced. This 
latter test will only distinguish brucei, a proportion of 
T. congolense, but not T^_ vivax infections. However Leeflang, 
Buys and Blotkamp (1976) reported that T. vivax infections during 
the early first parasitaemia phase could infect mice; as there is 
almost invariably a high parasitaemia at this stage the need to 
use this test for diagnosis is rarely necessary.
Blood films
Blood can be examined for the presence of trypanosomes in 
wet (whole blood or buffy coat) or after staining with Giemsa 
stain.
Wet film or whole blood are mainly used when large numbers 
of animals are being examined daily, in particular laboratory 
animals in which high levels of parasitaemia are to be expected.
Wet films are prepared by placing a drop of blood on a 
slide, and covering it with a coverslip. The blood is then 
examined with a microscope for the presence of trypanosome. A 
total magnification of about x 400 is adequate as the movement of 
the trypanosome can be detected by the disturbance produced among 
the red blood cells, especially if examination is carried out 
under phase-contrast or dark-field illumination (Murray, Murray
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and McIntyre, 1 977). The parasitaemia is expressed as 
trypanosomes per field, log equivalent value (Walker, 1968) or 
trypanosome/ml by matching and limited counting (Herbert and 
Lumsden, 1976).
Fixed films of thick and thin blood smears are usually 
stained with Giemsa's stain, although other formulations such as 
Romanovsky - type stain, Fields' and Leishman's stain can be 
used.
Two types of stained blood films are used in trypanosome 
diagnosis, thick and thin films.
'fliick blood films
Of the blood film techniques, thick blood films are the most 
efficient for detecting trypanosomes, particularly for the 
detection of scanty trypanosomes. A small volume of the blood is 
spread over a small circular area of a slide and left to dry 
completely. The film is then either placed directly into water 
or into an aqueous stain such as Giemsa's in order to stain any 
parasites present in the film and to bleach out the haemoglobulin 
in the host red cells - dehaemoglobinisation. Failure to remove 
the haemoglobin will result in a thick layer of stained host 
cells and the subsequent masking of any parasites present in the 
preparation. The lack of methanol fixation of thick films, 
however, results in poor preservation of the morphological 
features of the parasite making species identification difficult 
in such preparations. A staining modification introduced by 
MacLennan (1957) involving an initial one second staining in 0.5% 
aqueous methylene blue can improve the preservation of
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trypanosome morphology in thick films.
Thin blood films allow better preservation of the morphology 
of any trypanosomes present and hence are useful in morphological 
differentiation of species. Thin blood films should consist of a 
single layer of cells and are fixed in methanol before staining. 
The fixation stage results in the preservations of the 
morphological characteristics of the parasite. Thin film 
preparations are eminently suitable for species identification. 
Details of trypanosome morphology are usually studied using x 100 
oil-immersion objective. Species identification is based on 
difference in overall size, the presence of a free flagellum and 
the shape of the posterior end of the organisms and position of 
the kinetoplast. Other features such as the size and position of 
the kinetoplast and the distribution of cytoplasmic organelles 
are also useful.
In large-scale disease surveys it is more convenient to 
prepare thin and thick films from an animal on the same slide 
ensuring that the thin film is fixed in methanol. The thick film 
should be examined first for evidence of trypanosome infection 
and then the thin film can be used for species identification. 
Microhaematocrit centrifugation (MHCT)
This method is designed to increase the probability of 
detecting trypanosomes by using larger volumes of blood than can 
be used in blood film examination and by concentrating any 
parasites present into an easily examined volume. MHCT usually 
involve centrifugation and the separation of the trypanosome from 
host cells in the samples.
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It is important that blood samples are centrifuged for 
sufficient time to ensure the complete packing of host red cells 
e.g. goats blood with relatively small erythrocytes, needs to be 
spun for eight minutes while bovine blood requires only four 
minutes.
In the case of It_ congolense, which is a relatively small 
species, blood samples may first be mixed with a diluent 
containing magnesium ions and glycerol to increase the specific 
gravity of the erythrocytes (Walker, 1972) and this improves 
separation. This method is also known as the capillary 
concentration technique.
The microhaematocrit technique can detect trypanosomes in 
the blood of experimentally infected animals 6-10 days earlier 
than by wet or thick blood film techniques. Ruckmana (1972) 
found the technique useful for the detection of trypanosomes in 
cattle and Robson and Ashkar (1972), Geigy, Mwambu and Kauffmann 
(1971) used the test as an aid to diagnosis of trypanosomiasis in 
game animals.
Recently, small, handheld, battery powered microhaematocrit 
centrifuges, which are useful for field use were introduced, but 
these tend to have a lower sample capacity in terms of capillary 
volume and number than conventional centrifuges. At the same 
time, the packed cell volume (PCV) of the sample can also be 
obtained which indicates the severity of the infection.
Darkground - DG
The use of darkground/phase contrast microscopy to examine 
the buffy coat, has been found to be sensitive in detecting 
trypanosome species and also in identification (Paris, Murray and
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Mcodimba, 1982). . The technique has been recommended by many 
authors including Murray et al (1977), Murray, Murray, Murray, 
Morrison, Pyne and McIntyre (1979) and Dillmann and Townsend 
(1979) who emphasised the superiority of the technique compared 
to other diagnostic methods, such as HCT, thick and wet films. 
In addition, the workers have pointed out the advantage of the 
method over the HCT in the detecting of T. congolense organisms 
because of their sluggish movement. Furthermore, darkground test 
overcame many constraints encountered in other diagnostic 
techniques by allowing identification of trypanosome species even 
at very low concentration (Paris et al, 1982). Each species is 
recognised by its size and the way in which it moved, as 
described by Murray et al (1977). In mixed infections, 
identification is more easily accomplished by the darkground. 
Another advantage offered by the darkground and the HCT is that a 
packed red cell volume (PCV) can be read prior to carrying out 
the parasitological examination.
Silicone Centrifugation technique:-
The silicone centrifugation technique is based on the 
density differences between the hosts erythrocytes and the 
parasites. Under the conditions used, the red cells are pelleted 
by centrifugation through a layer of silicone fluid (density 
1.075) but the trypanosomes will not pass through this layer. 
Ogbunude and Magaji (1982) claim the technique gave results 
comparable to those obtained by the MHCT and by the miniature 
anion exchange chromatography technique.
71
Mini-anion exchange chromatography technique:-
This technique separates trypanosomes from host red cells by 
passing infected blood through a column of diethylamino-ethyl 
cellulose (DEAE). The trypanosomes pass through the column which 
retains the host rbc (Lanham and Godfrey, 1 970). In a 
modification of Lanham and Godfrey’s original technique, the 
eluate is collected in a sealed pasteur pipette which is 
centrifuged and the sealed end examined for trypanosomes under 
the microscope (Lumsden, Kimber and Strange, 1977).
Biological test (animal inoculation)
This technique is less frequently used due to the long 
prepatent periods in commonly used laboratory animals and the 
expense. Furthermore, the technique has been limited to the use 
of laboratory rodents which although useful for brucei- subgroup 
and congolense trypanosomes usually fail to demonstrate the 
presence of Trypanosoma vivax.
Serological tests far diagnosis:-
Many well established tests such as the mercuric chloride 
test, the formol-gel test and the thymol turbidity test which 
rely on increases in the levels of euglobulins (gamma globulins) 
in infected animals are used to detect trypanosomiasis 
(particularly Tj_ evansi) but these tests are not specific for 
trypanosomiasis and are insufficiently reliable for accurate 
diagnosis (Pegram and Scott, 1976).
Recently great improvement in serological techniques has 
been the use of labelled reagents such as the immunofluorescent 
antibody test (IFAT), the enzyme linked immunosorbent assay 
(ELISA) the capillary agglutination test (CAT) and the passive
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haemagglutination test (PHT). None of these tests however, 
differentiates between past and present infection owing to the 
persistence of antibodies for up to 100 days or more after 
chemotherapy has cleared trypanosomes from the blood stream 
(Luckins, Gray and Rae, 1978). Later, a variation of the micro 
ELISA has been developed which enables serum to be tested for the 
presence of trypanosomal antigen (Rae and Luckins, 1984). This 
test indicates when an animal is presently infected with 
trypanosomes, whereas the presence of antibody indicates either 
current infection or infections within the previous several 
months. However, more accurate and specific diagnosis with 
highly sensitive techniques are needed urgently.
Recent developments in molecular biology offer new 
opportunities for more sophisticated diagnostic techniques in the 
future. In particular DNA probes may be used for trypanosome 
species identification, by using single cloned repetitive 
sequences. Such sequences have often been isolated from species- 
specific DNA bands identified after agarose gel electrophoresis 
of endonuclease digested genomic DNA, or from differential 
hybridization of radiolabelled genomic DNA from several species 
to replicate cloned genomic libraries. These techniques have 
considerable potential both to the understanding of trypanosome 
epidemiology and disease detection.
73
CHAPTER TWO
A SURVEY OF BOVINE TRYPANOSOMIASIS IN SOUTHERN SOMALIA
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INTRODUCTION
A cattle trypanosomiasis survey was carried out between 
July, 1984 - July, 1985. The survey covered the southern half of 
Somalia which lies along the Shabelle and Jubba rivers. The six 
regions that were surveyed have an area 262,860 km^ and comprises 
41 per cent of Somalia.
According to the census of 1986 these regions are 
characterised by having 60 per cent of the human population, 50 
per cent of the camels, 77 per cent of the cattle, 15 per cent of 
the sheep and 23 per cent of the goats, and make up the most 
economically complex part of the country.
One of the main obstacles to the development of the 
livestock of the regions that were surveyed is the widespread 
infestations of the main rivers and some of the potentially most 
productive ranges of the country with the tsetse fly which 
transmits the casual agent of trypanosomiasis.
High temperatures combined with dryness and lack of cover 
make conditions in most parts of Somalia unsuitable for the 
tsetse fly (Glossina spp) but it has been known for about 100 
years that infestation is present in the riverine areas (personal 
ccmmmication, Abdullahi).
Generally the tsetse infestation occurs in three distinct 
areas, namely the Shabelle riverine area, the Jubba riverine 
area, and a salient extending from the Kenyan border into the 
drainage lines which flow into the Indian Ocean. It is also 
acknowledged that infestation extends outwards from these 
permanent foci as humidity and vegetation provide favourable 
habitats in the rainy seasons.
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Makin and Rose Innes (1 983) have described the ecological 
conditions and tsetse distribution of the surveyed area. Four 
species of tsetse fly are recognised in Somalia (see map 1) and 
their occurrence and characteristics are as follows
A. Glossina pallidipes -
The most widespread species, mostly feeds on wild animals 
(bush pig, bush buck, warthog and buffalo) often causing a high 
level of trypanosome infection. It also feeds on domestic 
animals and occurs on both the Jubba and Shabelle rivers.
B. Glossina loogipennis -
Occurs in the Shabelle valley intermittently between 
Awdhiigle and Afgooye, and extends up the river to Mahaday. This 
species inhabits rather dry country and takes about one-fifth of 
its meals from bovids and buffaloes, it also feeds on rhinoceros 
and elephants.
C. Glossina brevipalpis -
Occurs on the Shabelle river within the (k_longipennis 
distribution, and on the riverine island of Alessandra in Gilib 
district. This species feeds mostly on bovids and bush pigs.
D. Glossina austeni -
Is found in the valley of the Jubba river and within the 
Mahaday area of the Shabelle river. This species lives in humid 
evergeen thickets and feeds mostly on bovids and bush pigs.
The infestation of tsetse is mostly riverine, but varies in 
width according to the winding paths of the river's drainage and 
the presence of irrigation canals. The regeneration of 
Acacis arabic along the canals also encourages the infestation by
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Map 1 The distribution of Tsetse flies (Glossina)
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providing breeding and resting sites for the tsetse fly.
However, tsetse eradication in Somalia is feasible because 
of the nature of the infestation. The tsetse area of the Jubba 
and Shabelle regions is perhaps the only example in the whole of 
Africa of an isolated or near isolated tsetse population. The 
feasibility of eradication has encouraged the adoption of 
campaigns to rid Somalia of tsetse fly. The first trial was 
carried out using the ground-spraying technique by the 
application of residual insecticides, (Dielderin 15) by knapsack 
sprayers at Golweyn in 1 976 and the spraying of non-persistent 
insecticide from fixed-wing aircraft in 1983 - 1984 in the middle 
and one part of lower Shabelle regions. Recently in 1988, a 
final trial of the formerly sprayed areas was initiated with the 
intention of total eradication of the tsetse infestation from 
that area.
Somali pastoralism is characterised by multi-species herds, 
seasonal migratory movements and split level management 
strategies. However most of the cattle that were sampled in the 
survey were nomadic.
In the dry season when there is a shortage of surface water 
and when grazing is in short supply and at its lowest nutritive 
value, cattle become dependant on the permanent rivers rather 
than water holes for water and so have to be moved into tsetse- 
infested areas along the rivers and are thereby exposed to the 
risk of trypanosome infection (see map 2). The cattle owners 
attempt to control the incidence and effects of trypanosomiasis 
by chemotherapy and chemoprophylactic regimes and by adopting 
midday grazing and watering at night.
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It is extremely difficult to assess the direct losses due to 
trypanosomiasis and the affects of these losses on the national 
economy due to the largely nomadic nature of livestock husbandry, 
the severity of periodic droughts and the presence of the 
intercurrent diseases. In UNDP Reports (1976) it was estimated 
that mortality amounted to 12 per cent of the cattle south of the 
4°N latitude.
In the present survey cattle were examined and blood 
sampled, and their owners were interviewed. The collected data 
was entered on question sheets (Table 3). The survey was 
designed to examine equal numbers of animals within the tsetse 
infested areas and outside such areas but close enough to them to 
be ecologically comparable.
It was against this background that investigations into the 
incidence of trypanosomiasis and the relative occurrence of 
trypanosome species in cattle were carried out in these regions. 
It was hoped that improved knowledge of the epidemiological 
pattern could form part of the basis for a possible new approach 
to drug usage in the control of bovine trypanosomiasis.
MATERIALS AND METHODS 
Examination of Cattle
Clinical History
On the question paper the date on which animals were blood 
sampled, herd serial number, owner's name, animal's name and the 
distinguishing marks of the blood sampled animals were recorded. 
Also, the districts, villages and the residence or location were 
recorded.
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Table 3
Animal nnmo
HTTCP - VETEfUHARY CL1HICAL RECOUP 
_________ Herd / Animal Serial No,
CLlff
/
D i s t i n g u i s h i n g  mnrlca
Species Breed
' lowner'o 
opinion) yra non tlis
sox LLLorJLJ. If female, either, not oalTed*
fllnoe onlycd^ 
now suckling1
or aborted 
lactating*
(inolude
stillbirtlU
or, how many months -
or dry*
Selection — by owner* by us* othor*
Corner weor
Indoors (no.) T/ P score O - 3
Qirtho- 
oiieoT £1
Shoulder height 
Condition Bcoro
Hence age LE2. months
Wlint diBeoseo has tlio animal had in the last 6 months — inolude the presents
Bogan wontha Duration • How many Laat tiae-wecko Effect?
timen Coot Sha ngo (1/T/O)Disease wocko Treated with
Present clinicaJL symptoms, if any — score existence and severity 0 - 3 *  
Swollen nodes Pallor Injection• scars each side of neck /
Describe
SAMPLES TAKEN 
Ear/ve in blood
/ . Thiok .smear* ■tve'
Thin film - B*_ 
Paper opot* ^
Mini* or Micro*
BC* -tve*
^.Parasites seen
Vet fils - B* -tvs'
- BC* -tve*
Score
S coro
-haematocrit - -tve* PCV %
Faeces*
Honiezia
for oorutn* Decanted* frozen ref!
.Two chamber 
_ *65 counta: Strong-yles -ylpides^
Tick county 
Anus
Coccidia 
Hon. on
}{-bodyt Hootril 
Tail _______  Feet
Trichuris^ 
Sedimen- 
tatiom* ____
Ear Underneath 
Tick ‘
Other collection*
• - Write '1' for 'yes', ponitive, or 'sample taken'} 'O' for 'no*, 'none' or 
negative} 'x' for unknown, not answered, not asked or not dono| or enter 
information, nuwbors or scores, a a underll nc d. M,F,T it P moan mole, 
‘female, temporary*and permanent* For 'calved' read 'given birth'*
Hotesi
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Table 3 (Cont'd)
HTTCP - LIVESTOCK DISEASE SURVEY - HERD SUMMARY
Data ______________  Enumerator__________  Herd Serial Ho.
District _____________ Owner's name ___________________________
Village Location ____________________________________
■CAMELS CATTLE SHEEP & GOATS
Approx. Ho. of animals
present- Claimed/Seen / / /
How many of this owner's
stock are not present _____ _ _  ———
type .a )Nomadic/Semi-/Sedentary+ / / / / / /
b)Home/Satellite/Complete+ / / / / / /
What disease problems were ) Now affected Now affected Now affected
seen in the last 6 months i ) ' Recovered Recovered Recovered
Give the No. of animals - ) Dead Dead Dead
1.CBPP / CCPP ___ ___ __  ___ ___ ___ ___ ___ ___
2.Haemorrhagic Septicaemia _____ _____ _____  ____      ___ _ _
3.Trypanosomiasis   _____ _____ *     * _____   *
4 .__________________ __ ________ ___________ ____ __ ________
5 .______ ___________ __ ________ ___________ ____ __  __  __
■ 6.    __________
7._____ ;________ ________________________ ____________
How many abortions or stillbirths - Camels _______ Cattle _____ Shoats _____
* Tryps dead - no. slaughtered/sold " _______ " ___ " _____
The following movements involved - Camels* ___ Cattle* _____ Shoats*___
Movements - In what areas has this herd/flock resided in the last 12 months: 
Months in • Nearest village and/or Tsetse ? (*3) FROM MAPS: Fly
area (»1) description of locality (»2) Graze Water Grid Ref kms pop.
1. __________________________
2.   ___
3 ._______________________________________  ___
4 .___________________________ ______________________
5 . ________________________________________ _______
("1) No. of calendar months, area no. 1 is the present area. C*2) Show 
If one area is 'home1. (#3) Score owner's opinion of challenge 0 to 2.
Reasons for the above movements: Score the most important 2, others 1
1. To find grazing or fodder, .. a '.. < - , .
or just to go homa ~ H<”,e 40 3itel 1---------  ?•--4‘---
2. To find water _____ _____________ ______
3. To avoid tsetse flies ____
If camels have been sampled, how many days ago did they last drink? ______
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Table 3 (Cant'd)
m>
DRUGS - ACCESSiniLITY Aim USAGE (refers to trypanocides unless stated)
1.What drugs have you bought or
used in the last 6 months 7 _______ _____  ____  ____  _____ _____
2.(a) Where do you 6" firet A „Ba„ at vet ofriM D. other M.L.F.tl.
to get drugs 7 —  —
C. Vet assistant visits JJ. Elsewhere
(b) Are you able to get the drugs
you want from A/B/C/D — £lways Usually Sometimes 7
3. (a) How many kilometers to the nearest veterinary office 7 ^
(from where you spent most of the past month) 1
(b) If not first choice in question 2, do you ever get drugs
from the nearest veterinary office or local assistant 7 Yes / Ilo
4.-Your last drug purchase was —
(a) how many weeks ago , (b) from where (A/B/C/D)___,
(c) included which brands 
(d) in what amounts (g/ml/ds)
(e) at what prices (So Shs)
and (f) how much is left (g/ml/ds)
(g) Was all/how much , „ , /n .
or (d) minus (r) C«"»WC.Ule
used on present: ( Sheep 4 Goats _____ ____  _____ _  7
(h) If a container is seen: Batch no. ______ _____ _____ — —  _____*
(i) If response (c) includes Samorin,
did you take it in the form of bulk powder or single doses?
5.(a) Do you ever treat routinely, Cnmols/CatUo Shocp 4 (loots
whether animals are sick or not 7---    c-------
Some All Some All
(b) If 30, how many times per year 7 _____  <___ ____ _____
6 . In the average month in this area how many {Camelg (sh
animals do you treat because they are sick 7 [cattle (Goats
7»(a) In the last 6 months how many animals died Camels/Cattle Shoats
i) because a suitable drug was not available, ______ ____.
or ii) because correct treatment did not work?
(b) Which drug or drugs, if any, did not work?
8. or the trypanocidal drop you have ussd An(. Bep Sam (WEth
in the last 6 months (see question 1): ——  — “----  --- ---— —
(a) Which work the best in: Camels/Cattle +• ____ ____ ____ >
Sheep 4 Goats* ___ _____       7
(b) Wliat about the others, are they OK 7 + ____ ____ ____ ____ .
(c) Do you usually give - - - i) more* ____ ___ ____ ___ ______
than the standard dose, or ii) less* ___       7
9. If you have used Samorin do you know how to make up standard doses from
bulk powder 7 Yes / No
+ - Hark M' for yes, ’O' for no, or not applicable, ’X' if a
question is not asked or not answered. Circle the alternatives.
Assess reliability of responses: Score 'O' to '2' for pages 1 /2 — . _ /
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Sex: The sex of the animal (male or female) was noted.
Normally the animal owners sell the males at the age of three 
years or more in the markets of the large cities. If the males 
in their herds were many in number, the owners usually castrate 
most for fattening. In each herd the owners usually leave 
uncastrated the best male for breeding purposes. For females, 
the general points recorded on the question papers during the 
interview were calving and lactations, such as whether the blood 
sampled animal was in lactation and suckled by the calf, or 
whether the animal was dry. Also the number of months in which 
the animal was in lactation were recorded.
Breed: The breed of every blood sampled animal was recorded 
on the question paper. Surgo, Dawara and Boran were the only 
three breeds that were met during the survey.
Surgo breed is predominantly found in the area between 
Garyooley and Jilib districts. These animals are known for their 
long sharp-pointed horns. The coat colour is a mixture of white 
and red spots, compared with other breeds. Surgo is known for 
its low milk production. Many local people believe that Surgo is 
the most trypanotolerant breed although this has never been 
adequately investigated.
Dawara is found in the Hirraan and Middle Shabelle regions. 
This breed is short-horned with a dark red coloured coat. The 
animals are usually compact, and compared with other breeds, 
Dawara is a good milk and meat producer. One of the 
characteristics of most of the cows of this breed is the milk 
let-down in the absence of the calf, i.e. if the cow aborted in 
its late pregnancy or the calf died early. Because of its
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production level the breed has started to spread slowly into 
Lower Shabelle and some parts of the Jubba area replacing the 
Surgo breed.
The Boran breed of cattle is located nearer the border with 
Kenya or Ethiopia. The breed is known to be intermediate in 
production level. The main owners of this breed in Kenya are the 
Boran tribe and the breed was named after this tribe. The colour 
of the hair of these animals is mostly white. Their horns are 
strong and medium-sized. In addition, these animals are less 
compact than Dawara.
Condition scoring: The condition of each blood sampled
animal was recorded on the question paper. The method employed 
for measuring the condition of the animals was a modified 
Pullan's (1978) method. This depends on whether the ribs of the 
animals were generally visible (excluding when the animal drank 
water) and the profile of the hind leg behind the stifle. The 
condition scores were classified as follows: -
when the animal was pathologically emaciated it scored 0 
when the animal's profile of the hind leg was concave, it 
scored 1
when the animal's profile of the hind leg was approximately 
straight it scored 2
if the profile of the animal's hind leg was convex it scored 
3
if the dorsum lateral to the spinous processes was not 
concave and the lumbar spinous processes were easily 
palpable, it scored 4.
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if the spinous processes were palpable with pressure it 
scored 5
if the spinous processes were not palpable with pressure it 
scored 6
Age: The age of the animal was also recorded on the question 
paper. In Somalia the animal owners usually estimate the age of 
their animals in such a way that the animal is two years old as 
soon as the rainy season of the second year begins. The opinions 
of the owners were recorded on the question paper. In addition, 
the types and the numbers of the visible incisor teeth were 
recorded for each blood sampled animal. If the examined animal 
had eight permanent incisors the degree of wear of the corner 
teeth was scored as follows: -
if the incisors had no visible flattening or wear of the 
upper surface it scored 0
if the area of the worn, upper surface, was long and narrow 
it scored 1
if the area of the worn, upper surface, was elongated oval 
it scored 2
if the area of the worn, upper surface, was approximately 
round or the corner teeth were missing, the animal was 
obviously old and scored 3 
Diseases: During the survey the interviewed cattle owners were
asked to describe the diseases which affected their animals for 
the previous six months (the months before the day each herd was 
blood sampled). The diseases which they enumerated were, 
trypanosomiasis, which according to the opinion of the 
interviewed people appeared the most important disease. Lumpy
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skin disease, an outbreak which affected almost all the cattle in 
the Middle and Lower Shabelle regions during the survey. Most of 
the owners claimed that they had not seen the disease before. 
Abortion was also common, especially in heavily tsetse-infested 
areas.
Among other diseases which the stock owners enumerated were 
haemorrhagic septicaemia, contagious bovine pleuropneumonia, 
anthrax, blackquarter ephemeral fever and other diseases which 
the animal owners called "unknown diseases11. These diseases were 
sporadic, and they usually occurred at regional or village level. 
The district veterinary officers also mentioned that large 
gatherings of animals in some areas were often associated with 
outbreaks of these diseases as occurred for example during the 
dry seasons when animals gather at grazing areas in the vicinity 
of the two rivers. The animal owners were asked further 
questions in order to provide baseline data for the estimation of 
the effects of these diseases. In each herd, the owner stated 
the number of animals affected by each disease. The responses to 
specific questions on the numbers of animals affected and 
recovered, affected and still sick, or affected and died, were 
also recorded.
Movements: Normally nomadic herds experienced various
movements per year, while semi-nomadic herds with two resident 
sites experienced one move between the two sites. The owners of 
nomadic and semi-nomadic herds were asked the areas in which 
their animals had resided in the last twelve months. 
Furthermore, the owners were asked the number of months in which
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their animals reside at each site. The owners opinion of the 
risks of tsetse fly at the sites at which their animals grazed or 
drank water were recorded. The main reasons for the movements of 
the herds were, to find grazing, water, or to avoid tsetse flies. 
However some herd owners have mentioned other minor reasons, 
therefore the most important reasons were scored 2, others were 
scored 1.
Clinical examination: At the clinical examination, wet-films,
thin films and thick films, prepared from blood samples collected 
from the jugular veins of the individual animals were examined 
microscopically in order to detect the presence of trypanosomes 
and to differentiate between trypanosome species. Scores were 
given to the positive wet films. The results obtained from each 
diagnostic technique was recorded on the question paper. In 
addition, the PCV of the blood sampled animals was measured and 
recorded after centrifuging with either a mini-centrifuge (Compur 
electronic) or microhaematocrit centrifuge (Hawksley).
Clean evacuated tubes were used to collect blood samples. 
The blood was allowed to clot and serum was drawn off by pasteur 
pipette into clean tubes. Thereafter, the serum was frozen for 
serological testing and recorded on the question papers. 
Similarly, for later serological testing, drops of blood were 
spotted on to filter papers (Whatman) and were recorded on the 
question papers before stored. (Serological tests were not 
conducted by the author and the results are therefore not 
included in this thesis).
All other blood parasites observed in wet-films were also 
recorded. The most common one was microfilariae. Faecal samples
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of the animals were examined by a simplified "McMaster" technique 
and the eggs of various species of parasites, such as 
Stronqloides, Trichuris , Ascaris, Moniezia, Coccidia, 
Paraphistcmum cervi and other trematodes were recorded. Some of 
the sampled animals were selected systematically by the 
veterinary team while others were selected by the owners. During 
the survey, complete half-body tick counts were carried out 
systematically on some selected cattle and recorded according to 
both attachment site and identity. The sites were, nostril, ear, 
perineum, tail and feet. The peripheral lymph nodes were 
examined for signs of swelling. The pallor of each animal was 
recorded after the conjunctivae of both eyes and mucous membranes 
were examined. In addition the injection scars formed by 
trypanocidal drug injections on both sides of the neck of every 
animal were counted and recorded.
Drugs
In order to determine the availability and utilisation of 
trypanocidal drugs, the animal owners were asked to state the 
drugs that they bought and used in the last six months. Having 
stated the drugs that they bought, the owners were asked whether 
they went first to get their drugs from the nearest veterinary 
office or whether the veterinary assistant visited them 
regularly. When the owners mentioned their preference they were 
asked whether they got the drug and the amount that they wanted 
from the preferred source - always, usually or sometimes. 
However, in order to record the distance to the nearest 
veterinary office, the owners were asked to say where the nearest
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veterinary office was, or where the nearest veterinary assistant, 
who retailed drugs, resided, and the distance from the present 
homestead or cattle camp was recorded.
During the interview the animal owners were asked to list 
the brands included in their most recent purchase of drugs, and 
also to state the source, the quantities acquired, the price paid 
and the quantities remaining unused. Furthermore, if the owners 
mentioned that they bought Samorin, they were asked whether they 
bought in bulk or in small doses and whether they knew how to 
make up standard doses from the bulk powder. Likewise the animal 
owners were asked whether they treated all of their animals 
routinely regardless of whether animals were sick or not or 
whether they treated only the sick animals. If they treated 
routinely how many times per year. Owners were also asked the 
average number of sick animals which they treat monthly in each 
residence area. In addition the owners were asked the total of 
animals which died for lack of trypanocidal drugs or when the 
correct treatment did not work. If any drug did not work, the 
owners were asked to state the drug or drugs which did not work. 
The owners were also asked which trypanocidal drug they 
considered the best, and whether they considered that the others 
they had used in the last six months performed satisfactorily. 
The owners were asked whether they customarily used either a 
higher or lower dose than the standard dose.
Collection of Blood Samples
Cattle owners were asked to bring all their cattle for 
examination. Blood samples were collected in pairs of evacuated 
tubes, from the jugular vein. One sample was collected into an
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evacuated tube (vacutainer) containing the potassium salt of 
ethylenediamine tetra-acetic acid (EDTA) and the second sample in 
a clear tube for serum collections. The blood in the serum tube 
was kept in the shade until it clotted. The clotted blood was 
kept surrounded by ice in a cool box, and usually the serum was 
removed with pasteur pipettes over one, two or sometimes three 
consecutive days. All sera were inactivated at 56°C for 30 
minutes, and then kept at -20°C in plastic ampoules after it 
arrived at Mogadisho.
Examination of Blood Samples
Evacuated tubes with EDTA anti-coagulant were used for 
immediate testing of blood samples. Standard microscope slides 
were used, except when making direct examinations of mini­
centrifuge tubes and packed cell volume (PCV) measurements. For 
wet films, one drop of blood on a slide was slightly compressed 
under a coverslip and examined as soon as possible using semi­
dark ground illumination. This was obtained by partially closing 
the condenser diaphragm (Killick-Kendrick, 1968).
The microscopes used were Wild M11 binocular student 
microscopes with 6 volt illumination in the base operated by an 
extension cord from one half of a Land-Rover battery.
Initially the packed cell volume (PCV) was measured after 
the accomplishment of the day's sampling, with a Hawksley 
microhaematocritic centrifuge powered by a portable generator. 
Later a mini-centrifuge (Compur M1101) powered by 12, 7 or 5 
volts from a Land Rover battery was used.
Wet films were prepared from the buffy coat region of the
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microhaematocrit tubes (Paris et al, 1982; Murray, Trail, Turner 
and Wissocq, 1983), usually after reading of the PCV. This was 
only possible when time permitted preparation of films within 4 
hours of collection. When the tubes were examined directly, 
immediately after recording the PCV, they were put in a drop of 
water under a coverslip and the area of the buffy coat and 
adjacent supernatant was scanned at x 400 magnification. If 
positive, the magnification was increased to x 600 to assist 
species identification. The tubes were cut 1mm below the top of 
the red cell column and 1 mm of red cells was mixed on a slide 
with about 4mm of the adjacent plasma and examined.
Using a modification of the method of Paris et al (1982), 
the wet films (whole blood or buffy coat) were given scores. The 
scores were classified as following; depending on the number of 
trypanoscmes found in 80 fields.
* If only 1 trypanosome seen in 80 fields the score was 1
* If 2-9 trypanosomas seen in 80 fields the score was 2
* If 10-79 trypanoscmes seen in 80 fields the score was 3
* If 1 -9 trypanoscmes seen per field it was scored 4
* If 10-99 trypanosomes seen per field it was scored 5
* If the trypanosomes were 100 or more per field it was scored 
6
Thick smears were prepared separately, after finishing other 
tests, dried and haemolysed in water before staining. Later in 
the investigation, both thick and thin films were prepared 
together on the same slide in order to help identification of 
trypanosomes seen in other tests or if the PCV was lower than 
18%, these were haemolysed in the stain. For fixation, thin
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films were fixed for 30 seconds in absolute methanol before 
staining for 30 minutes, in a 10% dilution of Giemsa concentrate, 
freshly prepared each day.
In the case of stained preparations, over 80 fields were 
searched in order to determine whether the animals had a mixed 
infection (especially in animals suspected of being infected). 
Sampling
Healthy animals were poorly represented, particularly in the 
areas with the greatest trypanosomiasis problem. Only a few 
owners allowed the survey team to select animals and others 
expected their problem animals to be examined first. Some owners 
expected exclusive examination of their sick animals. Because of 
this, the intention of examining equal numbers of sick and 
healthy animals was not successful. From sunrise, until the 
herds left the cattle pen or stable for the day's grazing, a team 
was able to examine 30-40 animals selected from four or five 
different herds in the same village or nearby area in a typical 
day.
Faecal samples were routinely taken from every sixth animal 
in sequence, and from others as requested by the owners. Faecal 
sampling and examination was useful in the context of public 
relations, providing concrete results about a disease which 
farmers understand. Examination of faeces was done by flotation 
in saturated sodium chloride solution (a simplified McMaster 
Method) and some were examined by sedimentation for fluke eggs. 
Statistical Methods
Two statistical methods of analysis were used, namely Chi-
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Square tests and Logistic regression. Chi-Square tests 
investigate whether there is a significant association between 
two unordered categorical variables.
Logistic regression is used to model how a binary variable 
e.g. whether an animal has or has not T^_ congolense, depends on 
an ordered variable e.g. PCV range. It assumes that for example 
the logarithm of the odds on an animal having T. congolense is a 
linear function of an explanatory variable such as PCV range. A 
test of goodness of fit of the model and a test of whether the 
slope of such a function is significantly different from zero 
were both carried out at a 5% significance level. ('Using and 
Understanding Medical Statistics' by D.E. Matthews and V. 
Farewell (Karger), 1985).
RESULTS
A total of 4,152 cattle in 54 herds were examined. Of 
these, 246 cattle were examined mainly for public relation 
purposes, and therefore detailed histories were not obtained from 
these animals, because they were isolated animals from the 
various herds.
Table 4 shows that the highest number of herds examined were 
from Qoryooley, Jilib and Jamaame districts and the lowest number 
of herds from Kismayo district. Of the first three districts, 
each was surveyed on at least two separate occasions, because 
various herds from different places, were concentrated in these 
districts during the dry season in search of fodder. It appeared 
a good opportunity to examine animals in the endemic areas of 
trypanosomiasis.
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Table 4
The location and numbers of cattle examined in the survey
Total Total No. of Cattle Cattle Mean Percent
District herds cattle herds present examined herd examined
examined examined size
Buulobarde 23 173 21 647 151 31 23
Jowhar 31 292 29 1,694 284 58 17
Bajacad. 21 184 21 1,293 184 62 14
Afgooye 11 100 9 657 95 73 14
Marka 64 453 57 2,801 438 48 16
Qoryooley 87 634 68 3,140 547 46 17
Sablaale 11 90 11 394 83 36 21
Baraawe 48 370 49 3,101 367 63 12
Saakow 27 268 21 1,142 239 54 21
Bu,aale 12 77 12 734 66 61 9
Jilib 61 495 59 1,668 491 28 29
Jamaame 60 426 55 1,108 397 20 36
Afmadow 8 62 8 279 62 35 22
Kismayo 2 31 2 300 31 150 10
Buur,hakeba 10 61 10 172 61 17 35
Baydhabo 32 211 28 360 206 13 57
Diinsoor 38 225 35 1,044 204 30 20
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The few camel herds that were blood sampled and the flocks 
of goats and sheep were not included in the table. In order to 
establish a demarcation line between the animals in the sprayed 
and non-sprayed areas, six herds from the western side of Afgooye 
district were included in the Marka district. This was done 
because on the eastern side of Afgooye district the aerial 
spray trials were being carried out.
The herds in Kismayo and Afmadow districts were bled in the 
wet season, and it was not possible to obtain blood samples from 
sufficient numbers of cattle, except in a few herds. Therefore 
these herds were included with the Jamaame herds as these herds 
were close to the latter district.
The first four districts (see Table 4) were within an aerial 
spray area. The second ten districts were surveyed and it was 
confirmed that they were heavily infested with tsetse flies. The 
last three districts were all in the Bay Region which is known to 
be tsetse-free. These herds were blood sampled in order to 
determine whether mechanically transmitted vivax infections 
were occurring outside the tsetse belt. However, examination of 
blood films from these herds failed to detect any evidence of 
infection.
Tcypanosane Species
Wet film examination has been demonstrated to be a fairly 
accurate method for the identification of a single species. 
However, when mixed infections occur with the two pathogenic 
species (T^  congolense and T^_ vivax) the rapid movements of 
T. vivax may overshadow the sluggish movements of T^ congolense, 
particularly when the parasitaemia of the latter species is low.
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Inaccurate identification may also occur between congolense 
and brucei and a strain of congolense which was sent to 
Kenya for drug-resistance testing was eventually identified as a 
T. brucei strain. As no T^_ brucei strain was identified in the 
survey, it is possible that some brucei infections may have 
been missed. ,
A few strains of presumably evansi were observed from the 
wet films of some infected camels. These camels were brought for 
examination by their owners and as t h e camels were originally 
from a tsetse-free area, it is likely that Tabanidae had infected 
them mechanically. When the camels were blood sampled, they were 
in a Riverine area, but no tsetse-transmitted trypanosomes were 
detected in their blood. No simiae or theileri were met 
during the survey (although no warthogs or bushpigs were bled).
By reference to a small scale map showing the density and 
distribution of tsetse fly along the two rivers (prepared by Dr. 
Leigh Brown of NTTCP Somalia), tsetse habitat categories were 
classified as follows. If the working site was more than 50km 
away from a known tsetse habitat, it was characterised as 
category 0. If the working site was more than 5km but less than 
50km from tsetse habitat it was characterised as category 1. If 
the working site was outside the tsetse habitat, but within 5km 
it was characterised as category 2. Sites found inside the 
tsetse-infested zones, were classified according to the mean
number of tsetse flies caught by the traps in the last 24 hours.
v
(a) If the number of flies caught were less than two per trap,
category 3.
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(b) If the number of flies caught were between two and 20 flies 
per trap, category 4.
(c) If the results of the last 24 hours were more than 20 flies 
per trap, category 5.
The results of positive diagnosis of trypanosomiasis were 
compared with the various tsetse-challenge category zones of the 
period from two months to two weeks prior to sampling and the 
results are shown in Table 5.
The results show an overall infection level of 10%. No 
positive cases were observed in Category 0. Statistical analysis 
of the results in categories 1 to 5 show that the percentage of 
T. congolense infections show a significant increasing (linear 
logistic) trend with challenge category. However the percentage 
of T^ _ vivax infections shows no trend with challenge category. 
Challenge category 5 gave unexpectedly low levels of infection 
possibly because the stock owners have adopted several techniques 
to minimising the risks of tsetse challenge, such as watering and 
grazing their stock at night, grazing during the midday and even 
zero grazing. It should also be noted from the Table that a 
relatively high number of unidentified trypanosomes were 
recorded.
Haematological tests and wet film scares
The number of tests done during the survey were restricted
s.
by the availability of manpower, however, the following tests 
were performed, namely wet films (whole blood or buffy coat), 
stained smears (thin and thick films) and direct viewing of 
micrahaematocrit tubes.
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Table 6 shows a comparison between each type of test carried 
out and the positive samples obtained by each test. The Table 
illustrates that wet film examination of whole blood and direct 
viewing through microhaematocrit tube showed an equal degree in 
sensitivity for the two pathogenic trypanosomes. The Table also 
indicates that direct wet film examination was the best for 
detection and recognition of T. congolense infections.
The number of samples in the different wet film scores, were 
compared with infections of congolense and vivax and the 
results are shown in Table 7. The wet film scores indicated the 
existence of higher levels of infection with T. congolense in the 
first three scores (1-3) and low numbers of T. congolense in 
score categories 4 and 5, a suggestion of lower parasitaemias in 
T. congolense infections.
In T^ vivax infections the distribution was more evenly 
spread and fulminating parasitaemias were recorded with scores of 
4-5. Thus in general T^ vivax infections tended to have higher 
parasitaemias than T. congolense (Chi-Square Test).
Backed Oell Volume
Anaemia is a major feature of animal trypanosomiasis and is 
a reliable indicator of the progress of the disease. Table 8 
compares the numbers of positive and negative samples in a range 
of PCV classes. The Table shows a significant (linear logistic) 
trend between the percentage of positive samples and PCV.
The Table also indicates that the PCV of five positive 
animals were above the range of 30%. However, it may be that the 
parasites only appeared in the blood either on the day of
100
Table 6
A comparison of tests for the diagnosis of trypanosomiasis 
on the same positive animals
Tests • Positive for Trypanosome 
Performed Unidentified T. congolense T. vivax Total
i) Wet film and 6 86 47 139
buffy coat 5 53 45 103
ii) Wet film and 8 96 46 150
through the
tube 26 85 48 159
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Table 7
A comparison of wet film scores for T. congolense and 
T. vivax infections
Range represented 
by each score 1
Wet Film Scores 
2 3 4 5
Total
Samples
Scored
T.congolense 61 89 21 4 0 175
T. vivax 28 31 20 12 5 96
Total 89 120 41 16 5 271
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Table 8
A comparison of the numbers of positive and negative samples 
for trypanosome infections in a range of P.C.V. classes
P.C.V. range
Number of 
positive samples
Percent
positive
Number of 
negative samples
Over - 30 5 1.9 257
25 - 30 38 3.8 968
19 - 24 148 9.2 1,452
13 - 18 142 15.4 778
Under - 13 77 28.6 192
Total
Overall 410 10.1 3,647
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sampling or a few days before. The PCV level of some positive 
animals had fallen below 13%, an indication of severe infections 
or a combination of other factors.
Of the negative animals, nearly half the haemoatocrits 
ranged between 19-24% and indicated the existence of generalised 
anaemia in the cattle. The combinations of malnutrition, 
trypanosomiasis, tick-borne disease and helminths could have been 
the cause of the low PCV ranges that were observed.
Other Clinical Signs
Swollen lynph nodes
In the early stages of infection when the parasitaemia is 
readily detected there is intermittent pyrexia. At this time the 
superficial lymph nodes are palpably enlarged. The degree of 
swelling of the prescapular lymph nodes of the sampled animals 
was scored on a scale of 0, 1, 2 and 3. The last category was 
kept for grossly enlarged or abcessed and deformed nodes.
Tables 9A and 9B show the lymph node swelling scores 
according to the current challenge category of the herds and 
whether the animal was positive or negative on wet film 
examination for trypanosome infection.
Table 9A shows that the animals with higher lymph node 
scores tended to be in higher challenge categories. However, 
animals with enlarged nodes were found both in the fringes and 
far beyond the tsetse habitat. Of all the challenge categories 
the one with the highest tsetse challenge, category 5 had low 
lymph node scores. This may have been due to low stock density 
in the high tsetse challenge category 5 and also due to the fact 
that stock owners in these areas have adopted techniques of
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Table 9 (A and B)
The degree of lymph node swelling in cattle in different 
categories of tsetse challenge and trypanosome infection
A.
Challenge Category 
(2 months to 2 weeks)
0
1
2
3
4 
.5
B.
Diagnosis
i) Trypanosome infection 
Unidentified
T,congolense 
T. vivax 
Both
ii) Total of positives
iii) Total of negatives
Lymph node swelling score
1 2 3
345 47 4
393 84 5
508 143 15
757 129 13
500 170 16
77 18 1
Lymph node swelling score
1 2 3
27 11 1
151 46 8
82 24 3
3 1
263 82 12
2,317 509 42
0
91
114
212
241
163
34
0
6
34
18
58
797
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conserving their animals, such as zero grazing.
Table 9B does not indicate any marked differences in the 
size of the lymph nodes between animals infected with 
T. congolense or vivax, but the Table does confirm the 
existence of a significant trend between the presence of 
infection and lymph node swelling.
Pallor
One of the major features of trypanosomiasis in cattle is 
anaemia which is seen as pallor of mucous membranes. The 
conjunctiva of the eyes or the mucous membranes of the animals 
were assessed and the degree of pallor given a score on a scale 
of 0 to 3. The mucous membranes of many animals that were blood 
sampled was pigmented and therefore pallor was unlikely to be a 
useful substitute for PCV in the detection of anaemia (at least in 
this survey).
Table 10A shows that none of the positive animals scored 
scale 3 on the pallor score but three of the animals which had 
been microscopically negative, proved to be scale 3. The scores 
of most of the positive animals were 0 or 1. Generally, the 
pallor of the positive animals did not show any marked difference 
depending on which of the two species of trypanosome was present. 
However, the table indicated a significant (linear logistic) 
trend with pallor and infection with both T^_ congolense and 
T. vivax. There was also a significant association between 
pallor and PCV range, i.e. as the PCV decreased there was a 
general tendency for pallor to increase (Table 10B).
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Table 10 (A and B)
Ihe degree of pallor in cattle with different categories of 
trypanosome infection and haematocrit value (PCV)
A.
Diagnosis 0
Pallor Score 
1 2 3
i) Trypanosome 
infection
Unidentified 30 14 1
T.congolense 151 80 8
T. vivax 76 44 6
Both 2 1 1
ii) Total positives 259 139 16
iii) Total negatives 2,818 768 72 3
B. P.C.V. range 
Over -30 236 17 1
25-30 884 97 4
19 - 24 1,226 327 18
13-18 556 324 30
Under - 13 113 115 33 2
107
Injection scars
One of the problems with some trypanocidal drugs is the 
reaction to the drugs themselves, causing necrosis at the site of 
the injection. Accordingly the injection scars were scored to a 
maximum of six but sometimes when there was widespread 
deformities of the neck skin of the animal the extent of the 
deformity was scored on a scale of 0 to 3 on each side. These 
scores were later summated, as probably most of the lesions were 
several months old. The lesions represented the number of 
treatments experienced by the animal during its life. The 
majority of the scars or swelling were thought to be caused by 
injections of isometamidium chloride (Samorin), and this may be 
due to the following reasons
(i) Injected Samorin forms a deposit of drug at the injection 
site and from this deposit the drug is released over a period 
into the circulating blood (this is the reason that Samorin has a 
marked prophylactic action, in comparison with other trypanocidal 
drugs) and around the drug's deposit a marked tissue reaction is 
formed with consequential scar formation; (ii) sometimes the 
injection site may be contaminated by bacteria and this can 
happen with any drug; (iii) due to inaccuracy of deep injections 
the drug leaks back into a subcutaneous site.
Table 11 shows the mean of the injection scar scores of the 
animals found to be microscopically positive or negative in each 
of the tsetse challenge categories of the preceding two months. 
The figures in brackets represent the number of cattle from which 
each mean was determined.
108
Table 11
Hie severity of injection site scarring in cattle with different 
categories of challenge and trypanosane infection
Diagnosis
1
Challenge Category 
2 3 4 5 iOverall
i) Trypanosomes
Unidentified 3.7(3) 2.4(8) 1.2(16) 1.5(17) 5.0(1) 1.8(45)
T.conqolense 2.3(32) 2.4(41) 2.2(88) 2.4(67) 4.5(10) 2.4(238)
T. vivax 1.4(11) 1.6(37) 1.2(89) 1.6(34) 2.8(5) 1.5(126)
Both 1 2 (1) 1 (2) 1.2(4)
ii) All positive 2.2(46) 2.0(87) 1.8(44) 2.0(120) 4.0(16) 2.0(413)
iii) Negative 1.2(545) 1.4(789) 1.4(995) 1.8(729) 2.8(600) 1.7(3656)
Figures in parenthesis represent the number of cattle in each group
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The Table shows that the injections scores were highest in 
challenge zone 5. It appeared that cattle recently affected by 
the disease had received a higher number of injections over the 
long term compared to the recently negative cattle. Perhaps the 
difference was due to injections within the time-span of the 
current incident of trypanosomiasis. In other words, the 
necrosis formed by the recent treatments were still visible. The 
animals infected by Tt_ congolense had almost twice as many 
palpable injection scars as those animals infected by T. vivax. 
Moreover, the results of the Table illustrate that the mean of 
the mixed infections were relatively small in number.
Age Susceptibility
There are indications that young animals may be less 
susceptible to trypanosomiasis than adults. Table 12 shows the 
results of studying the possibility that T^ _ vivax and 
T. congolense species could differ in the frequency of their 
occurrence in cattle of various ages. The Table shows that the 
number of animals infected with T^ congolense increases as the 
age of the animals increase, and T. congolense is the most 
predominant species in infections of the older animal. In 
contrast there is no trend between T^_ vivax infection and age. 
In Somalia, cattle owners usually sell their oxen at early ages, 
therefore the increasing overall percentage of infections with 
T. congolense from 18 months of age may reflect the increasing 
percentage of female cattle in the population, and the 
combination of various factors such as malnutrition, pregnancy 
and lactation may affect the ability of these animals to build up 
immunity against the disease.
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Table 12
Hie relationship between cattle age and the incidence of trypanosane infection
Diagnosis
0.0-0.5
Age range (years) 
0.6-1.5 1.6-3.5 3.6-7.5 Over 7.5 Total
i) Trypanosome 
infection
Unidentified 3 9 9 20 4 45
T.conqolense 10 22 37 121 48 238
T. vivax 13 23 32 46 13 127
Both 2 1 1 4
ii) Total of 
positives
26 54 80 188 66 414
iii) Negatives 299 562 624 1,196 472 3,153
iv) Absolute % of 
animal infected
T.conqolense 3.1 3.6 5.3 8.7 8.9 6.7
T.vivax 4.0 3.7 4.5 3.3 2.4 3.6
Overall 7.1 7.3 9.8 12.0 11.3 10.5
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Treatment
Cattle owners were asked during which of the two seasons 
(wet or dry season) they usually gave more treatment to their 
cattle. The interviews were done during the dry season as no 
survey was carried out during the wet season due to 
inaccessibility of the cattle herds. Therefore, the percentage 
of animals was biased towards the dry season situation where 
semi-sedentary and nomadic herds are more in contact with tsetse 
flies. The need for treatment may be affected by the movement 
patterns. The results of the interviews are compiled in 
Table 13. From the Table it can be noted that there is not much 
difference in treatments of the two seasons of the sedentary 
cattle. But in the semi-sedentary or nomadic cattle, more 
treatments are given in the dry season than in the wet season. 
However, these animals move away from the tsetse belts in the wet 
seasons, which could save the animals from the risk of 
trypanosomiasis and also reduce drug costs.
Therapy of animals with symptoms
Animals affected by trypanosomiasis were usually treated by 
their owners as soon as they observed clinical symptoms, and 
there after continuing treatments are given at intervals of days 
or weeks until the animal recovers. The animal owners were 
either mixing two different trypanocidal drugs e.g. Samorin and 
Berenil, interchanging one with another or repeating treatment 
with the same drug.
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Table 13
The reports of frequency of trypanocidal drug treatments 
in different seasons and differing herd management
Treatments Sedentary Semi-Sedentary Ncmadic Overall
More in 
wet season
54 38 32 124
More in 
dry season
46 62 68 176
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Table 14 shows the drugs used by the cattle owners during 
the preceding month and it is apparent that Berenil and Samorin 
were equally used by the animal owners at least for the first 
injections. But, in contrast to this, the animal owners took 
diminazene aceturate as their drug of choice in the repeated 
injections.
Probably, the reasons why animal owners prefer diminazine 
aceturate for repeated injections are that the drug does not 
create skin reactions at the injection sites, like isometamidium. 
Also the animal owners believed that Berenil does not affect milk 
production of the treated animal, in contrast to isometamidium. 
Finally the owners feel that this drug permanently cures the 
infections whilst isometamidium according to the animal owners 
often fails to clear the parasites from the blood.
Drug Preference
The animal owners were asked first of all, which 
trypanocidal drug they thought the best and then whether they 
believe the other drugs they had administered to their cattle in 
the previous six months had worked adequately or not.
Table 15 shows the results of their responses. The Table 
illustrates that diminazene aceturate and isometamidium chloride 
appeared to be equally popular first choices of trypanocidal 
drugs for treatment. On the other hand ethidium and novidium are 
listed in the satisfactory category. It appears that if 
resistance by trypanosomes is encountered by animal owners they 
use Berenil and Samorin alternatively. Some owners added 
supplementary remarks to the effect that they observed relapses
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Table 14
Trypanocidal drug usage by cattle craners during the 
preceding month
Repeat
Injections None
First Injections 
Berenil Samorin Ethidium or
Novidium
Total
None 176 343 344 102 965
Berenil 27 48 12 87
Samorin 42 4 3 49
Ethidium or 
Novidium 19 6 11 36
Total cases 176 431 402 128 1,137
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Table 15
Overall trypanocidal drug preferences by cattle owners
Berenil Samorin Ethidium or 
Novidium
Other
First choice 
(or equal 1st) 166 114 55 2
Also satisfactory 59 58 72 3
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after Berenil treatments, and a temporary reduction of milk 
production after Samorin had been given, with subsequent necrosis 
at the injection sites.
Dosages
In the interview, the animal owners were asked whether they 
gave their cattle the recommended doses, or if they commonly 
treated the affected animals with either an overdose or 
underdose. The majority of the people responded that they gave 
double doses of Samorin, if the animals did not respond 
immediately to the initial injection. A relatively small number 
of the people mentioned that they usually gave higher doses at 
the beginning. In most cases the owners stated that they used 
the standard dose of each drug, even in the mixed form or 
simultaneous injections of two different drugs. However, none of 
the interviewed people admitted to drug failure due to mal­
administration or using reconstituted trypanocidal drugs in the 
field. These could have contributed to the development of drug 
resistance which may have gradually developed without the animal 
owners becoming aware that resistance was developing.
Samorin
Isometamidium chloride is known for its chemotherapy and 
chemoprophylactic activities, but in Somalia most of the animal 
owners usually use it for chemotherapy only. Those interviewed 
mentioned the difficulty of preparing the requisite dose of 
Samorin from the 10g bulk packet. However, the doses they use to 
treat their animals, are either prepared by veterinary assistants 
or by the retailers. Thus, these pre-prepared doses of Samorin 
may result in underdosing due to the adsorption of the drug onto
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the paper in which it was wrapped. In addition, profiteering by 
unscrupulous retailers may also produce underdosing. Therefore 
the impression which animal owners have is that using these 
prepared doses of Samorin the actual weight of the dose which is 
administered to their animals is usually less than that which is 
recommended.
In the interviews, the animal owners reported that some of 
their animals died from trypanosomiasis. They were therefore 
asked the number of animals which had died due to the 
unavailability of a suitable drug at the time the sick animals 
required treatment. One hundred and seventy three (15%) of 1,102 
deaths were attributed to the lack of drugs, by 26 out of 346 
owners interviewed.
Similarly, the animal owners were asked when they obtained a 
suitable drug and used the correct dose level how many treatments 
were unsuccessful. Seventy two of the 346 owners interviewed 
attributed 740 deaths to the unsatisfactory performance of either 
Berenil or Samorin. This represents 76% of all mortality from 
suspected trypanosomiasis. Those animals were the ones they 
named "Salaaf". Therefore the results of the interviews strongly 
supports the existence of drug resistance.
Health status
The health status of the cattle which were blood sampled was 
classified by asking the owners whether trypanosomiasis had 
affected their animals recently or in the past six months. They 
were also asked if some other unrecognised sickness other than 
trypanosomiasis had affected their animals or had they been
118
continuously healthy for the past six months. The results of the 
interview are compiled in Table 16. The Table shows the numbers 
of animals sampled according to their health status and tsetse 
challenge category of the herd for the period from two months to 
two weeks before sampling. The proportions of 'allegedly 
healthy1 cattle are significantly different across the different 
challenge categories but they do not follow a linear logistic 
model as does the corresponding data in Table 5.
Trypanotolerance
In Somalia there are three local breeds of cattle, Surgo, 
Boran and Dawara. Various groups of cattle owners have suggested 
that the Surgo breed is tolerant to trypanosomiasis. They 
believe this is the reason that the latter breed has become the 
most dominant one throughout the areas south and west of 
Qoryooley excluding Jamamme district. However, comparing them to 
the other two breeds, Surgo appears less productive in milk and 
meat. The question was whether or not cattle of the Surgo breed 
could resist or tolerate trypanosome species relatively better 
than cattle of the other breeds.
Table 17 shows the numbers of positive animals of these 
breeds according to their wet film scores and infection with 
trypanosomes. Statistical analysis showed that there is no 
significant relationship between the wet film score and breed for 
either T. congolense, T. vivax or the total number of positives. 
Thus there is no evidence from these results to support the view 
that the Surgo breed has lower levels of parasitaemia than the 
Boran and Dawara breeds.
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Table 16
The opinions of cattle owners on the health status of their 
animals in various challenge categories
Challenge
Category
Allegedly Affected 
by Trypanosomiasis
Now Formerly
Allegedly
Healthy Total
0 0 1 479 480
1 171 22 313 506
2 422 57 308 787
3 533 99 404 1,036
4 455 87 203 745
5 63 14 33 110
Totals 1,644 280 1,740 3,664
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Table 17
The incidence of trypanoscme infections in three local 
Sanali breeds of cattle
Wet Film 
Scores
Boran
congolense vivax
Dawara
congolense vivax
Surgo
congolense Vivax
3 and 
Over
4 4 9 11 11 21
2 14 1 34 10 38 18
1 10 2 21 9 27 15
Not
Available
8 5 23 10 33 15
Total 36 12 87 40 109 69
Per 100
Cattle
Sampled
75 25 69 31 61 39
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DISCUSSION
Trypanosomiasis in the riverine areas of Somalia is such 
that it is necessary to treat most of the cattle during the dry 
season to prevent the debilitating effects and loss of production 
caused by infections of T^_ congolense and vivax. The 
incidence of infections with T  ^congolense showed a significantly 
increasing trend with the level of tsetse challenge, whilst the 
incidence of TL_ vivax infections showed no such trend.
In Somalia, it appears that tsetse populations remain 
relatively stable throughout the year both as regards numbers and 
distribution (Leigh Brown, personal communication). However, in 
the wet season animals are usually away from the tsetse infested 
areas, but in the dry season they concentrate on the infested 
areas and this permits a more extensive exploitation of tsetse- 
infested resource during the dry period of the year, than would 
otherwise be the case. The increased availability of 
trypanocidal drugs which reduce morbidity and mortality losses, 
have encouraged more extensive utilisation of grazing.
During the survey, it was observed that the incidence of the 
disease increased towards the delta of the Shabelle river and in 
the vicinity of the lower parts of the Juba river. This could be 
assumed to be an indication of the co-existence of a high degree 
of tsetse infestation and wildlife hosts. It would seem that in 
this ecological zone where wild ungulates were common trypanosome 
infections are more prevalent than in areas where they were 
scarce (e.g. upper parts of Shabelle and Juba rivers).
The rate of trypanosome infections are high in Glossina 
species, mainly G. pallidipes which is the most dominant one
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(Ahmed and Dirya, 1987). Bushpigs and warthogs were the 
predominant wild hosts since other wild game have been reduced by 
poaching. The warthogs were also reported to be resistant to 
T. vivax (Ashcroft, 1959; Lumsden, 1962).
In T. congolense species it has been confirmed that the rate 
of infection in Glossina usually remains the same whatever the 
frequency of either their suid or bovid feeds (Moloo, Kutuza and 
Boreham, 1979). Therefore it is conceivable that the
T. congolense infections encountered in the blood sampled cattle, 
originated from other animals like buffaloes, which normally 
harbour trypanosomiasis, and warthogs, because all nomadic 
cattle are usually away from tsetse habitats in the wet seasons.
Both T^ congolense and vivax were the most frequently 
reported pathogenic species in endemic areas of trypanosomiasis 
of the upper and lower Shabelle regions of Somalia in previous 
smaller surveys e.g. NTTCP report, 1982. That report also 
recorded that T^ brucei was the least encountered species. While 
the cattle blood sampled in the present survey did not reveal 
T. brucei infections in wet films, an isolate sent to Kenya as a 
T. congolense for drug-resistance tests was found later to be 
T. brucei. In a recent study, the later strain has shown a high 
degree of multiple drug-resistance (Zweygarth and Rottcher, 
1989).
Earlier work has shown a higher proportion of Tt_ vivax 
infections in animals when first introduced into tsetse habitat 
and greater frequency of Tj_ vivax in tsetse vectors (Wilson, Le 
Roux, Dar, Paris, Davidson and Gray, 1975a). Therefore, the
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high proportion of T. vivax infections observed from the tsetse- 
infested areas could be due to the introduced animals which had 
been bom while their dams were away from the tsetse habitat and 
which became highly infected when they first encountered the high 
density of the vector during the dry season.
The regional variations in the level of infection within the 
two rivers is probably due to differences in wildlife 
agricultural development with consequent differences in 
availability of tsetse-breeding sites and concentrations of the 
animals on non-agricultural areas, during dry season grazing.
The circulation of these different trypanosome species, via 
tsetse, between various hosts has perpetuated the continuous and 
indiscriminate use of chemotherapeutic and prophylactic drug 
regimes. The cost of these drugs is, however, substantial. The 
livestock owners are often prepared to obtain these drugs at any 
cost and they administer them personally to their animals. 
Considering the price of the drugs in Somalia it is uneconomic to 
use the drugs at higher dosages, but up to now this system 
appears to be the only solution to the problem of drug-resistant 
parasites.
The results obtained from the interviews with the cattle 
owners concerning drug preference and drug related deaths, 
revealed the inefficiency of trypanocidal drugs used in the 
field. Breakthrough infections, treated earlier with a single, 
double or mixed dose of trypanocidal drugs were reported by many 
of those interviewed. However, the subsequent isolation of two 
drug-resistant strains of T^_ congolense (see Chapter 3) and the 
previous isolation of a multidrug-resistant T. vivax (Schonefeld,
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Rottcher and Moloo, 1987) at Buulabarde, are in agreement with 
the results obtained in the interviews with these animal owners.
Therefore the long standing suspicion that drug-resistance 
of the pathogenic cattle trypanosomes are prevalent is further 
substantiated. No important differences were encountered in 
the study on the susceptibility of the three local breeds and the 
suggestion that the Surgo breed is trypanotolerant was not 
substantiated.
Definite diagnosis of the disease was dependent ultimately 
on the detection of the trypanosome in blood samples from 
infected animals but generally the diagnosis of the animal owners 
and the results of wet film examinations were well correlated. 
This suggests that the animal owners had acquired diagnostic 
acumen through long experience.
Many workers have described the inferiority of the wet film 
method compared to the phase contrast buffy coat method (Paris 
et aly 1982; Robson and Ashkar, 1972), but in the present field 
experience the wet film was marginally superior, at least with 
T. congolense infections, although the time which elapsed before 
examination of the buffy coats may be a factor which made this 
method inferior.
It is believed that nutritional status of the host can 
influence the severity of the disease, therefore during the dry 
season when there is poor pasture, and the animals gather along 
the tsetse infested areas, those cattle in poor condition may be 
more susceptible to the risk of the disease. However, the low 
mean packed cell volume observed in allegedly healthy as well as
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infected cattle, blood sampled in areas inside the tsetse habitat 
may be attributed to a combination of poor pasture and the effect 
of pathogenic trypanosomes.
Finelle (1 976), Leach and Roberts (1 981) and other workers 
have reported the severity of the swellings and abscesses at the 
injected sites, after the administration of isometamidium. These 
local reactions, the risk of subsequent necrosis and sloughing of 
the skin was experienced by many of the cattle probably because 
of poor methods of drug administration.
The animal owners were not able to measure indirect losses 
of the trypanosome-affected animals. However, they estimated 
that the annual direct loss in mortality due to trypanosomiasis 
was about 16%.
In conclusion, this study provides the most comprehensive 
information currently available on the prevalence of cattle 
trypanosomiasis in Southern Somalia. It is clear from the 
survey that vivax and T^ congolense are the predominant 
pathogenic cattle trypanosomes along the riverine areas and the 
cause of significant losses. Moreover, many cattle owners 
reported the apparent inefficiency of trypanocidal treatments. 
It is hoped that the results of this survey may assist in the 
future control of bovine trypanosomiasis in Somalia.
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CHAPTER THREE
STUDIES CN DRUG-RESISTANT STRAINS OF Trypanosoma ocogolense
SECTION I
THE ISOLATION OF EKDG-RESIST3VNT STRAINS CF conqolense 
FROM THE LOWER SHABELLE REGION CF SOUTHERN SOMALIA
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Drug-resistance in txypanosomes has been reported from many 
parts of Africa (see review in Chapter I and Jones-Davies, 1967a; 
Graber, 1968; Mwambu and Mayende, 1971; Lewis and Thomson, 1974 
and Williamson, 1979). In East Africa drug-resistant strains of 
T. conqolense have been described in Ethiopia (Scott and Pegram,
1 974) and Kenya (Gitaha, 1 981). However, to date, they have not 
been reported from Somalia although their existence has been 
suspected for many years. In Southern Somalia there have been 
persistent rumours of drug-resistant strains of trypanosomes in 
local livestock and this condition has been given the name 
"Salaaf" by the animal owners.
The results of the survey of bovine trypanosomiasis reported 
in Chapter 2 confirmed these observations by cattle owners.
At the present time the most widely used trypanocidal drugs 
in Somalia are isometamidium chloride (Samorin, RMB) and 
diminazene aceturate (Berenil, Hoechst AG).
Drug resistance is usually suspected when a curative drug 
fails to achieve a clinical cure. However the existence of drug 
resistant strains of trypanosomes may be only one of several 
possible explanations for such failures. The animals may have 
been underdosed because bodyweight was underestimated or the drug 
may have been incorrectly prepared or kept too long before use.
Cattle weighing crates are rarely available in Somalia and 
similarly facilities for weighing doses of drug do not exist in 
the countryside. Isometamidium comes to Somalia in bulk (10g or 
1 g) and diminazene aceturate comes also in multiple and single 
doses (10 doses and single doses 3.5 mg/kg). However, animal
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owners are not capable of measuring the exact doses required. 
This has introduced an empirical system of handling the 
trypanocidal drugs in the field particularly isometamidium 
chloride which is the most valuable drug in the country.
Lack of veterinary supervision has also complicated the 
problem of drug usage and injection. For example, a cattle owner 
admitted during the survey that he reconstituted (1 Og) ten grams 
of isometamidium chloride and kept and used the reconstituted 
solution in a bottle for about 48 days. The abuse of the 
recommended handling procedures and the improper use of the drug 
may play a part in producing drug resistance if these cattle 
owners misused the drugs in this way.
To prove that drug resistant trypanosomes are, in fact, 
involved it is necessary to first discount the difficulties of 
drug preparation, handling and administration outlined above, and 
secondly to demonstrate the response of the trypanosomes involved 
to treatment under carefully controlled conditions. Ideally this 
should be carried out in the host species of interest, i.e. 
Bos indicus cattle for strains isolated from East African Zebu 
cattle, although in many situations it is necessary to use small 
ruminants or laboratory animals because of limited, finances and 
facilities.
In the present study the isolation of trypanosome strains 
from the field was attempted using a modified method of Jones- 
Davies and Folkers (1966c) who transported trypanosome-naive 
calves by lorry to treatment camps in Nigeria and subinoculated 
them with blood collected from cattle presented for treatment.
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Large numbers of subinoculations were carried out simultaneously, 
up to 80 in one calf. Calves were then transported back to the 
laboratory and 24 hours later treated with 1mg/kg homidium 
chloride (Novidium). Treated animals were then monitored for the 
development of parasitaemia and the appearance of infection in a 
calf was taken as evidence of homidium resistant strains in one 
or more of the cattle from which blood had been inoculated.
The aim of the present study was to determine whether drug- 
resistant strains of T. conqolense are present in the livestock 
of villages of the Lower Shabelle Region and particularly in 
villages in the tsetse belt along the river bank. In addition, 
the strains were examined in comparative studies in cattle, goats 
and mice.
MATERIALS AND METHODS 
Experimental design
Two studies were conducted. One in the Afgooye district and 
the seond in the district of Shallanbood. The basic protocol of 
each study is presented in Figure 1. In each study an 'isolation 
calf' was purchased from a tsetse-free area and transported into 
the study area by Landrover. In the villages the animal owners 
were invited to present their cattle in poor condition for blood 
examination on the understanding that any found to be infected 
with trypanosomes would be treated with a trypanocidal drug. 
When cattle were found which were infected with T^ congolense 
five millitres of blood was taken by jugular venepuncture and 
injected subcutagnpusly into the 'isolation calf'. The 
'isolation calf' received up to ten such injections over a one to 
two day period and was then transported back to the animal
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Fig. 1 Protocol for isolation of drug-resistant strains of 
T. congolense
Methods
Local sick cattle 
blood sampled
T. conaolense-infected blood 
injected into ’ Isolation calf’
2. Relapse infection
3. Blood subinoculated into :
Calves (10) Goats (3) Mice (35)
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facility. At the animal facility the calf was carefully 
monitored for the presence of a trypanosome parasitaemia. After 
a few days of patent parasitaemia the calf was treated with 
0.5 mg/kg isometamidium chloride and continually monitored for 
the development of a relapse infection. The development of such 
an infection was taken to be indicative of the presence of a 
drug-resistant strain of congolense and blood was taken at 
this time from the 'isolation calf1 and injected into groups of 
calves, goats and mice for subsequent trials to determine the 
level of drug resistance. In each study ten calves were used and 
randomly allocated into three groups of three animals with the 
remaining single calf used as an untreated control. Following 
the development of patent parasitaemias, calves in groups A + E, 
B + F and C + G were treated with 0.5 mg, 1.0 mg and 2.0 mg/kg 
isometamidium respectively. It was planned to treat any 
subsequent relapse infections with increasing doses of diminazene 
aceturate (Berenil) to determine the degree of cross-resistance.
In each study three goats received blood from the isolation 
calf and two were treated with 0.5 mg/kg isometamidium. In 
addition groups of mice were infected and treated with 0 - 
20 mg/kg isometamidium in order to compare the drug-resistance 
of the isolate of T. conqolense in different hosts.
Trypanosane Isolation
In the first study in Afgooye district a total of 35 cattle 
were blood sampled and examined by wet films. Ten of these 
animals were found to be infected with T. congolense. The other 
infected animals were either positive with T. vivax or had mixed 
infections of T. conqolense and T. vivax. The animals were from
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six different herds, two of them from the first and second 
villages and the other herds were from the third and fourth 
villages.
Each group or herd belonged to different individuals 
resident in these villages. 5 ml of blood was taken from every 
animal that was only infected with congolense. The blood from 
ten different animals (each 5 ml) was inoculated subcutaneously 
into the isolation calf at different sites along each flank.
The villages, where the animals were sampled included 
Moordiinle, Buulajini, Afgooye and Libsome (see map 3). The 
environs of these villages were highly infested with tsetse flies 
and the most predominant species was Glossina pallidepes (Leigh 
Brown, personal communication, entomologist in the Tsetse 
Department). However, the first isolation was done during the 
wet season and the flies had dispersed into the Acacia thickets 
approximately 2-4km away from the river, in these particular 
areas. Ahmed and Dirie (1987) have reported an infection rate of 
G. pallidepes of 2.6% and 1.5% during the wet and dry seasons >C
respectively in an area 3km south-west of Afgooye district.
The isolate from Afgooye district was entitled AFI.
The second isolation was carried out in two villages of the 
Shallanbood district, Mishaani and Kaliasayle villages (see map).
It was winter time (March, 1987) and most of the animals which 
were found in these two villages were nomadic and had come near 
the river in search of grass and water.
A total of 30 animals were blood sampled and the wet blood 
films examined by light microscopy. Five animals (four cows and
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a female camel) were found to be infected with T. conqolense and 
5 ml of blood from each animal was injected subcutaneously into 
a second 'isolation calf1.
The infected animals which were blood sampled had previously 
been treated with isometamidium chloride, homidium or diminazene 
aceturate by their owners several days before blood samples were 
collected from them. Most of the treatments were either with a 
single dose of one trypanocidal drug or a combination of two 
doses of two different drugs e.g. one dose of isometamidium 
chloride and one of diminazene aceturate.
The trypanosome isolate from Shallanbood was entitled SH2. 
Calves
The calves that were used in these experiments were Zebu 
type. Their ages ranged from 13-27 months in the first study and 
in the second study from 6-12 months. They were all bought from 
Mogadishu animal market. Originally they were from Aliyaale, 
Warsheekh, inside Mogadishu or Waharocade. The areas from which 
these animals came are considered to be tsetse-free. A total of 
22 calves were used for the two experiments. Eleven for the 
first study of which three of them were females and eight were 
males.
The other eleven calves were used for the second study, two 
of then were females and the other nine were steers. v
The distribution of the calves and their treatments are 
presented in Table 18.
The animals were brought to the cattle pens at Afgooye at an 
ex-dairy farm by means of a lorry and they did not pass through 
any tsetse infested territory. All the animals were identified
135
Table 18
Calf numbers and trypanocidal drug treatments
Group Calf no. 
First Study AF1
Drug treatments (mg/kg) 
Samorin Berenil
A 45301
18840
45303
0.5 3.5 7.0
B 45302
45304
45306
1.0 3.5 7.0
C 45305
45307
45308
2.0 3.5 7.0
D 18839 0 3.5
Group Calf no. 
Second Study SH2
Drug treatments (mg/kg) 
Samorin Berenil
E 260
261
262
0.5 3.5 7.0
F 263
264
265
1.0 3.5 7.0 10.5
G 266
267
268
2.0 3.5 7.0 10.5
H 269 0 3.5 7.0(x2) 10.5
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with an eartag and weighed on their arrival at the cattle pen at 
Afgooye. Blood sampling and faeces examination was also carried 
out before they were infected with trypanosomes.
Goats
The goats were white Galla goats. They were six in number, 
three for the first study and the other three for the second 
study. All of them were brought from Mogadishu animal market. 
Originally, they were from the tsetse-free region of Aliyaale and 
Warsheekh. Their ages ranged from 3.5-5 years.
Maintenance of the calves and goats
The main food for these animals was hay, silaged maize and 
sorgham stalks. Ground maize grains were supplied when the above 
mentioned items were in short supply in the dry season. Sliced 
cassava roots were supplied to the calves for one month (June) as 
a minimal supplementary feed. Sodium chloride dissolved into the 
drinking water was also given to these animals. The animals were 
allowed free access to the drinking water but they were not 
allowed to graze, in order to avoid contact with the tsetse fly. 
The cattle pen was located in a tsetse-free area.
Mice
Two groups of healthy white Swiss mice (one group locally 
bred) of both sexes were used in these studies. The first group 
(the locally bred), kindly supplied by the Serum and Vaccine 
Institute at Mogadishu, were 9-10 weeks of age and 28-37g in 
weight. The second group, kindly supplied by the International 
laboratory for Research on Animal Diseases (ILRAD), Nairobi, was 
six weeks old and 20-26g in bodyweight. The mice were kept at 
the animal house of the Serum and Vaccine Institute at Mogadishu.
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They were kept in clean plastic cages and allowed free access to 
drinking water. They were given ground sorghum grains, carrots 
and salad ad libitum.
Trypanocidal. Drugs
Isometamidium chloride (Samorin, RMB) was administered to 
the calves by deep intramuscular injection into the neck, and in 
the goats into the hind limb. Mice were given the drug by 
intraperitoneal injection.
In the case of the calves diminazine aceturate (Berenil, 
Hoechst) was given by intramuscular injection.
Other drugs
The other drugs that were given to calves were 
sulphadimidine tablets which were ground into powder and used for 
spreading on the wounds caused by foot rot. The tablets were 
also given for control of diarrhoea. The calves were sprayed 
every thirty days with an acaracide (Bacdip) to control ticks.
An anthelmintic (Panacur,Hoech&tj was given to the calves 
before the trypanosome infection in order to remove existing 
nematode infections.
Several injections of oxytetracycline were administered 
intramuscularly to one calf (45304) which had received a bruise 
on the lower part of a front leg.
Blood Sanpling and Examination.
Blood samples were collected three times per week from the 
infected calves, goats and mice for parasitological examination. 
Fixed thin smears of blood were also collected once per week and 
stained by Giemsa's method. Blood was collected from the
ruminants by jugular venepuncture into evacuated tubes containing 
EDTA and centrifuged in capillary tubes in a microhaematocrit 
centrifuge. After reading the haematocrit value the buffy coat 
was placed on a slide and examined for the presence of 
trypanosomes.
Blood was collected from the mice by tail snip venesection 
and placed directly on a slide for wet film microscopic 
examination.
Immunosuppressive Treatment of Mice
In the first study the mice had to be immunosuppressed in 
order to allow a patent parasitaemia to develop. This was 
achieved by the intraperitoneal injection of 0.2 ml (4mg/mouse) 
of cyclophosphamide (Sigma) in saline.
Body Weight
Periodically throughout the studies and immediately prior to 
trypanocidal drug treatment the calves and goats were weighed 
using a weighing crate.
The mice were weighed before treatment on a top-pan balance. 
RESULTS
First Isolation - API 
Cattle
Parasitaemia
The isolation calf became parasitaemic seven days after the 
subinoculation of blood from the village cattle. Following 
treatment with 0.5mg/kg isometamidium on day 18 it became 
aparasitaemic until day 32. On day 35 infected blood was taken 
from the isolation calf and inoculated into ten calves, three 
goats and 35 mice (see experimental design).
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The ten calves in Groups A, B, C and D all became 
parasitaemic on day 11 post inoculation (see Figures 2, 4, 6). 
On day 29 the calves in Groups A, B and C were treated with 0.5, 
1.0 and 2.0mg/kg isometamidium respectively. Following treatment 
there was a period of aparasitaemia before relapse infections 
developed. In Group A treated with 0.5mg/kg isometamidium 
relapses occurred on days 44 and 46, and one calf (18840) died on 
day 44. In Group B relapse infections developed on days 53-58, 
and in Group C, treated with 2.0mg/kg relapses were delayed until 
days 66-67.
The control calf (18839) Group D was not treated with 
isometamidium and by day 44 had a high parasitaemia and died 
despite treatment that day with diminazine aceturate (Berenil) at 
3.5mg/kg.
Following the development of relapse infections after 
isometamidium treatment in Groups A, B and C, the calves were 
treated with diminazine aceturate first at a dose of 3.5mg/kg and 
later with 7.0mg/kg.
Following the first treatment with diminazine aceturate the 
calves became aparasitaemic for approximately 30 days-(range 29- 
33 days) before trypanosomes were again detectable in the blood. 
Following the second diminazine aceturate treatment, this time at 
7.0mg/kg the period of aparasitaemia was relatively short in all 
the groups, namely 19 days (range 14-25 days) and all the calves 
developed moderately high levels of parasitaemia by termination 
of the experiment on day 149 post infection.
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Calves Infected with T. congolense AF1
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Fig. 2 Parasitaemias of calves infected with T. congolense AF1
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Fig. 3 Packed cell volumes of calves infected with T. congolense AF1
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Calves Infected with T. congolense AF1
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Fig. 4 Parasitaemias of calves infected with T. congolense AF1
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Fig. 5 Packed cell volumes of calves infected with T. congolense AF1
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Calves Infected with T. congolense AF1
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Fig. 6 Parasitaemias of calves infected with T. congolense AF1
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Fig. 7 Packed cell volumes of calves infected with T. congolense AF1
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Anaemia
The haematocrit values of the calves in Groups A, B and C 
are presented in Figures 3, 5 and 7.
It is apparent that following infection all the calves 
developed anaemia and by day 40 the haematocrit values had been 
reduced to approximately 20%. In the two calves that died by 
day 45 (namely' 18840 of Group A and 18839, the control (Group D) 
both had haematocrit values of 20% immediately prior to death. 
In the surviving calves treatment with Samorin was followed by 
some improvement in haematocrit values to approximately 25%. 
However the development of subsequent relapse infections were 
followed by falls in haematocrit value to below 20%.
Bocty Weights
All the calves lost weight (Figures 8, 9 and 10) as a result 
of the infection despite chemotherapy.
Goats
Three goats (Nos. 1, 2 and 3) were infected with the 
T. congolense isolate AFl by inoculation of parasitaemic blood 
from the first isolation calf (see experimental design). 
Following inoculation the goats developed a patent parasitaemia 
on days 23, 19 and 19 respectively. By day 34 all three goats 
had high parasitaemias (Figure 11) and goats 1 and 2 were treated 
with 0.5mg/kg Samorin, whilst goat 3 remained untreated. 
Following treatment goats 1 and 2 became aparasitaemic until 
days 46 and 47 respectively. On day 43 goat 3 and on day 51 
goats 1 and 2 were treated with diminazine aceturate (3.5mg/kg). 
Following this treatment the goats became aparasitaemic and 
remained so until termination of the experiment on day 62,
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Goats Infected with T. congolense AF1
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Fig. 11 Parasitaemias of goats infected with T. congolense AF1
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although goat 2 died suddenly of unknown causes on day 57.
Infection was associated with a decrease in haematocrit 
values in the three goats (Figure 12). By day 34 the values of 
goats 1, 2 and 3 were 21%, 18% and 21% respectively and despite 
treatment with isometamidium and/or diminazine aceturate they 
remained at 20% or below until termination of the experiment. 
Goat 2 which died on day 57 had an haematocrit value of 16% 
immediately prior to death.
Mice
A total of 35 mice were infected with T^ congolense isolate 
AFl and divided into seven groups of five mice (Groups A - G). 
Following the development of patent parasitaemias they were 
treated with isometamidium at doses between 0.5 - 20mg/kg. One 
group (G) remained as untreated controls. The mice were 
monitored regularly for the development of relapse infections and 
these occurred in Groups B, C, D, E and F (see Table 19). In 
Group F, four of the five mice remained parasitaemic following 
treatment. There was a correlation between the time of relapse, 
the incidence of relapse and the dose of drug such that mice 
treated at lower doses showed a shorter time to relapse and a 
greater incidence of relapse than mice treated at higher doses. 
Mice in Group A, treated with 20mg/kg Samorin did not relapse 
during the period of observation (60 days).
Second Isolation - SH2 
Cattle
Parasitaemia
The isolation calf became parasitaemic nine days after the 
subinoculation of blood from the infected village cattle.
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Table 19
Hie development of relapse infections in mice infected with 
T, congolense isolate AFl and treated with various doses of
i snmptanri di nn
Group Treatment Days to relapse No.
No.
relapsed/
treated
Comments
A 20 mg/kg x 
Samorin
No relapse 0/5
B 10 mg/kg 
Samorin
42, 51 2/5
C 5 mg/kg 
Samorin
25, 38, 25, 25, 
31
5/5
I
D 2 mg/kg 
Samorin
10, 14, 14, 18, 18 5/5
E 1 mg/kg 
Samorin
00 o o 00 5/5
F 0.5 mg/kg 
Samorin
10 5/5(1/5) 4 of 5 mice 
remained 
positive after 
treatment
G No
treatment
- -
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Following treatment with 0.5mg/kg isometamidium on day 22 it 
became aparasitaemic until day 40. On day 44 infected blood was 
taken from the isolation calf and inoculated into ten calves, 
three goats and 35 mice (see experimental design).
The ten calves in Groups E, F, G and H became parasitaemic 
on days 14-18 and by day 36 all had developed moderate to heavy 
parasitaemias (Figures 13, 15 and 17). On day 39 the calves in 
Groups E, F and G were treated with 0.5, 1.0 and 2.0mg/kg 
isometamidium respectively. Following treatment there was a 
period of aparasitaemia which varied in duration with the dose of 
drug. In Group E treated with 0.5mg/kg isometamidium relapses 
occurred within 7-9 days i.e. 46-49 days post infection.
In Group F relapse infection developed within 14 days i.e. 
days 52-53 post infection, whilst in Group G, treated with 
2.0mg/kg isometamidium relapses occurred by 24 days post 
treatment. The control calf 269 (Group H) which did not receive 
isometamidium maintained a moderate parasitaemia until it was 
treated with diminazine aceturate (3.5mg/kg) on day 49. 
Following the development of relapse infections after 
isometamidium treatment in Groups E, F and G, the calves were 
treated with diminazine aceturate, first with 3.5mg/kg and later 
with , higher doses.
Following the first treatment with Berenil all the calves 
became aparasitaemic for approximately 16 days (range 1 3 - 2 2  
days) and then relapsed although two calves in Group E (261, 262) 
died eight and ten days after treatment respectively. The second 
treatment with Berenil was given at a dose of 7.$mg/kg. In 
Group E the remaining calf (260) died 25 days later, on day 88
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Fig. 13 Parasitaemias of calves infected with T. congolense SH2
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Fig. 14 Packed cell volume of calves infected with T. congolense SH2
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Fig. 15 Parasitaemias of calves infected with T. congolense SH2
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post infection. In Group F relapse infections developed 13, 14 
and 20 days after treatment. Similarly the calves in Group G 
relapsed 15 days after treatment with 7.5mg/kg. The calf in 
Group H (269) received two treatments at this dose and relapsed 
at 21 days and 18 days after each treatment. Finally the 
surviving calves in each group were treated with three times the 
normal dose, i.e. 1 0.5mg/kg Berenil. In Group F, one calf (263) 
died 18 days later on day 109 post infection whilst the remaining 
two calves relapsed 28 days later. In Group G relapses occurred 
25, 19 and 25 days post treatment. The calf in Group H relapsed 
22 days after treatment. Three of the remaining six calves died 
before termination of the experiment at 136 days after infection.
Anaemia
The haematocrit values of the calves in Groups E, F and G 
are presented in Figures 14, 16 and 18.
Prior to infection the values ranged between 27 - 30% and 
following infection they decreased to between 18 and 24% on the 
day of Samorin treatment (day 39). Following this treatment the 
haematocrit values stabilised in Groups E and F before declining 
further later in the experiment. In Group G the haematocrit 
values showed some increase following the Samorin and subsequent 
Berenil treatments before falling during the final relapse 
infection.
Body Weights
The calves in the second study were younger and had lower 
bodyweights than in the first experiment. As in the first study 
all the calves lost weight as a result of the trypanosome 
infection.
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Goats
Three goats (Nos. 4, 5 and 6) were infected with the 
T. congolense isolated SH2 (see experimental design). Following 
infection the goats developed a patent parasitaemia on days 8, 9 
and 8 respectively. By day 18 all three goats had high 
parasitaemias and two goats (4 and 5) were treated with 0.5mg/kg 
Samorin, whilst the third goat (No.6) remained untreated. 
Following treatment goats 4 and 5 became aparasitaemic and 
remained so for 10 and 11 days respectively. On day 24 goat 6 
and on day 31, goats 4 and 5 were treated with Berenil 
(3.5mg/kg). Between 14 and 16 days later all three goats 
developed relapse infections. A subsequent Berenil treatment at 
7mg/kg on day 50 (goats 4 and 5) or day 41 (goat 6) resulted in a 
period of aparasitaemia in goats 4 and 5 until termination of the 
experiment on day 57, whilst goat 6 died nine hours after 
treatment.
Infection was associated with a decrease in haematocrit from 
values of 27 - 30% at the beginning of the experiment to values 
of 23 - 25% by the time of the isometamidium treatment. The 
haematocit values continued to decline and the values of goats 4, 
5 and 6 at termination of the experiment or death in the case of 
goat 6 were 17, 21 and 15% respectively.
Mice
A total of 35 mice were infected with T. congolense isolate 
SH2 and divided into seven groups of five mice (Groups H - N). 
Following the development of patent parasitaemias they were 
treated with isometamidium at doses between 0.5 - 20mg/kg. One
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group (N) remained as untreated controls.
The mice were monitored regularly following treatment. 
Groups L and M remained parasitaemic whilst the mice in the other 
treated groups became aparasitaemic before developing relapse 
infections (Table 20). There was a correlation between the time 
to and incidence of relapse infection with drug dosage and in 
Group H treated with 20mg/kg only three of five mice developed 
relapse infections and these occurred between 50-55 days after 
treatment.
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Table 20
The development of relapse infections in mice infected with 
T. congolense isolate SEE and treated with various doses of
isometamidium
Group Treatment Days to relapse No. relapse/ 
No. treated
Comments
H 20 mg/kg 
Samorin
55, 50, 55 3/5
I 10 mg/kg 
Samorin
27, 29, 42 3/5 1 mouse died 
before treatment
J 5 mg/kg 
Samorin
17, 27, 20, 31 4/5 1 mouse died 
before treatment
K 2 mg/kg 
Samorin
18, 9, 14, 14, 9 5/5
L 1 mg/kg 
Samorin
5/5 All 5 mice re­
mained positive 
after treatment
M 0.5 mg/kg 
Samorin
5/5 All 5 mice re­
mained positive 
after treatment
N No
treatment
-
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DISCOSSICN
Two isolates of congolense have been obtained from the 
Lower Shabelle region of Southern Somalia which displayed high 
levels of resistance to therapy with Samorin (isometamidium 
chloride) and Berenil (diminazine aceturate) in experimental 
cattle, goats and mice.
Drug resistance by trypanosomes has been reported from 
several areas of Africa but the strains isolated in the present 
experiment displayed a remarkably high level of resistance to the 
two most commonly available trypanocides. Furthermore these two 
compounds are normally regarded as a 'santative pair1 since 
cross-resistance between them has rarely been reported at least 
by congolense, although isolates of vivax from the Tana 
River area of Kenya have been shown to possess multiple 
resistance (Rottcher and Schillinger, 1985). Other examples of 
high levels of drug-resistance by T^ congolense have been 
reported by Gitaha (1981) from Kenya and Pinder and Authie (1984) 
in West Africa.
In the present study unsophisticated and relatively low cost 
methods were used to isolate and examine drug resistant strains 
of T. congolense. This was because of logistical and financial 
restraints in Somalia. Nevertheless the methods used were shown 
to be highly effective and clearly demonstrated the existence of 
drug-resistant strains in the sampled village cattle. For
reasons of eonomy multiple inoculations into a single recipient A
Z1
calf were conducted and for that reason it is not possible to 
know how many of the donor cattle were infected with drug- 
resistant strains of T^ congolense. All that can be stated is
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that in both sampling exercises at least one of the donor animals 
was infected with a drug-resistant strain. The subsequent 
treatment and expansion of the relapse infection into naive 
cattle, goats and mice was a novel development and is a valuable 
demonstration of a procedure which could be adopted in many field 
situations in Africa, with the proviso that the experimental 
cattle are not exposraed to tsetse challenge.
Other methods for the detection of drug-resistant 
trypanosomes have often relied on direct subinoculation into mice 
or more recently by adaptation of the trypanosomes to laboratory 
culture and tests in vitro. Both of these techniques have a 
number of disadvantages (Sones, Njogu and Holmes, 1988). In the 
case of the former, not all strains of congolense are 
infective to mice and the results from mice may only give a 
general indication of drug resistance. In the case of in vitro 
culture it is frequently difficult and time-consuming to adapt 
‘field* strains to culture and requires relatively expensive 
sophisticated laboratory equipment.
In the present study it was possible to make direct 
comparison between cattle and mice and to a limited extent from 
goats also. In the case of both isolates the minimum curative 
dose in cattle was above 2mg/kg for isometamidium and above 
7.5mg/kg and 10.5mg/kg for Berenil for isolates AFl and SH2 
respectively. In mice the minimum curative dose was less than 
20mg/kg isometamidium for isolate AFl and more than 20mg/kg for 
isolate SH2. These results support the general view that there 
is an approximate ten-fold relationship for many strains of
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T. congolense between the minimum curative dose for trypanocidal 
drugs in mice and cattle (e.g. Pinder and Authie, 1984).
A different approach to the quantitation of drug-resistance 
was suggested by Williamson and Stephen (1 960) who developed a 
method using sheep, to assess the sensitivity of strains of 
T. vivax to homidium, based on the interval from subcurative 
treatment to subsequent relapse. The interval from subcurative 
treatment to relapse was taken as an index of the degree of 
homidium resistance : the shorter the interval, the more
resistant the strain. A good indication of the relative 
sensitivities of the two isolates of T^_ congolense used in the 
present study could be obtained by a similar approach. Thus 
isolate SH2 which was found to be more resistant to isometamidium 
in mice than isolate AFl, consistently had a shorter time to 
relapse in cattle following treatment with isometamidium and 
Berenil. However in goats the distinction was less clear, with 
SH2 relapsing at 10 and 11 days post-treatment whilst AFl 
relapsed on days 11 and 12 in the two treated goats.
A further important observation in the present study was 
that both isolates were highly pathogenic and this was especially 
the case with the more resistant isolate, SH2, in which most of 
the cattle died before termination of the experiment. Previously 
it has been suggested that drug-resistant strains of trypanosomes 
may be less pathogenic then drug-sensitive strains (Stephen, 
1962).
The high levels of drug-resistance and pathogenicity 
observed in the two isolates raises important practical problems 
over the control of such infections in the field. Fortunately it
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would appear from field observations and anecdotal evidence that 
such infections are relatively rare but this can only be 
determined by much wider use of tests for drug-resistance in the 
field possibly using similar methods to those used in the present 
study. In the meantime it is important for veterinarians to 
develop possible strategies for the control of drug-resistant 
strains of trypanosomes in the field. One possible approach is 
examined in the following chapter.
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CHAPTER THREE
STUDIES CN DRUG-RESISTANT STRAINS CF TrypanosciDa conqolense
SECTTCN H
A GGMPARISCN CF INTRAVASCCJLAR AND INTRAMUSCULAR ISOMETEAMIDIUM 
ADMINISTRATION F O R THE TREATMENT CF A DBDG-KESISTANT 
STRAIN CF T.oonqolense IN GOATS
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iMmoDCJcncN
It is apparent from the literature reviewed in the 
introduction and the studies in Somalia described in Section I 
of this chapter that drug-resistance can emerge as a serious 
problem in the control of bovine trypanosomiasis. In situations 
such as that described in Somalia where resistance to the 
'sanative pair1 of drugs, namely isometamidium and diminazine 
aceturate, exists, the veterinarian is faced with serious 
difficulties in selecting suitable treatment.
In most cases of drug resistance the resistance is not 
absolute and is generally dose dependent. Therefore if higher 
levels of drug concentration in the blood can be achieved it may 
be possible to successfully treat the infection. A possible way 
of achieving high blood concentrations was investigated in the 
present study using isometamidium to treat a strain of 
T. congolense in goats which had been previously shown to be 
resistant to treatment with 1.0 mg/kg in cattle (Sones et al, 
1988). The treatment consisted of intravenous administration of 
isometamidium. Administration of isometamidium by the intravenous 
route has been used by various workers in the past (Toure, 1973; 
Balis, 1977; Schillinger, Maloo and Rottcher, 1984) and it has 
recently been advocated as a valuable method of treatment in 
cattle by field veterinarians working at the Kenyan coast 
(Dowler, 1987 personal communication; Munsterman, 1988 personal 
communications). They claim it has two important advantages over 
the intramuscular route, namely that tissue lesions in muscle at 
the site of injection are avoided, and it is a more effective 
treatment in areas where drug-resistant trypanosomes may be a
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problem, possibly because higher blood concentrations of drug may 
be achieved by this route. This method of treatment was compared 
with the more conventional intramuscular administration of 
isometamidium in goats.
In this study there was also an opportunity to quantify the 
concentration of isometamidium in the blood of the treated goats 
using a recently developed ELISA technique (Holmes, Rowell, 
Phillips, Sutherland, Gault and Urquhart, 1988). The competition 
micro ELISA is in the process of development for the detecion of 
isometamidium of treated ruminants in field laboratories in 
Africa. The optimal assay conditions have been determined and 
using spiked samples, standard curves within the range of 0.05 - 
500ng/ml have been obtained. The assay is apparently specific 
for isometamidium and there is insignificant cross reactivity 
with Ethidium (homidium bromide) or Berenil (diminazine 
aceturate). Only small amounts (5ul) of serum or plasma are 
required for the assay.
Experimental design
Groups of two or three goats were infected with a drug- 
resistant strain of T. congolense and subsequently treated with 
isometamidium at a dose of 0.5 mg/kg by intravenous (iv) 
(goats 106,107 and 108) or intramuscular (im) (goats 109 and 115) 
injection. Following the development of relapse infections the 
goats were retreated at the higher dose of 1.0 mg/kg by the same 
method as previously. One goat (114) was maintained as an 
infected untreated control but subsequently treated by 
intravenous injection at 0.5mg/kg isometamidium and later by
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intramuscular injection at a dose of 1.0mg/kg. The animals were 
examined for at least 50 days post treatment.
Materials and methods 
Experimental goats
British cross-bred goats were obtained from a commercial 
source. The goats were aged approximately nine months. Prior to 
infection all goats were treated with 10% suspension of 
fenbendazole (Panacur, Hoechst).
The goats were housed in a fly-proof isolation unit on a 
concrete floor and bedded with wood shavings. They were cleaned 
out daily. The goats were provided with hay ad libitum, 
supplemented with 1.0 kg/day of concentrate (306 Ewbol store lamb 
finisher pellets, BOCM Silcock Ltd., England). Water, rock-salt 
and a mineral lick (super chelated rockies Tythebarn Ltd., 
England) were always available.
Trypanoscmes
An isometamidium-resistant strain of T^ congolense 
GRVPS 56/2 (originally isolated by Pinder and Authie, 1984 and 
subsequently designated KETRI 2880 by Sones et al, 1988) was used 
in- this experiment. Each goat was infected intravenously, with 
1 x 10^  trypanosomes.
Tcypanoscme detection
Jugular blood samples were regularly obtained using 
heparinised vacutainers. Prior to examination the blood samples 
were placed on a rotary mixer for at least five minutes to ensure 
thorough mixing. Duplicate plain capillary tubes were filled 
with blood, sealed at one end with cristaseal and centrifuged for
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five minutes using a microhaematocrit centrifuge. Following 
centrifugation the buffy coat was subjected to microscopic 
examination.
Drugs
The trypanocidal drug used in this experiment was 
isometamidium chloride (Samorin, RMB). It was administered 
either by intramuscular or intravenous injection of a 0.25% w/v 
solution. The doses of isometamidium used in this experiment were 
0.5 and 1.0 mg/kg.
Backed cell volume
The packed cell volume (PCVj was determined using the 
jugular blood sample, prior to examination of the buffy coat for 
trypanosomes. Blood samples were centrifuged in a 
microhaematocrit centrifuge for five minutes and PCV's read using 
a microhaematocrit reader (Hawksley, England).
Body temperature
The rectal temperature of the goats was measured thrice 
weekly at approximately 10.00 a.m.
Body weight
The goats were weighed once per week.
Drug assay
Preparation of Innunogen and floating Conjugate
Isometamidium chloride (Samorin) was conjugated with bovine 
serum albumin (BSA), Keyhole limpet haemacyanin (KLH) or porcine 
thyroglobulin (PTG) and used to immunise sheep.
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ELISA Method - Indirect Heterogenous 96 Well Competition Micro 
ELISA
The wells of microtitre plates were coated by passive 
adsorption with isometamidium-protein conjugate in coating 
buffer. After overnight incubation at 4°C, the plates were 
washed twice with distilled water, dried at 37°C and stored at 
20°C in the dark. The plates were washed four times with 
phosphate buffered saline/Tween (PBST) pH 7.2 immediately prior 
to assay.
Test serum samples (5ul) or isometamidium standards diluted 
in pooled normal serum were added to the wells followed by sheep 
anti-isometamidium antisera (100ul of 1 : 100 dilution in PBST). 
Assays were performed in duplicate and standards in triplicate.
The plate was incubated overnight in the dark at room 
temperature. The wells were emptied, then washed five times in 
distilled water. Alkaline phosphatase - anti-sheep IgG (H + L) 
conjugate solution (100 ul of a 1 : 1000 dilution in PBST) was 
added to each well. After incubation for a further hour the 
plate was again washed with water x 5 and 10Oul of enzyme 
substrate solution (2mg/ml~^, Sigma 104) added. Plates were read 
in a Multiscan MOC at 405nm after 30 minutes.
RESULTS
Parasitaemia
The results from individual goats are presented in 
Figures 24-29 and summarised in Table 21. Trypanosomes were 
first detected in the blood between days 14 and 17 post-infection 
and treatment with 0.5 mg/kg of isometamidium was given on 
day 23. In the case of the control (goat 114) treatment was
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Table 21
'Hie response to treatment with isometamidium by the intravenous 
or intramuscular route to goats infected with 
T. congolense GRVPS 56/2
Goat
No.
1st Treatment (0.5mg/kg) 2nd Treatment (1.Omg/kg) Termination
Route DA1* Days to 
Relapse
Route DA1 Days to 
Relapse
DA1
106 IV 23 14 IV 45 No relapse 62
107 IV 23 14 IV 45 27 83
108 IV 23 16 IV 45 25 83
109 IM 23 12 IM 45 No relapse 104
115 IM 23 12 IM 45 No relapse 104
114 IV 37 14 IM 63 28 104
DA1* = Days after infection
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delayed until day 37.
In the goats given the intravenous injection (goats 106, 107 
and 108) parasites rapidly disappeared from the blood and became 
undetectable. However within 14-16 days parasites reappeared in 
all three goats. On day 45 after infection the goats were 
retreated, this time with 1 mg/kg. One goat (106) remained 
aparasitaemic until its premature removal from of the experiment 
whilst the other two goats in this group developed relapse 
parasitaemias at 25 and 27 days after treatment respectively.
In the two goats (goats 109 and 115) given intramuscular 
doses of isometamidium treatment with 0.5 mg/kg produced only a 
brief period of aparasitaemia (12 days) before relapse infections 
developed. However a subsequent treatment with 1.0 mg/kg on 
day 45 achieved cures in both animals.
Finally a single goat (114) was kept as a control but on 
clinical grounds had to be treated. The first treatment given on 
day 37 was 0.5 mg/kg of isometamidium by intravenous injection to 
which the infection relapsed in 14 days (Figure 29). 
Subsequently the animal was treated with 1.0 mg/kg isometamidium 
on day 63 by intramuscular injection and following an 
aparasitaemic period of 28 days a relapse infection developed. 
Haematocrit
The haematocrit values showed that infection with this 
strain of T^_ congolense was pathogenic in goats and caused the 
animals to become anaemic (Figures 24-29). By day 20 post 
infection the mean haematocrit had fallen to 25% and in the 
control goat (114) in which treatment was delayed the haematocrit 
had reached 16% by day 35 post infection.
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Treatment at 0.5 mg/kg was associated with a rise in 
haematocrit in all the goats, with a subsequent fall as the 
relapse infections developed. Following the second treatment a 
rise in haematocrit was again observed and this improvement 
continued until preinfection levels were reached in all the goats 
in which the treatment at 1.0 mg/kg isometamidium achieved a 
cure, namely goats 109, 112, 115 and 117. In the goats which 
were not cured by the second treatment the haematocrits remained 
low and subsequently declined.
Body temperature
All the goats showed intermittent periods of pyrexia and 
these were closely correlated with the peaks in parasitaemia both 
before and after treatment (Figures 24-29). In the four goats 
which were cured by the second treatment body temperatures 
remained in the normal range until termination of the study.
Body weight
All the goats showed modest weight gains for approximately 
the first three weeks of the study (Figures 24-29). However 
later the weights did not increase and in some animals there was 
a fall in body weight. Successful cures following the second 
treatment were in general not associated with marked improvements 
in weight gain.
Drug assay
The plasma concentrations of isometamidium as measured by an 
ELISA assay are presented in Figures 30-33.
At ten minutes after the intravenous injection of 0.5mg/kg 
of isometamidium very high blood concentrations (mean 270ng/ml)
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were detected. By four hours after injection goats receiving the 
intravenous injection had on all occasions higher blood levels 
than goats which received the same dose of drug by intramuscular 
injection. However by 24 hours and beyond there were wide 
differences between individual goats and from day to day but no 
obvious effect of the route of administration of the drug.
Mean values from Day 1 to Day 8 of the blood concentration 
of isometamidium are presented in Table 22 and confirm the lack 
of obvious differences between treatment groups.
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Table 22
Mean plasma concentration of iscmetamidiim over 8 days 
following injection, as measured by ELISA
Group Treatment Goat
no.
Mean isometamidium plasma concencentration (ng/ml)
Following 1st infection 
(0.5 mg/kg)
Following 2nd infection 
(1.0 mg/kg)
106 0.53 0.07
Isometamidium
A 107 0.37 9.15
iv
108 1.60 0.04
Isometamidium 109 0.16 0.09
B
im 115 0.08 0.03
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DISCUSSICN
Two routes of administration, namely intravenous and 
intramuscular, of isometamidium were used to treat goats infected 
with a drug-resistant strain of congolense. The results 
indicate that following treatment at 0.5mg/kg both treatments 
were equally ineffective in that relapse infections developed 12- 
16 days post treatment. However following retreatment with a 
higher dose of drug there were clear indications that intravenous 
administration was less efficacious than intramuscular treatment 
as relapses developed in two goats on days 25 and 27 after 
intravenous treatment (goats 107 and 108). Unfortunately the 
third goat (106) had to be removed from the experiment on day 17 
after treatment due to a persistent urinary infection.
In contrast neither of the two goats (109 and 115) treated 
with 1.0mg/kg by the intramuscular route developed relapses 
during the 59 days of observation after treatment. However the 
parasitaemic profile of the control goat (114) which was 
initially treated with 0.5mg/kg intravenously and later with 
1.0mg/kg intramuscularly suggests that the efficacy of the 
1 .Omg/kg intramuscular treatment in goats 109 and 115 may in part 
be due to the residual effect of the first intramuscular 
treatment. In the control goat a relapse infection developed 28 
days after treatment with 1.Omg/kg im at a similar time to the 
relapses which developed in the IV treated group.
It must be recognised that the number of animals used in 
this experiment was very small, due to limited facilities in 
Glasgow for maintaining trypanosome-infected ruminants, and 
therefore caution should be exercised in evaluating the results.
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Nevertheless they do strongly suggest that the intravenous 
administration of isometamidium confers no obvious benefits over 
intramuscular administration when treating drug-resistant strains 
of T. congolense, and may possibly be less efficacious.
The strain of T^ congolense used in this study had 
previously been demonstrated to be resistant to isometamidium at 
a dose of 1.Omg/kg im by the workers who originally isolated this 
strain (Pinder and Authie, 1984) and later by Sones et al (1988). 
The latter workers demonstrated a minimum curative dose of 2mg/kg 
for this strain in cattle. In the present study the response to 
treatment at 1 mg/kg has most probably been influenced by the 
early treatment 22 days previously and the results suggest that 
there was a greater residual effect when the earlier treatment 
was given by the intramuscular route rather than intravenously. 
The timing between treatments in the present experiment was 
largely dictated by the clinical condition of the goats as many 
of the goats became severely anaemic following the development of 
relapse infections after the first treatment at 0.5mg/kg. 
Likewise the severe anaemia of the control goat (114) required 
that treatment be given to this animal by day 37 post infection.
The advocates of the use of intravenous isometamidium (e.g. 
Dowler and Munstermann) claim that in addition to being an 
improved treatment for drug-resistant strains of T. congolense it 
also avoids tissue damage at the site of injection, which can in 
certain circumstances lead to lameness or neck deformities 
particularly if short and/or unclean needles are used. Certainly 
intravenous administration would avoid these potential adverse
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reactions. However the intravenous administration of 
isometamidium requires considerable care for several reasons. 
First, rapid injection of concentrated solutions can lead to 
collapse and even death (Schillinger et al, 1985), and secondly 
perivascular or subcutaneously leakage of drug can lead to 
sloughing. For these reasons alone it is difficult to recommend 
intravenous administration tty unskilled operators. Thirdly the 
prophylactic effects of the drug are considerably reduced 
following iv injection (Toure, 1973).
The development of an ELISA assay for isometamidium holds 
considerable promise for the quantitation of the drug in cattle 
in the field. Furthermore it offers greater sensitivity than any 
available technique including HPLC. The intention is that the 
test could not only be used to quantify drug levels in treated 
cattle, but also indirectly could indicate the presence of drug- 
resistant trypanosomes when parasitaemias are observed in cattle 
with drug levels normally considered to be trypanocidal.
In the present experiment an unrefined form of the ELISA 
test was used and the test requires further development. 
Nevertheless the results do indicate perhaps not surprisingly 
that by four hours post injection intravenous administration does 
result in higher blood concentrations of drug than intramuscular 
administration. However by 24 hours and beyond this difference 
was no longer apparent. The tentative suggestion from this 
result is that to be effective against drug-resistant strains of 
T. congolense high drug levels must be attained for longer than 
four hours. Possibly new formulations of isometamidium may 
achieve this in the future for the treatment of drug-resistant
184
strains.
In conclusion, the results of the present study, although 
involving a relatively small number of animals, indicate that the 
intravenous administration of isometamidium offers no clear 
advantage over intramuscular administration in the treatment of 
drug-resistant strains of T. congolense and may possibly be less 
efficacious than the conventional route of treatment. Further 
studies using larger numbers of animals, preferably Zebu cattle, 
are required to confirm these preliminary observations.
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CHAPTER FOUR
STUDIES CN THE CHEMOTHERAPY CF T. evansi INFECTIONS
SECTION I
STUDIES IN MICE
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H7EOXJCTICN
The first trypanocidal drugs used in the treatment of 
T. evansi infections were various compounds of arsenic and 
antimony (Lingard, 1899; Salmon and Stiles, 1902). The authors 
used these drugs in Surra-infected equines, bovines and canines. 
Later, suramin which is a member of the naphthalene compounds was 
found to be effective against naturally occurring T. evansi and 
T. equiperdum infections (Knowles, 1925).
The general pattern of chemotherapy and chemoprophylaxis has 
been reviewed by many workers and Williamson (1980) commented 
that "reviews of this subject tend to be reviews of reviews 
because of the almost complete absence of new drugs since the 
1950's". Leach and Roberts (1 981) also mentioned that between 
1950 and the early 1960's was the period when most of the current 
trypanocidal drugs were introduced and when they were tested in 
the laboratory and in the field.
When trypanocidal drugs were first introduced the system was 
effective mainly because the treatments were professionally 
supervised and controlled. Although they were expensive in terms 
of drugs, when both chemotherapy and chemoprophylaxis were used 
together, they allowed the animals to be reared in tsetse endemic 
areas. The efficacy of the trypanocidal drugs were usually 
assessed by their action against bloodstream forms which occur in 
the mammalian host, however resistance has been detected with all 
the compounds which are currently in commercial use. In 
addition, toxicity, especially in certain species of animals, has 
been observed.
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However, the effectiveness of quinapyramine sulphate against 
Trypanosoma evansi infections in all species had been recognised 
by many workers including Pellegrini and Bonelli (1951). 
Moreover, Arshadi and Farhangear (1971), stated that 
quinapyramine sulphate provides protection of three to four 
months in camels. The drug disappeared from the market in early 
1970 (Holmes and Scott, 1982) but it is now available again from 
a number of different companies under various commercial names 
such as Trypacide (RMB) and Noroquin (both as sulphate and 
prosalt by Norbrook Laboratories).
Compounds such as diminazene aceturate (Berenil) and 
isometamidium (Samorin), which are not normally used in camels, 
due to their toxicity, have also been tried against Tt_ evansi, 
using lower than normal doses, on many occasions in the field.
Deaths have been recorded after 7.0mg/kg of diminazene was 
given to camels (Leach, 1961) and Raisinghani and Lodha (1980), 
suggested that the best curative dose of diminazene for camels, 
experimentally infected with Th_ evansi was 2.5mg/kg 
intramuscularly. A few years earlier, Petrovskil and Khamiev 
(1977) found that 5mg/kg of diminazene aceturate was effective in 
clearing T^ ninae lohlyakimovae (T. evansi) from the blood of 25 
Bacterian camels without any adverse effects.
In India, isometamidium chloride (Samorin) was found not to 
be effective against T. evansi in dogs (Srivastava and Malhotra, 
1967). Likewise Schillinger, Maloo and Rottcher (1982) reported 
isometamidium to have low trypanocidal action against T. evansi 
in East African camels. These authors also observed local 
toxicity, high doses producing abscesses at the injection sites,
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and these local reactions were similar to those caused by the 
drug in cattle. To avoid the local reaction which the drug 
produces at the injection site, these workers administered the 
drug intravenously and camels tolerated 1.0mg/kg intravenously. 
Temporary paralysis and severe shock reactions were reported with 
doses higher than 1.0mg/kg (Schillinger et al, 1982; Balis and 
Richard, 1977).
Karebe, Bottger, McCann, Sjoerdsma and Freitas (1982) found 
that difluoromethylomithine (DFMO) has the ability to arrest the 
multiplication of tumour cells in mice and prevent replication in 
different protozoa and is effective in treating early infections 
of trypanosomes.
In the late-stage infections the trypanosomes pass into the 
central nervous system (CNS). Here the immune mechanisms cannot 
be expressed and so long as the blood-brain barrier remains 
reasonably intact, the trypanosomes in the CNS can survive.
However, in his recent work, Jennings (1988) has found that 
both CNS and blood circulating infections of T. b. brucei can be 
cured permanently by the combination of DFMO and reduced 
quantities of melarsoprol injections. The author also stated 
that the use of such small quantities of melarsoprol might reduce 
the incidence of encephalopathies encountered in the treatment of 
human trypanosomiasis.
Melarsoprol (Mel B) and Trimelarsan (Mel W) which were known 
for their effectiveness in the treatment of Trypanosoma gambiense 
and Trypanosoma rhodiense infections, were screened against 
animal trypanosomes and shown to be effective against Surra
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(Gill, 1961a; 1961b; 1977; Gill and Sen, 1971).
In this thesis, all of the above mentioned trypanocidal 
drugs have been used against experimental infections with several 
T. evansi strains. In addition, the thesis records experiments 
carried out to investigate the efficacy of Mel Cy, a new compound 
which is a melaminylthioarsenate, for its chemotherapeutic 
activity against both late and early infections of T. evansi. The 
prophylactic effect of this compound was also tested. Since this 
compound (Mel Cy) is in the early development stages, there is no 
published information on its use in animal trypanosomiasis. As 
trypanosome strains and stabilates can be genetically 
heterogenous, clones were prepared at the beginning of these 
experiments in order to obtain populations grown up from single 
organisms.
MATERIALS AND METHODS 
Mice
Swiss white mice (CD-1) were purchased from the animal 
suppliers (Charles River Ltd., Margate, England). All the mice 
were female, weighed between 25-30 g and were 6-8 weeks of age at 
the start of each experiment.
Feeding and Housing
All the mice were housed in metal/plastic cages with sawdust 
bedding which was changed twice weekly. The cages were kept on 
the shelves of metal stands in an animal house where the 
temperature was kept at approximately normal room temperature 
(21 °C). The animals were fed ad libitum on pellets (Angus 
Milling Company, Kirriemuir, Perth, Scotland). Drinking water 
was constantly available.
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Trypanosomes
The trypanosomes used in these experiments were kindly 
supplied by Dr. F.W. Jennings from the Department of 
Parasitology, Veterinary School, Glasgow. The stabilates were 
derivatives of TREU 1412, TREU 1444 and TREU 1445 originally 
obtained from the Centre of Tropical Veterinary Medicine, Royal 
(Dick) School of Veterinary Medicine, Edinburgh.
Infection
Each mouse was inoculated intraperitoneally with 1 x 10~* 
trypanosomes in phosphate buffered saline pH 8.0 prepared 
directly from the frozen stabilates, which were maintained in 
liquid nitrogen. All mice were checked for circulating 
trypanosomes, before drug treatment and at least two times per 
week after treatment. Fresh blood smears from the tail of each 
mouse were examined for at least 20 microscope fields at x 400 
magnification. Mice which developed relapse infections were 
removed from the experiment and any deaths were noted.
Drugs
The drugs used in these experiments were Samorin 
(isometamidium) RMB, Dagenham, England; Moranyl (suramin) 
Specia Ltd., Paris; Berenil (diminazene aceturate) Hoechst, 
Frankfurt, West Germany; Difluoromethylomithine (DFMO) supplied 
by Merell, Dow Research Institute, Strasburg, France; Arsobal 
(melarsoprol) diluted in rapeseed oil, supplied by Specia Ltd., 
Paris; Trypacide and Trypacide Pro-salt (quinapyramine) RMB, 
Dagenham, England; melarsonyl potassium (Trimelarsan, Specia, 
Paris) and Mel Cy which has no generic name as it is under
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experimental study (Rhone Merieux, Toulouse, France). The drugs 
were all prepared according to the manufacturers recommendations 
so that the requisite amount (mg/kg) could be administered at a 
dose of 0.05ml per/5g bodyweight, and the drugs were administered 
either orally, intraperitoneally or subcutaneously. The mice 
were injected either at the early stage or chronic stage of 
infection.
Preparation of Clones
This experiment was carried out to prepare clones of 
T. evansi, from the stabilates GVR 72, GVR 74 and GVR 75 and two 
drug-relapsed stabilates of GVR 74 named GVR 87 and GVR 91 (see 
the history of the trypanosomes) (Figures 34, 35 and 36).
Groups of five mice were irradiated with 600 rads (cobalt-60
c
source), the mice were infected with at least 1 x 1 0  
trypanosomes of each stabilate to be cloned. The parasitaemias 
were high within a few days. Initially, a mouse with a high 
parasitaemia was bled into heparin so that the blood did not clot 
and the blood was kept on ice, and was diluted in PBSG.
For each stabilate one 96 well "NUNC plate" with lid was 
used. The cloning operation was carried out by filling the two 
outside rows with water (approximately 200ul) so that the 
atmosphere in the plate would remain saturated and delay 
evaporation of the very small drops containing the trypanosomes. 
The first four wells of each row were used and down the side of 
each well 30ul of PBSG, was carefully introduced so that it 
formed a bead. A pointed needle was taken and dipped into the 
diluted trypanosomes solution and a microdroplet was transferred 
into the first four wells, so that it was beside but not into,
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TREU 1412
Isolated from a camel, Hadaliya, Kassala P r o v i n c e ,  Sudan, 23.03.77
Mice 1x 
Rate 11x 
CTVM 0 5 .0 4 .7 7
TREU 1412
I Mice Ix
GVR 72 (Reserve Stabilate)
Mice 1x
GVR 72 (Working Stabilate)
Mice 6x
Cloned 29.11.85
GRVPS 19
Fig. 34 History of T. evansi TREU 1412 and clone GVRPS 19
TREU 1445
Isolated from camel, Hadaliya, Kassala Province, Sudan 19.04.78
Mice 10x 
Rate 2x
CTVM 2 7 .0 5 .7 8  
|  Mice 1x
TREU 1445
J  Mice 1x
GVR 75 (Reserve Stabilate)
^  Mice 1x
GVR 75/1 (Working Stabilate)
I Mice 5xCloned 29.11.85
GRVPS 23 
GRVPS 24  
GRVPS 25
Fig. 35 History of T. evansi TREU 1445 and clones GRVPS 23, 24, 25
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Fig. 36  History of T. evansi TREU 1444 and seven cloned isolates.
Isolated
Cloned
GRVPS 13 
GRVPS 14
TREU 1444
from camel Hadaliya, Kassala Province, Sudan 19.04.78
Mice 3x
Rata 8x  
CTVM 2 8 .0 5 .7 8
I mice 1x
i mice
TREU 1444
mice 1x
GVR 74 (Reserve Stabilate)
^  mice 1x
GVR 74/1 (Working Stabilate)
Relapsed a lter Ro 15 -6547 t/m ent 
Cloned In mice
Relapsed after suramin t/m en t 
Cloned in mice
GRVPS 16 
GRVPS 18
GRVPS 26 
GRVPS 27 
GRVPS 28
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the bead of PBSG. These droplets were examined using an inverted 
microscope. Each droplet was searched thoroughly and those wells 
containing only one trypanosome in the droplet were marked whilst 
the plate was still in position under the microscope. A second 
observer was invited to check the drops and if a single 
trypanosome was confirmed, the droplet and the bead of PBSG were 
mixed. Then a further 100ul of PBSG were added and the total 
volume was taken up into a 1.0ml syringe. The liquid containing 
the single trypanosome was injected intravenously into an 
irradiated mouse, ensuring that the complete contents of the 
syringe was inoculated. The used plate was discarded and a fresh 
plate was taken for each isolation.
Examination of the infected mice was carried out by wet- 
films of the tail blood from day 2 onwards. Blind passage was 
done every three days by taking the maximum amount of blood 
(approx. 1.0ml) and transferring it by injection into another 
irradiated mouse until a population of trypanosomes adequate for 
cryopreservation, was obtained i.e. until circulating 
parasitaemia became high (> log 8.0).
The mice were killed at this peak parasitaemia by cervical 
dislocation. The chest was cut open and the main arteries and 
veins to the heart were cut. Also several cuts were made in the
heart. Blood collected was pooled and kept on ice. The amount
\
of blood was measured with a pipette and glycerol, to a final 
concentration of 12.5% as cryopreservative was added. The blood 
and glycerol were mixed well, and left for a few minutes. The 
blood-glycerol mixture was taken up into capillaries and both 
ends were sealed in a hot flame by forming a terminal bead.
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Capillaries were put into plastic tubes, with four holes and 
a square of gauze in the bottom. The plastic tubes were 
suspended in the vapour phase of liquid nitrogen and slowly 
frozen. They were stored finally, in the vapour phase of liquid 
nitrogen, following the proposals of Dar, Lighthart and Wilson 
(1972) and Dar, Wilson and Goedbloed (1973).
The clones were each named under the Veterinary Physiology 
trypanosome research code, GRVPS (see Table 23).
Table 23
Relation between various stabilates of T. evansi and GRVPS clones
Original stabilates Clones made
GVR 74 GRVPS 13
[TREU 1444] GIVPS 14
GRVPS 15
GVR 87 QIVPS 16
[TREU 1444] GRVPS 17
Relapse after RO 15-6547 GRVPS 18
GVR 91 GRVPS 26
[TREU 1444] GRVPS 27
Relapse after suramin GRVPS 28
GVR 72 GRVPS 19
[TREU 1412]
GVR 75 GRVPS 23
[TREU 1445] GRVPS 24
- GRVPS 25
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Infectivity Test of the Stabilates
Occasionally, some difficulty was encountered in the 
infectivity of cryopreserved stabilates, because some of the 
organisms were either killed by shock during the process of 
cryopreservation or they revealed very slow activity during the 
suspension of the trypanosome i.e. before they were inoculated 
into normal recipient mice.
Infectivity tests on all prepared stabilates were carried 
out and for each stabilate groups of 15 mice were infected. The 
infecting dose was 1 x 104 trypanosome in 0.2ml of PBSG injected 
ip, and the' prepatent period and the behaviour of each stabilate 
was studied. There was a total of 13 stabilates used and none 
gave a good infection at the first attempt.
In most of the stabilates, death of the organism was 
observed, immediately after suspension in PBSG. Therefore a new 
solution of PBSG (15% glucose) was prepared which contained an 
addition of 20% foetal calf serum (20%) and Minimum Essential 
Media (MEM). This PBSG preparation improved the condition of 
some of the stabilates while others were still unsatisfactory 
after thawing from the frozen stabilate giving low numbers of 
motile trypanosomes with lots of dead trypanosomes. The results 
also showed that in some of the stabilates the numbers of 
trypanosomes rapidly declined after being prepared in PBGS and 
MEM while others were stable in the solution of PBSG and foetal 
calf serum.
Five stabilates proved to be in good condition after 
employing the later preparations (solution of PBSG and 20% of 
foetal calf serum and MEM) and these stabilates were used for the
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experiments recorded in this section of the thesis.
I. Sensitivity of five cloned evansi stabilates to 
quinapyramine (Trypacide sulphate)
The objective of this experiment was to examine the 
sensitivity of the five cloned T^_ evansi stabilates (GRVPS 1 3, 
GRVPS 18, GRVPS 19, GRVPS 23 and GRVPS 27) to quinapyramine at 
three different dose levels of 0.05, 0.5 and 5mg/kg administered 
on day 7 of the infections.
All non-treated infected controls were removed from the 
experiment after making Giemsa stain smears weekly for four 
weeks.
A summary of the results on the use of quinapyramine with 
the five cloned stabilates is given in Table 24. Treating seven 
day-old infections of T. evansi GRVPS 13 with 0.05mg/kg dose 
level of quinapyramine showed an initial removal of the parasites 
from the circulation but relapses occurred in all mice between 
day 23-40 after treatment. Similar relapses occurred when 
quinapyramine at 0.5mg/kg was administered. However, no relapses 
occurred when the mice were treated with 5mg/kg.
-In the case of T^_ evansi GRVPS 18 infections all the mice 
relapsed after being treated with 0.05mg/kg but when 0.5kg of the 
drug was given only three out of five mice relapsed, while in the 
5mg/kg treatment group, four out of five mice were permanently 
cured.
In fact it would appear that the "suram in-re lapse GRVPS 27" 
was slightly more resistant to quinapyramine than the original 
stabilate, while the "nitroimidazole-relapse GRVPS 18" was
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Table 24
Sensitivity of murine infections with five stabilates of 
T. evansi to quinapyramine sulphate when administered 
seven days after infection
Group T.evansi 
stabilates
Dose rate 
mg/kg
Cured/
Treated
Day of relapse
0.05 0/5 23,25,32,35,40
1 GRVPS 13 0.5 0/5 35,47,47,54,75
5 5/5 -
0.05 0/5 28,28,30,30,54
2 GRVPS 18 0.5 2/5 40,61,75
5 4/5 47
0.05 0/5 All remained +ve
3 QKVPS 27 0.5 0/5 23,23,28,35,35
5 5/5 -
0.05 0/5 All remained +ve
4 GRVPS 19 0.5 2/5 47,54,61
5 4/5 47
0.05 0/5 All remained +ve
5 GRVPS 23 0.5 2/5 49, 49, 100
5 5/5 -
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perhaps slightly more sensitive.
T. evansi GRVPS 27 was totally insensitive at 0.05mg/kg 
Trypacide. All mice relapsed at 0.5mg/kg, after initial 
disappearance of the parasite. 5mg/kg was high enough to clear 
blood parasites immediately and to give permanent cures.
T. evansi GRVPS 19 was completely insensitive when treated 
on day 7 with 0.05mg/kg of the drug and the mice remained 
positive. However, after an initial clearance of the parasites, 
three out of five mice relapsed following treatment with 0.5mg/kg 
dose level whilst four out of five mice were cured (80%) at the 
5mg/kg treatment level.
In the case of evansi GRVPS 23 infections 0.05mg/kg 
failed to clear the parasite from the circulation. However, 
using 0.5mg/kg of the drug, after an initial clearance of 
infection, three out of five mice relapsed. All mice were cured 
using 5mg/kg trypacide sulphate, thus proving that this stabilate 
was also sensitive to quinapyramine.
II. Sensitivity of two stabilates of evansi to six 
trypanocidal drugs
(a) Quinapyramine (Trypacide)
In this experiment two stabilates (GRVPS 13, GRVPS 19) which 
showed the greatest differences in sensitivity to quinapyramine 
were treated on day 7 and day 21 after infection with six 
different trypanocidal drugs at various dose levels. Treatment 
with Trypacide sulphate of T. evansi GRVPS 13 at day 7 and day 21 
after infection produced permanent cures at the dose rate of 
5mg/kg and this confirmed the sensitivity of this stabilate to
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the drug quinapyramine.
When the same dose rate of 5mg/kg of Trypacide sulphate was 
used to treat the evansi GRVPS 19 the treatment on day 7 cured 
four out of five mice. However, when the treatment was delayed 
until day 21 after infection, all five mice were permanently 
cured (see Table 25).
Chemotherapy of both evansi GRVPS 13 and 1 9 infections 
with Trypacide Prosalt demonstrated that if treatment was 
initiated seven days after infection then Trypacide Prosalt at 
5mg/kg could clear the parasites and give permanent cures. 
However, when the treatment was delayed until day 21 after 
infection a few relapses occurred with both stabilates.
(b) Diminazene Aceturate (Berenil)
Permanent cures were produced when 10mg/kg of diminazene 
aceturate (Berenil) was used to treat T. evansi GRVPS 13 
infections on 7 and 21 days after infection. However, when 
T. evansi GRVPS 19 infections were treated with diminazene 
aceturate at 10mg/kg, on day 7 and day 21 after infection, one 
out of five mice relapsed from the day 7 and three out five mice 
from the day 21 treatments (see Table 25).
(c) Iscmetamidiixn (Samorin)
Treatment with isometamidium (Samorin) of evansi GRVPS 13 
infections indicated permanent cures when the treatment was 
started on day 7 after infection at 1 mg/kg, but when the 
treatment was delayed until day 21 after infection, two out of 
the five mice relapsed. On the other hand when isometamidium was 
used to treat evansi GRVPS 19 infections at the same dose rate 
(1 mg/kg) two out of five mice relapsed after treatment on day 7
201
Table 25
Sensitivity of two stabilates of T-_ evansi to 
various trypanocidal drugs
Drug
Dose
mg/kg GRVPS 
Day 7*
Stabilate 
13 GRVPS 19 
Day 21 Day 7 Day 21
Quinapyramine 
(Trypacide Sulphate)
5 mg/kg 5/5** 5/5 4/5 5/5
Quinapyramine 
(Trypacide Prosalt)
5 mg/kg 5/5 3/5 5/5 3/5
Diminazine
aceturate
(Berenil)
10 mg/kg 5/5 5/5 4/5 2/5
Isometamidium
(Samorin)
1 mg/kg 5/5 3/5 3/5 1/5
Melarsoprol 
(Arsobol)
3.6 mg 
x 4 days
5/5 5/5 5/5 5/5
Difluoromethyl- 
omithine (DFMO)
2% soln. 
(5-19 days)
5/5 - 5/5 -
Suramin 20 mg/kg 0/6 0/5 S / 5 0/5
40 mg/kg 0/6 0/6 5/5 2/5
80 mg/kg 1/6 0/6 - -
160 mg/kg 6/6 0/5
* Day of treatment
** Cured/treated
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and four out of five mice relapsed after treatment was given on 
day 21. This result confirms the difference in sensitivity of 
the two stabilates to this drug.
(d) Melarsoprol (Arsobalf Mel B)
Melarsoprol (Arsobal) (diluted with rapeseed oil) was used 
against an early infection of T. evansi GRVP 13. The treatment 
was begun five days after infection and drugs were given daily 
for four consecutive days i.e. day 5,6,7 and 8. The result 
indicated permanent cures. When the treatment was delayed until 
day 21 the same result of permanent cures was obtained. This is 
in contrast with the findings with 21 day-old T^ _ brucei 
infections, were 4 x 3.6mg/kg failed to permanently cure any of 
the mice (Jennings, 1988). Moreover, a collateral experiment 
carried out using T. evansi GRVPS 19 stabilates infections with 
similar dose rates of melarsoprol and the same days of treatment 
also demonstrated permanent cure of the mice. This result showed 
that this drug is effective against experimental murine Surra,
(e) PifluorcHDethylornithine (DEMO)
The effect of oral difluoromethylornithine (DFMO) 
administration for 14 days was studied. The administration of a 
2% solution of DFMO in the drinking water was begun on day 5 
after infection in both T. evansi stabilates, GRVPS 13 and 
GRVPS 19. All mice receiving 2% DFMO in drinking water showed a 
rapid clearance of circulating trypanosomes and were permanently 
cured during a period of observation of 114 days for both 
stabilates.
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(f) Suramin (Moranyl)
As it was already known the GRVPS 13 was suramin-resistant, 
different dose rate levels of suramin (40, 80, 1 60mg/kg) were 
used to treat infections of T. evansi GRVPS 13, and the mice were 
monitored for relapse infections. It was found that mice 
infected with evansi GRVPS 1 3 and treated with 40mg/kg of 
suramin at day 7 and day 21, failed to clear the circulating 
parasitaemias. It was also found at higher doses of suramin up 
to 80mg/kg and 160mg/kg were still unable to produce permanent 
cures of T. evansi GRVPS 13. (Although 160mg/kg is approaching 
the maximum tolerated dose).
Two different dose levels of 20 and 40mg/kg of suramin were 
given to mice infected with T^_ evansi GRVPS 1 9 stabilate, on 
day 7 and day 21. Both dose levels on day 7 treatment, 
demonstrated 100% cures, however, when the treatment was delayed 
until day 21, three out of five mice relapsed at 40mg/kg and all 
the mice relapsed in 20mg/kg. This illustrates that early 
infections of T^ evansi are more readily treated than are the 
more established infections.
III. Studies of chemotherapeutic activity of Mel Cy and Mel W 
against both early and late infections of T. evansi
The results of groups of mice infected with T^ evansi 
GRVPS 13 and treated with various dose ranges of Mel Cy and 
Mel W (Trimelarsan) are shown in Table 26.
The mice treated with dose rates of 20, 10, 5, 2.5, 1.25, 
0.625 and 0.3125 mg/kg of Mel Cy on day 7 and day 9 after 
infections were permanently cured.
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Table 26
'Hie sensitivity of the arsenicals, Mel Cy and 
Trimelarasan against early (7-9 DAI) and late (21 DAI) 
infections of T. evansi GRVPS 13
Group
Dosage
mg/kg
Treated
DAI
Number Cured/Total Treated 
Mel Cy Trimelarsan
A 20 9 5/5 5/5
B 10 9 5/5 5/5
C 5 9 5/5 5/5
D 2.5 9 5/5 5/5
E 1.25 7 4/4 5/5
F 0.625 7 5/5 5/5
G 0.3125 7 5/5 3/5*
H 40 21 4/4 5/5
I 20 21 5/5 5/5
J 10 21 5/5 5/5
K 5 21 5/5 5/5
L 2.5 21 4/4 3/4**
* relapsed 49 & 49 days after treatment
** relapsed 73 days after treatment 
Observed for 60 days (Groups A to G) and 100 days (Groups H to L) 
after treatment
DAI - Days after infection
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The lowest dose used was effective against the stabilate 
used in this experimental work. However, it is reasonable to 
assume that the dose range of the drug could be further reduced.
The response of the other groups of mice infected with the 
same stabilate of evansi GRVPS 1 3 and then treated with the 
corresponding dose ranges of another compound, Trimelarsan, was 
also interesting. The first six groups of mice covering the 
range of dosages of 20mg/kg to 2.5mg/kg were permanently cured, 
and no breakthrough was observed up to the termination of the 
experiment. However, two out of five mice treated with 
0.3125 mg/kg (see Table 26) both showed circulating trypanosomes 
only on day 49 after treatment. However, 60% of the mice treated 
with this dose were cured.
Another experiment was carried out to test the efficacy of 
the two compounds, Mel Cy and Trimelarsan, against more chronic 
T. evansi infections in mice.
Mice, infected with evansi GRVPS 13 were treated with 
various dose ranges of Mel Cy (40, 20, 10, 5 and 2.5 mg/kg) after 
21 days of infection. The parasites disappeared from the blood 
1-2 days after treatment and the blood remained free of 
trypanosomes until the end of the experiment, which was 100 days 
of observation (see Table 26). It was interesting to note the 
absence of toxic reactions even at the 40 mg/kg dose level of the 
drug in mice, which is a higher dose rate than can be 
administered to larger animals. One mouse died before treatment 
from group L and another mouse died the day after treatment.
Following the same procedure, mice infected with T. evansi 
GRVPS 13 were given Trimelarsan. The dose rates and the day of
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treatment were the same as Mel Cy treatment. This compound 
exhibited a high therapeutic activity against the stabilates of 
T. evansi. All doses removed the parasites from the blood of the 
infected mice. Monitoring the infection by the diagnostic 
methods used in this thesis, the blood remained negative until 
the end of the experiment (14 weeks). Only one mouse relapsed on 
day 73 after treatment with 2.5 mg/kg of Trimelarsan. Another 
mouse died at treatment (see Group L).
IV. Period of prophylaxis given by Trypacide Prosalt against 
T. evansi infections
This experiment was designed to study the period of 
prophylaxis which a single dose of Trypacide Prosalt could give 
against an experimental infection with T^ evansi.
So that all the groups of mice could be infected on the same 
day, the injections of the Trypacide Prosalt was staggered at two 
weekly intervals. Two groups of five mice were each injected 
with 2.5mg/kg or 5.0mg/kg Trypacide Prosalt on 0, 2, 4 and 6 
weeks and then all the groups of mice were challenged with 
T. evansi at week 8; corresponding to 2, 4, 6 and 8 weeks 
after treatment.
Two stabilates, T. evansi GRVPS 18 and GRVPS 19, were used 
to challenge the mice.
The results are shown in Table 27 and show that using 
2.5mg/kg Trypacide Prosalt with the stabilate T. evansi GRVPS 18 
one mouse out of five became infected at two weeks and at four 
weeks and it was only at six weeks that all 5/5 mice were 
infected.
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Table 27
The prophylactic period conferred by quinapyramine 
(Trypacide Prosalt) against T^ _ evansi (3?VPS 13 challenge
Weeks after 
treatment
Drug dose 
(mg/kg)
Number of mice infected 
after challenge with 
GRVPS 18 GRVPS 19
0 0 5/5 5/5
2 2.5 1/5 1/5
5.0 0/5 0/5
4 2.5 1/5 3/5
5.0 0/5 2/5
6 2.5 5/5 5/5
5.0 1/5 2/5
8 2.5 5/5 5/5
5.0 5/5 5/5
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In the case of T\_ evansi GRVPS 1 9 using 2.5mg/kg Trypacide 
Prosalt, 1/5 mice became infected at two weeks, 3/5 at four weeks 
and all 5/5 at six and eight weeks. Therefore it would appear 
that 2.5mg/kg cannot give prophylaxis for even a period of two 
weeks and certainly not beyond four weeks. The results also show 
that evansi GRVPS 18 is more sensitive to Trypacide than 
GRVPS 19.
Using a dose level of 5.0mg/kg the prophylactic period 
against T^ evansi GRVPS 18 was at least six weeks when only 1/5 
mice became infected. In the case of T^ evansi GRVPS 1 9 the 
prophylactic period does not extend beyond two weeks, although 
some mice failed to become infected at both four and six weeks.
V. Studies on chemoprophylactic activity of Mel Cy against 
T. evansi infections in mice
This experiment was designed to determine the protection 
period which Mel Cy could confer against a challenge with a 
T. evansi stabilate. The results of groups of mice treated with 
30 mg/kg of Mel Cy and then challenged with T^ evansi GRVPS 13 at 
approximately weekly intervals after administration of the drug 
are summarised in Table 28.
As can be seen from the table all the mice challenged on 
week 4, 3 and 2 after treatment became infected and at one week 
four out of the five became parasitaemic. Those challenged three 
days after treatment failed to become infected indicating a 
prophylactic period for this dose rate of only three days.
The parasitaemia of the trypanosome-positive mice from the 
week one challenge, remained scanty for about 48 days (i.e. one
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Table 28
Hie prophylactic period conferred by Mel Cy against 
challenge with evansi GRVPS 13
Time 
after 
Mel Cy 
treatment
Mel Cy dose 
mg/kg
No. of mice infected 
after challenge with GRVP 13
3 days 30 0/5
1 week 30 4/5
2 weeks 30 5/5
3 weeks 30 5/5
4 weeks 30 5/5
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trypanosome per ten fields). However when blood was taken from 
one of these mice and inoculated intraperitoneally into five 
naive recipient mice, all these mice developed high parasitaemias 
nine days after infection. These infections caused mortality in 
the mice by 23-27 days which was very similar to the 
pathogenicity of the original stabilates. Some of the mice 
showed debility after two weeks of infection. However, this 
experiment demonstrated the inability of Mel Cy to protect the 
mice against T^ evansi for any significant period of practical 
value when administered as a water-soluble injection of 30 mg/kg. 
DISCUSSION
From its inception, quinapyramine consistently yielded good 
results against natural infections of Surra (Pellegrini and 
Bonelli, 1951; Ray, Short, Shivnani and Hawkins, 1953; Novinska, 
1961; Auguadra, 1963).
The activity of the soluble quinapyramine dimethesulphate 
against most of the trypanosomes pathogenic to livestock in 
Africa was demonstrated experimentally by Curd and Davey (1949; 
1950), and in field trials by Davey (1950).
Investigating the sensitivity of five cloned evansi 
stabilates to quinapyramine at different dose levels has produced 
some interesting results (Experiment I). Three out of the five 
stabilates showed 100% sensitivity while the remaining two showed 
80% sensitivity at 5mg/kg of quinapyramine. It was noted that 
0.05mg/kg was not effective against these stabilates and 
moreover, similar failures occurred at the 0.5mg/kg dose level, 
which although it cleared the circulation of trypanosomes 
immediately after treatment, allowed many of the mice to relapse.
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The results of this experiment clearly demonstrated that the 
highest dose level (5mg/kg) of quinapyramine can eliminate the 
parasitaemias caused by the five cloned stabilates and effect 
permanent cures.
This experiment also indicated that, although all the 
stabilates tested were cured by 5mg/kg of quinapyramine, there 
were minor variations in sensitivity between the various 
stabilates. It was also encouraging to see that GRVPS 13 which 
was a derivative of TREU 1444 was sensitive to quinapyramine as 
this stabilate is highly resistant to suramin (see history of the 
clones) (Abebe et al., 1983).
A significant problem in the chemotherapy of animal 
trypanosomiasis is the failure of some drugs to eliminate the 
parasitaemia from infected animals if treatment is delayed. 
However, Jennings, Whitelaw and Urquhart (1977a) showed that 
treatment, if given late in T. brucei infections (21 days) may 
fail to remove a cryptic focus of trypanosomes residing in the 
brain, which subsequently gives rise to a relapse parasitaemia 
once the drug concentration has fallen below a critical level.
The results of experimental studies, with six different 
trypanocidal drugs against mouse infections of T. evansi GRVPS 13 
and T. evansi GRVPS 19 (Experiment II) showed varying 
trypanocidal activities when treated on day 7 compared with 
day 21.
Melarsoprol (Mel B) diluted for administration to mice by 
mixing with rapeseed oil and difluoromethylorinithine (DFMO) used 
chemotherapeutically against early infections (day 7) and delayed
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infections (day 21) of both T. evansi GRVPS 13 and T. evansi 
GRVPS 19 stabilates illustrated their effectiveness against these 
parasite stabilates. This is in contrast with the finding with 
the pleomorphic T. brucei infections and might possibly indicate 
that monomorphic evansi do not penetrate into the central 
nervous system (CNS) at least during the first 21 days of the 
infection.
This aspect was investigated in a later experiment 
(Section II) in which groups of black mice (C57 Bl) were 
infected with Tj_ evansi and treated with 40mg/kg of diminazine 
aceturate given 60 days after infection.
It has been shown that DFMO is remarkably effective in 
curing acute trypanosomiasis. This is true not only in the case 
of infections with the veterinary trypanosomes. T^_ brucei and 
T. congolense, (Schillinger and Gorton, 1984) but also those 
which mainly affect humans, rhodesiense and gambiense 
(Sjoerdsma and Schechter, 1984).
The quinapyramine (Trypacide sulphate) was effective against 
T. evansi GRVPS 13 and evansi GRVPS 19 at a dose rate of 
5mg/kg after administration or either 7 or 21 days after 
infection. Trypacide sulphate, which again became available 
recently, is the only available alternative in suramin-resistant 
T. evansi infections in camels. Trypacide Prosalt at 5mg/kg also 
provided an effective cure against evansi GRVPS 13 and 
GRVPS 19 after treatment on day 7 and day 21.
Both quinapyramine sulphate and prosalt are used against 
T. brucei and T. evansi infections, but resistance to this drug 
is widespread, and this has been confirmed by many workers
x
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including Gill (1971). In equines, quinapyramine can be 
administered by giving 4.4mg/kg in 10% solution, divided into two 
subcutaneous doses, the second half at a different site five or 
six hours after the first (Leach and Roberts, 1981).
Diminazene aceturate (Berenil), which is more active against 
T. congolense and vivax, was used against the two strains of 
T. evansi (GRVPS 13 and GRVPS 19). All doses given to T. evansi 
GRVPS 13 produced permanent cures, while relapses were observed 
in both early and delayed treatments of evansi GRVPS 19 
infections. There was a difference of sensitivity of the two 
stabilates, T. evansi GRVPS 13 being resistant to suramin and 
sensitive to diminazene aceturate while evansi GRVPS 1 9 is 
sensitive to suramin and relatively resistant to diminazene 
aceturate.
Isometamidium (Samorin) which was once described as "an 
irritant but valuable drug against animal trypanosomes" (Boyt, 
1971) was used successfully at 5 mg/kg against evansi GRVPS 13 
and T^_ evansi GRVPS 19 infections. Only a few reports have 
indicated high activity of the drug against evansi in dogs 
(Srivastava and Malhotra, 1967). However, the results obtained 
from the present tests showed its remarkable effectiveness in 
curing early infections of T. evansi GRVPS 13. In spite of this, 
the delayed treatment of T. evansi GRVPS 13 and, both early and 
delayed treatment of evansi GRVPS 19 have shown a slightly 
reduced effectiveness of the drug. Balis and Richard (1977) 
carried out trials in guinea pigs and dromedaries in Ethiopia 
with isometamidium chloride and they found that it was curative
214
in guinea pigs at a dose rate ranging from 0.25mg/kg body weight. 
Their experiments in dromedaries were extremely disappointing and 
from their results one, could conclude that isometamidium was 
only moderately active against T. evansi infections.
The results of early treatments against T^  evansi GRVPS 19 
infections indicated its sensitivity to suramin, but in contrast, 
the delayed treatments of both evansi GRVPS 19 and T^_ evansi 
GRVPS 13, and the early treatments of T. evansi GRVPS 13 
infections demonstrated their resistance to suramin.
However, the results obtained from Experiment III indicated 
that Trimelarsan and Mel Cy are highly effective and can easily 
cure both early and chronic infections of T. evansi and so could 
be added to the available compounds useful in treating Surra, and 
especially suramin-resistant strains.
Many authors including Williamson (1980) have recommended 
the employment of the arsenicals against T^_ evansi strains. 
Later, Schillinger and Rottcher (1986) obtained remarkable 
results from camels infected with T^ evansi and treated with a 
melaminyl arsenical compound (melarsoprol). The results obtained 
with the two melaminyl compounds (Trimelarsan and Mel Cy) in this 
thesis and those of Schillinger and Rottcher (1986) indicate that 
the arsenical compounds could be used as a reliable therapeutic 
agent against T. evansi infections. One possible explanation for 
the arsenical compounds high activity against T^ _ evansi 
infections, is that these compounds were never used extensively 
in the field.
Leese (1927) has described adverse side effects of the 
arsenical compounds, but both compounds (Mel Cy and Trimelarsan)
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used in these experiments showed neither side effects nor 
toxicity in all dose ranges given to the infected mice.
The minimum effective dose level of Mel Cy has still to be 
determined in the mouse model as the lowest doses used against 
the stabilate in this study were effective.
The results of these experiments suggest that further 
studies should be done especially in camels infected with 
suramin-resistant strains of T. evansi. Also it would be wise to 
study the side effects and toxicity of the drugs in camels under 
field conditions.
There has been little published on the prophylactic activity 
of quinapyramine prosalt (Trypacide Prosalt) against infections 
of T. evansi (Surra) in both experimental or naturally infected 
animals. The main reason for this could be due to the withdrawal 
of this drug (Antrycide) from the market for a considerable 
period and its only recent reintroduction.
Wilson (1984) reported that Antrycide only provided a 
relatively short period of prophylaxis. Other workers however, 
claim that Antrycide Prosait could give cattle protection against 
trypanosome infection for up to twelve months (Lodha and Singh, 
1963? Fernandez et al., 1965 and Woo, 1977). The explanation for 
this conflict of opinion may be possibly due to variations in the 
risk of infection and the degree of susceptibility of the local 
strains of trypanosomes.
After many years of field experience with naturally infected 
animals, MacLennan (1970) recommended that the drugs used as a 
curative and a prophylactic should be chemically different. If
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one recognises this point, the limited number of drugs available 
for treatment of T. evansi infections, restricts the possibility 
of utilising a chemoprophylactic approach.
In Experiment IV it would appear that 5.0mg/kg dose of 
quinapyramine prosalt (Trypacide Prosalt) confers reasonable 
protection for at least four weeks against a relatively sensitive 
strain of T. evansi but only two weeks against a more resistant 
strain.
A dose of 2.5mg/kg could not be recommended as a 
prophylactic dose in mice, but as the relationship of effective 
dose between cattle and that in mice has still to be evaluated it 
is highly probable that the recommended dose of 0.5mg/kg would 
confer a reasonable period of prophylaxis in cattle.
The study (Experiment V) testing the prophylactic activity 
of Mel Cy against T^ evansi infections in mice unfortunately 
failed to demonstrate any protection beyond three days.
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CHAPTER FOUR
STUDIES ON THE CHEM3THERAPY OF T. evansi INFECTIONS
SECTION H
FURTHER STUDIES IN GOATS AND MICE
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INTRODUCTION
The control of African trypanosomiasis in domestic animals 
largely depends on the effective use of chemotherapy and 
chemoprophylaxis (Holmes and Torr, 1988). This is particularly 
so in the case of T. evansi infections because the control of the 
principal vectors is impractical (Nieschulz, 1 929; Sergent and 
Donatien, 1922). However, as no new drugs have been marketed for 
the last 30 years and because of the small range of drugs 
suitable for use in T. evansi infections there is a major problem 
in the control of the disease. Furthermore there are reports of 
drug resistance, as judged by the failure of trypanosomes to 
disappear from blood or the detection of parasitaemia at 
comparatively short intervals of time after treatment (Trail 
et al.r 1985).
The need for improved diagnostic techniques, the development 
of new drugs and/or the improved use of trypanocidal drugs 
presently available has been recommended on many occasions. A 
further series of experiments were conducted on evansi 
infections. The development of an isolation unit at the 
University of Glasgow Veterinary School licenced for work with 
trypanosome infected ruminants provided an opportunity to conduct 
some of these studies in goats, as well as mice. Following the 
success of the new arsenical compound Mel Cy in mice (Section I) 
an experiment was conducted in goats to test its therapeutic 
activity against T. evansi in a ruminant host (Experiment VI).
It is a common feature in both animal and human 
trypanosomiasis for the parasite to be temporarily absent from 
the blood circulation for a period, only to be followed by
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recrudescence of the parasitaemias. A similar behaviour can also 
be attributed to drug-resistance, which appears to be acquired by- 
exposure of the trypanosomes to inadequate trypanocidal dosages 
(Whiteside, 1962a). Sometimes the relapse infections retain 
equal sensitivity to the drug as the first infections.
This latter relapse infection was reported by Jennings 
et al. (1977a, b) in T. brucei infected mice. The brain was 
found to be the site where the trypanosomes, which escaped the 
action of the drug, finally emerged and re-established the 
circulating parasitaemia (Jennings et al., 1979).
It is well established that T.b.brucei is a pathogenic 
trypanosome which penetrates the brain of animals in chronic 
infections. However, in the closely related species, T. evansi, 
incoordination in a dog infected by the parasites has been 
reported by Hutyara and Marek (1938). Later Innes and Saunders 
(1962), found T. evansi in the grey and white matter, and in the 
CSF of dogs. The latter two workers also mentioned that the CSF 
from infected horses caused infections when inoculated into rats.
However, little attention has been paid to T^ evansi 
infections so that less is known about the possible role of CNS 
involvement. The second experiment described here 
(Experiment VII) was designed to study whether or not during 
infections of T. evansi the parasite passes to the brain like 
T. brucei.
From its introduction up to the present time, isometamidium 
chloride has been shown to be efficacious against most of the 
pathogenic trypanosomes of cattle (Trail et al, 1985).
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In their extensive work on camel trypanosomiasis 
(T. evansi), Schillinger et al (1982) found a low trypanocidal 
action for isometamidium chloride against T. evansi infections in 
East African camels. These authors also emphasised the 
development of local toxicity reactions at the injection sites, 
temporary paralysis and shock reactions in the treated camels.
The effectiveness of Samorin in treating T^ evansi 
infections has also been described by Petrovskii (1974). However, 
the prospect of using isometamidium chloride against T. evansi 
infections in camels appears to be hampered by the severity of 
the toxic reactions. In contrast there is a growing awareness of 
the importance of T. evansi in cattle and buffaloes, particularly 
in Asia and this drug may be used there in the future.
To date, there is little evidence in the field indicating 
the existence of Samorin-resistant strains of T. evansi but it is 
possible this may emerge as a problem. An experiment was 
conducted in mice to determine whether it was possible to build 
up Samorin-resistance in two strains of T. evansi.
One of the strains T. evansi GRVPS 13 was highly resistant 
to suramin (Abebe et aJ, 1983) and the other strain T^_ evansi 
GRVPS 19 was initially slightly resistant to Samorin.
MATERIALS AND METHODS 
Mice
Details of the materials and methods used in the mice 
studies have been described in Section I of this chapter.
Goats
Details of the goats, their housing and maintenance and the 
measurements of parasitaemia, haematocrit, body temperature and
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body weight have been described in Chapter Three (Section II).
Trypanoscmes
The origins of the trypanosomes used in these studies have 
been described in Section I of this chapter.
VI. The therapeutic activity of Mel Cy in goats infected with 
T. evansi GKVPS 13/3
The aim of this study was to determine the efficacy of 
Mel Cy to treat goats infected with T^ _ evansi.
Three goats only could be used because of the limitations of 
accommodation in the isolation unit. Each goat was infected with 
T. evansi GRVPS 13/3 by the intravenous injection of 1 x 10^ 
trypanosomes. After sufficient time had elapsed to allow 
establishment of the infection the goats were treated with Mel Cy 
kindly provided by RMB Animal Health at a dose of 0.25mg/kg. The 
drug was dissolved in saline and administered by subcutaneous 
injection as a 0.25% (w/v) solution. At weekly intervals 
throughout the latter part of the study sublethally irradiated 
mice were subinoculated with blood (0.5ml) by intraperitonea 1 
injection in order to identify infections undetectable by 
standard microscopy.
The results of the three goats (179, 180 and 189) are 
presented in Figures 37, 38 and 39.
The prepatent period of goat 180 was 35 days whilst in 
goats 179 and 189 it was delayed until 44 and 42 days 
respectively. However, in the latter two goats subinoculation of 
their blood into irradiated mice on day 28 revealed they had 
circulating parasitaemias. When the goats had had patent
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parasitaemias for approximately three weeks they were treated 
with Mel Cy on day 61 post infection. Following this treatment 
the parasitaemias became undetectable by microscopy and 
subinoculation for at least 30 days. However before termination 
of the experiment all three goats had developed relapse 
infections which were detectable by mouse subinoculation. These 
were first detected on days 33, 33 and 29 post treatment in 
goats 179, 180 and 189 respectively.
Measurement of body temperature revealed a brief period of 
pyrexia at approximately 20 days post infection. Intermittent 
pyrexia was later detected in goat 189 but not in the other two 
animals. Similarly a fall in haematocrit was found at 
approximately 20 days post infection and two goats (179 and 180) 
had two other brief periods of anaemia. However in general the 
infection was of low pathogenicity and body weights were not 
adversely affected with the exception of a brief period of weight 
loss in goats 179 and 180 at about 20 days post infection (see 
Figures 37, 38 and 39.
VIC. The treatment of chronic evansi infections in mice
Twenty C57 B1 mice were infected intraperitoneally with 
1 x105 T. evansi GRVPS 13, prepared from the frozen stabilate. 
Tail-blood from the mice was examined for trypanosomes by the wet 
film technique for about 60 days prior to chemotherapy. At 60 
days after infection, 40 mg/kg of diminazene aceturate (Berenil) 
which is known not to penetrate through the blood-brain barrier 
was given to the mice.
Tail blood was examined every second day for 120 days after
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chemotherapy to determine whether relapse infections developed.
The results are presented in Table 29. The prepatent period 
of the 20 infected C57 B1 mice was between 13-17 days.
Following the onset of patent parasitaemia there was a 
remission of the infection and the number of parasites in the 
blood circulation was low. This was followed by a long 
aparasitaemia period (28 days) during which no trypanosomes in 
the circulating blood were observed. Later, the reappearance of 
the parasites in the circulating blood was confirmed by tail- 
blood examination. It was after this that some of the mice had 
their maximum parasitaemias while others remained at low levels.
Ten highly parasitaemic mice died between 45-60 days after 
the initial onset of the infection. The remaining ten mice which 
were treated with 40 mg/kg of diminazene aceturate, were all 
permanently cured and no relapse infections were encountered 
through the whole period of observation of 120 days.
Table 29
C57 Bl mice infected with evansi GRVPS 13 
and treated with Berenil
No. mice Treated Dosage No. mice died No. cured/ Observation
infected DAI mg/kg before total days after
treatment treated treatment
20 60 40 10 10/10 120
DAI - Days after infection
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VIII. An attempt to decrease the drug sensitivity of evansi 
GRVPS 13 and GRVPS 19 by repeated subcurative treatments with 
iscmetamidium
Groups of normal and irradiated CD-1 mice were infected 
intraperitoneally with T. evansi GRVPS 19 and T. evansi GRVPS 13, 
prepared from frozen stabilates.
Ten passages and eight passages through normal and 
irradiated mice respectively were conducted and at each stage 
either similar or increased doses of isometamidium chloride were 
administered. Stabilates were prepared and stored in liquid 
nitrogen after each passage.
The Samorin dosages given to T^ evansi GRVPS 1 9 infected 
mice ranged between 0.001 - 5 mg/kg while the dose ranges given 
to T. evansi GRVPS 13 infected mice ranged between 0.001 - 
1.5 mg/kg of samorin. The exact experimental regimens are given 
in Figures 40 and 41.
The two stabilates GRVPS 13 and GRVPS 19 were tested at the 
beginning for their sensitivity to Samorin and it was found that 
both relapsed after treatment with 0.1 mg/kg. This dosage was 
taken as the starting point in producing a Samorin-resistant 
stabilate. At each relapse the trypanosomes were taken and 
inoculated usually into both irradiated and normal mice and the 
resulting infections subjected to increasing dosages of Samorin. 
The exact regimen varied between the two strains but the details 
are set out in Figures 40 and 41. It was found that the 
sensitivity of GRVPS 13 increased from 0.1 mg/kg at the beginning 
to 1.5 mg/kg while GRVPS 19 increased from 0.1 mg/kg to
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5.0 mg/kg.
DISCOSSICN
The course of Trypanosoma evansi infections in goats 
demonstrated that there were long pre-patent periods. However, 
the finding that blood subinoculated from the three infected 
goats, apparently aparasitaemic in the prepatent period, resulted 
in establishment of parasitaemias in irradiated recipient mice 
indicated that the parasites were present at a low level despite 
being microscopically undetectable. This finding substantiates 
the reports of Cross (1921a) and Kuppaswamy (1941) who described 
the course of T. evansi infections in goats as a chronic form in 
which the parasites are normally scanty in the circulating blood.
The temperature rise in the early stage of infection about 
day 20, when no trypanosomes were detected in the blood, and then 
the low but intermittent rise of temperature when the 
trypanosomes appeared in the peripheral blood, indicated that the 
pyrexia was not correlated with the number of trypanosomes.
It is perhaps possible that the high fever recorded during 
the prepatent period was, due to the tissue invasion of the 
parasites, as T^ _ evansi is known for its extracellular invasions.
Similarly the PCV values of the goats dropped during the 
prepatent period, but were later correlated with the parasitaemia 
to some degree.
All goats gained weight during the experiment. This weight 
gain was similar in all the goats. The therapeutic activity 
demonstrated by Mel Cy at a dose rate of 0.25mg/kg was reflected 
in the negative microscopical blood examinations for circulating 
trypanosomes. However, blood collected 30 days after treatment
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from all three treated goats and subinoculated into irradiated 
mice resulted in patent infections. Previously mice infected 
with a suramin-resistant strain of T. evansi and treated with the 
0.5mg/kg of Mel Cy recorded permanent cure. However, as the drug 
is still under experimental study, it may be possible that this 
dose rate 0.25mg/kg is not the optimum dose level to use for 
T. evansi infected ruminants.
The results of experiment VII indicated that infections of 
T. evansi are different from the closely allied T^_ brucei 
infections observed by Jennings et al (1977a; b). This work had 
shown that treatment with diminazene aceturate failed to 
permanently cure chronic infection of T. brucei in mice. 
However, with this T. evansi GRVPS 13 infection, permanent cures 
were obtained to chronic infections which indicates that no focus 
of infection such as in the brain remained in the mice which 
could re-establish parasitaemia. This does not correlate with 
those reports that record CNS involvement in T. evansi infections 
(Laveran and Mensil, 1912; Leese, 1927; Wilson, 1984) However, it 
is possible that 60 days does not allow sufficient time in the 
mouse for the establishment of a CNS infection.
It does, however, correlate with the work of Evans and 
Brightman (1980) who were able to clear a fairly chronic 21-day 
old infection of T^ evansi with SHAM-glycerol, which also 
suggested that there was no CNS involvement.
The development of resistant Trypanosoma strains is of great 
importance in view of the wide application of trypanocidal drugs. 
The results of experiment VIII indicate that in the laboratory
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the development of Samorin-resistance could be readily promoted 
by using irradiated mice infected with T. evansi rather than the 
normal mice infected with the same strain.
After T. evansi GRVPS 19 was passaged ten times and 
T. evansi GRPS 13 was passaged eight times through normal or 
irradiated groups of mice, receiving increasing dosages of 
Samorin, the two strains built up a high degree of Samorin- 
resistance, 5 mg/kg for T. evansi GRVPS 19 and 1.5 mg/kg for 
T. evansi GRVPS 13. Such rapid acquisition of Samorin-resistance 
was mainly observed in irradiated groups of mice. Furthermore 
the irradiated mice demonstrated the. shortest intervals between 
treatment and relapse infection and in some cases no 
aparasitaemic interval was observed and the mice died shortly 
after treatment. The interval period of the normal mice was 
longer than the irradiated mice and some normal mice did not show 
any relapse infection.
It would appear that the irradiated-infected groups of mice 
have lost their humoral immune responses to the disease and the 
treatment alone was not able to prevent rapid re-establishment in 
the irradiated mice while the combination of immune response and 
trypanocidal effects were able to slow up the re-establishment of 
the parasites in non-irradiated animals.
Similarly, Von Jansco and Von Jansco (1935) and Schnitzer, 
Laferty and Buck (1946) have suggested that the rapid-passage 
method of producing resistant strains in the laboratory may have 
an advantage because the rapidly emerging trypanosomes may avoid 
the effect of the host's immune response.
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The present experiment suggests that under laboratory 
studies, building up of Samorin-resistance may be promoted more 
readily in immunosuppressed mice than in normal mice.
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